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Abstract 
Tuberculosis (TB) is a deadly, yet curable, infectious disease that continues to be a global 
health threat. Armenia suffers from rising TB incidence and mortality rates. Armenians 
living in Los Angeles (LA) County, where TB incidence is higher than national averages, 
is the second largest Armenian community in the world; therefore implications are that 
many TB cases are attributed to this group. Using the social ecological model as a 
theoretical framework, this concurrent, mixed-methods study compared Armenians to 
non-Armenians in LA County about their knowledge of TB and perceived barriers to 
seeking and adhering to treatment. Bivariate chi-square analysis from online surveys of 
55 Armenians and 72 non-Armenians revealed significant differences in their source of 
TB knowledge and compliance upon diagnosis. Multinomial logistic regression analysis 
was completed using the following significant predictor factors: classification, home 
remedy use, age, education, and primary household language. Parallel, in-depth 
interviews of 10 Armenians and 8 non-Armenians further corroborated that, although 
both populations were aware that TB exists, knowledge relating to TB mode of 
transmission, global incidence, and treatment options was generally lacking. However, 
the Armenian population was more eager to help others and urge seeking treatment when 
receiving a positive diagnosis, whereas non-Armenians expressed lack of willingness to 
physically assist patients. These findings have implications for positive social change, as 
they can inform the efforts of public health and health care entities in more effective 
disease management, resource allocation, and patient care. Such efforts should help 
decrease TB prevalence in the U. S. Armenian population and potentially Armenia.  
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Chapter 1: Introduction to the Study 
Introduction 
Tuberculosis (TB) is an ancient, communicable disease that has adversely 
affected humanity for centuries. Antiquated terms used to describe this disease 
characterized by wasting include phthisis by the ancient Greeks, tabes by the Romans, 
rajayakshma by the Hindus, and consumption in Victorian England (Nelson & Williams, 
2007, p. 653). Despite medical advances and extensive research into biological 
characterizations of the disease and the causative agent, Mycobacterium tuberculosis, TB 
continues to be a detriment to the health of modern society. 
TB is one of the world’s deadliest, yet curable, diseases. In 2014, there were an 
estimated 6.0 million new cases of TB and 9.6 million total who fell sick with the disease 
(either from active or latent forms), 5.4 million of which were men, 3.2 million were 
women and 1.0 million were children (World Health Organization, 2015). In total, there 
were 1.5 million TB-associated deaths, ranking alongside HIV as the leading cause of 
death worldwide, primarily afflicting those living in low- and middle-income countries 
(Centers for Disease Control and Prevention, 2012b; WHO, 2015). In developed 
countries, disease management has improved and therefore new infections have declined; 
however, significant morbidity and mortality associated with disease persists, particularly 
in susceptible populations (WHO, 2012b).  In both developed and developing countries, 
the populations most susceptible to TB infection and complications with treatment 
include HIV/AIDS patients, immigrants, the homeless, low socioeconomic populations, 
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and those in correctional facilities. In 2014, of the 1.2 million deaths associated with 
HIV, 400,000 (one-third) were co-infected with TB (WHO, 2015). 
In particular, the Eastern European country of Armenia is adversely affected by 
tuberculosis and complications associated with the emergence of multi-drug resistant 
(MDR-TB), extensively drug resistant TB (XDR-TB), and total drug resistant TB (TDR-
TB). The World Health Organization (WHO) has designated Armenia as one of the 18 
high-priority countries for TB control among the WHO’s European Region and the top 
27 in MDR-TB burden countries in the world (Hayrapetyan, 2012). In 2010, Armenia’s 
Ministry of Health (MOH) began working in conjunction with Stop TB in order to reduce 
TB incidence in the country by taking control of the National Tuberculosis Programme, 
NTP, (WHO, 2013). Furthermore in 2011, Armenia’s MOH joined and participated with 
other health ministries from at-risk Eastern European countries in establishing annual 
TB-related symposia (Medecins Sans Frontieres, n.d.). Efforts in Armenia are ongoing to 
improve the national health care infrastructure in order to strengthen the program’s 
impact on disease incidence and associated morbidity and mortality. 
TB incidence in Los Angeles County (LA County) is higher than national 
averages. In 2013, there were 667 confirmed cases (7.0 per 100,000), which is higher 
than California’s case rate of 5.7 per 100,000 and more than twice the national of 3.0 per 
100,000 (California Department of Public Health, 2015; County of Los Angeles Public 
Health, 2015; Salinas et al., 2016). Furthermore, the Armenian population in this area, 
particularly in the City of Glendale, is the second largest Armenian community in the 
world, second only to Yerevan, Armenia (Hayk the Ubiquitous Armenian, 2012). Based 
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on the high Armenian population and high disease incidence in the community, the 
implications are that many of the TB cases are attributed to Armenians living in the area. 
Therefore, the study explored the perceived barriers to TB treatment-seeking and 
treatment-adherence among Armenians living in LA County, barriers that could impact 
TB incidence among the target population. Using a concurrent, mixed-methods study 
including in-depth surveys, ethnography (qualitative), and questionnaires (quantitative), 
Armenians and non-Armenians living in LA County were interviewed to gain a better 
understanding of their TB knowledge and perceived barriers to treatment. Differences 
between Armenians living in LA County and non-Armenian populations with respect to 
physical, psychosocial, cultural, or behavioral factors and beliefs may impact TB 
knowledge, treatment-seeking, and treatment-adherence. Thus, public health approaches 
to treating and decreasing TB incidence in this population would be influenced. The 
implications for social change involve decreasing TB incidence and prevalence in the 
Armenian population within the United States, and potentially within native Armenia, 
through more effective disease management, resource allocation, and patient care efforts. 
Such approaches and efforts may be extended to other diseases as well. 
The following overview covers disease history, current trends in TB research, 
including diagnosis, genetic variants, treatment and therapy, susceptible populations, and 
major barriers to treatment seeking and treatment compliance, both in developing and 
developed countries, particularly Armenia and the United States, respectively. A more 
thorough review of many of these topics is presented in Chapter 2. Next, brief 
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descriptions of the study’s purpose, theoretical framework, research questions and 
hypotheses, assumptions, limitations, scope, and significance will be discussed.  
Chapter 3 is devoted to a more thorough discussion of research methodology for 
this study. Chapter 4 is centered on addressing the research questions and hypotheses, 
including data collection and detailed analysis using statistically-derived findings. 
Finally, Chapter 5 is a review of the study’s purpose, methodology, and research 
questions with interpretations of the data and the study’s implications for social change. 
Background 
Disease History and Etiology 
TB has historical negative implications on the health of mankind. Dating back to the 
Middle Ages, TB incidence has experienced fluctuations due to associated time-specific 
events, for example the HIV/AIDs pandemic in the 1980s, or changes in public health 
practices (Beltz, 2011, pp. 208–209). If left untreated, active  TB—and latent TB 
infection (LTBI) upon reactivation—can be deadly, with mortality rates of up to 50% 
(Beltz, 2011, p. 211). 
In 1882, Robert Koch discovered the causative agent of tuberculosis, Mycobacterium 
tuberculosis (Mathema, Kurepina, Bifani, & Kreiswirth, 2006). M. tuberculosis is a slow-
growing obligate aerobic bacillus with a thick waxy cell envelope that is readily 
transmitted through aerosols: coughing, sneezing, laughing, talking, or singing.  It’s 
primary targets are  the lungs and respiratory tract, where only a few viable bacilli are 
required to initiate infection (CDC, 2012a). Inhalation of released mycobacteria may 
result in active (primary) or latent infection, with one-third of those exposed becoming 
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infected and 10% becoming symptomatic (Mathema et al., 2006). Primary active 
pulmonary TB may take several weeks from the time of exposure; it manifests as a 
persistent illness with bloody sputum and shortness of breath. With latent TB, 
mycobacteria are present but go dormant and infected individuals are asymptomatic 
(CDC, 2012a). A weakening of the immune system years later may cause bacterial 
replication to take over and persist, leading to reactivation and ultimately active 
pulmonary TB infection (Paulson, 2013). 
Diagnosis, Therapy, and Prevention 
TB diagnosis and detection may be achieved through several avenues, depending 
upon available resources, infrastructure, extent of infection, and bacterial load. Active 
pulmonary TB is traditionally diagnosed through smear microscopy or culture-based 
methods of sputum specimens (Ferguson et al., 2016).  While microscopic analysis of 
sputum samples is rapid, cheap, and specific, it suffers from low sensitivity, particularly 
for specimens with low bacterial load (paucibacillary), cases of extra-pulmonary TB, and 
analysis in microscopy centers or voluntary counseling and testing centers (VCTs) with 
minimal infrastructure (Niemz, Ferguson, & Boyle, 2011). Culture-based methods have a 
greater degree of sensitivity but are limited by the time taken to culture the slow-growing 
TB bacterium, which may take 4–6 weeks (Nelson & Williams, 2007, p. 656). The longer 
turnaround time presents a major hurdle to effective disease treatment and patient case 
management (Niemz & Boyle, 2012).  
Some nonculture–based methods for TB diagnosis include chest X-rays, Mantoux 
tuberculin skin tests, and nucleic acid testing (NAT).  For chest X-rays, lesions in adults 
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are typically found on the apical or posterior portion of the upper lobes of the lungs 
(Beltz, 2011, p. 214). The Mantoux tuberculin skin test reveals a hypersensitive lesion 
from the injection of purified protein derivative (PPD) under the skin of the forearm. 
Previously exposed individuals or those who have been vaccinated will react to form a 
10mm reddened lesion 3 days post-PPD injection (Beltz, 2011, p. 214). While effective, 
neither method can discern between active and latent TB infections. 
NAT is rapidly emerging as the most sensitive, specific, and rapid method for TB 
diagnosis, including MDR-TB, particularly in developed countries, resulting in positive 
patient outcomes (Niemz & Boyle, 2012; Niemz et al., 2011; Schumacher et al., 2016). 
While gaining regard as the most reliable method for TB detection, NAT may be 
complicated by cell physiology (including sample preparation and nucleic acid isolation), 
specimen type and pathogen load, patient age, and HIV-1 co-morbidity (Ferguson et al., 
2016; Niemz & Boyle, 2012). Current NAT may use the polymerase chain reaction 
(Ling, Flores, Riley, & Pai, 2008) or isothermal amplification schemes such as loop-
mediated isothermal amplification (Boehme et al., 2007, 2010), cross-priming 
amplification (Fang et al., 2009), helicase-dependent amplification (Ao et al., 2012; 
Motré, Kong, & Li, 2011; Torres-Chavolla & Alocilja, 2011), or transcription-mediated 
amplification (Pfyffer, Kissling, Wirth, & Weber, 1994). Cepheid’s GeneXpert MDR/RIF 
is a fully integrated NAT-based system that has received WHO’s endorsement for TB 
diagnosis and rifampin-resistant testing in laboratories of developing countries, and has 
undergone large-scale rollout in high-TB-burden countries, notably South Africa 
(Kingsley, 2011). Since the massive rollouts of the GeneXpert, time to treatment 
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initiation, particularly for Rif-resistant MDR-TB, has been decreased significantly, 
improving treatment outcomes (Stagg et al., 2016). 
Morbidity and mortality are highly associated with a rigorous treatment regimen, 
drug resistance, and nonadherence (Phillips, 2013). M. tuberculosis contains a thick waxy 
cell envelope that is highly impermeable to antibiotics and the bacilli may be present in 
various stages of growth: actively growing, semi-dormant, and dormant (Nelson & 
Williams, 2007, p. 666). Therefore, drugs with different modes of action are required for 
effective treatment and treatment must be adhered to for 6–12 months. This, in 
conjunction with hepatotoxicity from an extensive drug regimen, results in treatment 
nonadherence and the emergence of drug resistance (MDR-TB, XDR-TB, or TDR-TB). 
First-line TB drugs include isoniazid, rifampicin, pyrazinamide, streptomycin, 
ethambutol, and thiacetazone. The first three are bactericidal and the last three are 
bacteriostatic (Nelson & Williams, 2007, p. 666). As resistance to the first line of drugs 
began to emerge, second-line treatment for TB was developed. Second-line treatment 
involves fluoroquinolones or injectable drugs such as amikacin, kanamycin, or 
capreomycin (Warren et al., 2009). Worldwide, the incidence of single-drug resistant TB 
ranges from 0–56% and MDR-TB from 0–23% of TB cases, with the highest incidence 
of MDR-TB cases in the Soviet Union, Eastern Europe, and China (WHO, 2008). XDR-
TB, which is resistant to fluoroquinolone, rifampicin or isoniazid, and any of the three 
injectables and TDR-TB, began emerging in 2006 and 2009, respectively (Udwadia, 
Amale, Ajbani, & Rodrigues, 2012; Velayati et al., 2009). 
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In 1995, the WHO and StopTB initiated the Direct Observed Therapy Short 
Course (DOTS) in an effort to improve adherence through patient supervision by 
healthcare workers (Naidoo, Dick, & Cooper, 2009). With DOTS, health care workers 
are assigned to monitor patients closely and actively observe that patients are taking each 
prescribed dose of the antituberculin medication. While DOTS was initially viewed as an 
effective means to manage patient compliance, it is now viewed as flawed. Much of the 
inconsistency in DOTS’ success is attributed to lagging government involvement, 
insufficient resources, and insufficient support systems (Naidoo & Mwaba, 2010). 
Susceptible Populations and Reported Barriers 
Populations highly susceptible to TB infection and complications with treatment 
in both developed and developing countries include HIV/AIDS patients, immigrants, the 
homeless, drug users, low socioeconomic populations, and those in correctional facilities. 
Reported psychiatric and psychosocial factors affecting treatment adherence include 
poverty, disease coinfection (e.g., cardiovascular, HIV, hepatitis), social stigma, 
unsupportive social and work environments, disbelief in the health facility and staff, 
helplessness, hopelessness, and depression (Fry et al., 2005; Kandula, Dworkin, Carroll, 
& Lauderdale, 2004; Naidoo et al., 2009). Molecular factors also play a role, where 
genetic variation in both host and pathogen are highly influential in the efficacy of 
disease transmission (Mathema et al., 2006). Many such studies have been conducted on 
a variety of susceptible populations, including various ethnicities; however, TB 
prevention studies specific to Armenians living within the United States and in their 
native country are lacking. 
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Current State of TB in Armenia 
In Armenia, TB continues to be a major public health challenge, with escalating 
incidence and mortality rates. In 2011, there were an estimated 55 newly reported cases 
per 100,000 and a mortality rate of 8.8 per 100,000 (WHO, 2012a) with a growing 
burden of MDR-TB (WHO, 2014). Of the newly diagnosed TB cases in Armenia, 
roughly 9.4% were found to be MDR-TB and 43.0% of previously treated cases became 
MDR-TB (Truzyan, Crape, Grigoryan, Martirosyan, & Petrosyan, 2015; WHO, 2015). 
The country of Armenia faces several challenges in achieving adequate TB control: (a) 
high incidence of MDR-TB, (b) low socioeconomic status among its population, (c) 
emigration/immigration, (d) lack of public awareness, (e) HIV/AIDS co-infection, (f) 
poor hygiene, (g) unsanitary conditions, and (h) transmission in children (Ministry of 
Health of Republic of Armenia, 2007; WHO, 2015). While there is a fundamental 
understanding about some of these national hurdles, deficiencies remain. As a result, this 
controllable and curable disease is proving to be national health threat to Armenians. As 
Armenians immigrate to other countries, including the United States, infected individuals 
pose an international health risk to everyone they come in contact with. 
Current State of TB in the United States 
In the United States, TB is a highly managed disease where all 50 states and U.S. 
territories are mandated to report TB cases (Myers, Westenhouse, Flood, & Riley, 2006).  
All states have TB control programs that report to the national surveillance systems, the 
Online Tuberculosis Information System (OTIS) and the National Prevention Information 
Network (NPIN). As a result, TB incidence in the U.S. is at its lowest since the 1950s 
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when national surveillance was first implemented. From 1985–1992, the United States 
experienced a resurgence of TB, which was accompanied by MDR-TB and to a lesser 
extent, XDR. In 2015, 9,563 cases of TB were reported in the United States, an increase 
from the 9,406 cases reported in 2014 but a decline from the 10,528 cases reported in 
2011 (CDC, 2012d; Salinas et al., 2016). This is promising but falls short of goals set by 
the CDC. In 1989, its Strategic Plan for the Elimination of Tuberculosis called for 
complete eradication by 2010. However, the goal has been hindered by the resurgence of 
TB due to the HIV/AIDS epidemic, increased immigration by individuals from countries 
in which the disease is endemic, MDR-TB, and transmission in congregate settings 
(CDC, 2011). In 2011, 62% of all TB cases in the United States were attributed to 
foreign-born persons, where the case rate for foreign-born persons was estimated to be 
11.5 times higher than among U.S.-born individuals. MDR-TB cases has shown a 
decrease since surveillance began in 1993 with 1.3% of cases showing resistance to 
multiple drug treatments (CDC, 2012d). The cost of hospitalization for an XDR TB 
patient in the United States was estimated to average $483,000, approximately twice the 
cost for MDR TB patients. Due to TB’s limited response to antibiotics, mortality rates 
among XDR patients parallel those of TB patients in the pre-antibiotic era (CDC, 2009a). 
California has one of the highest incidence rates of TB in the United States (CDC, 
2013). In 2013, TB incidence in California was estimated to be 7 cases per 100,000, of 
which 30.5% were located in LA County (County of Los Angeles Public Health, 2015). 
LA County has a high population of immigrants, where native countries may have 
endemic TB. Many immigrants enter the United States without reporting latent or active 
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disease for fear of being deported. Therefore LA County has a high incidence of both 
latent and active TB, particularly in clustered communities. Furthermore, the homeless 
population is highly susceptible due to a nomadic lifestyle and insufficient tracking for 
continuous treatment. LA County is home to one of the largest homeless populations, 
particularly in Skid Row, where recent spikes in TB have been experienced 
(“Tuberculosis Outbreak Among Homeless In Los Angeles, Calif. [VIDEO],” 2013). 
LA County’s Department of Public Health Tuberculosis Control Program (TBC) 
has a multifaceted control program that concentrates on disease surveillance and 
epidemiology.  The program includes vital case reporting into the TB registry, MDR-TB 
treatment and monitoring, screening of refugees and immigrants entering the county, 
health education for medical staff and at risk communities regarding disease treatment 
and recognition (both latent and active forms), and legal enforcement of noncompliant 
carriers and offenders who may be putting communities at risk for disease transmission 
(including homeless populations). Such an approach is essential for achieving the 
program’s vision of eliminating TB from “indigenous and resident populations”  (Los 
Angeles County Department of Public Health, n.d.). It is a nationally and internationally 
renowned program due to essential elements such as assigned Extended Role Nurses 
(ERN) who are made available to help ensure treatment compliance.  Enlisted specific 
health care facilities throughout LA County are equipped with specialized staff and 
equipment to support program needs, and provide informational and educational 
programs for staff and the community (Nitta & Davidson, 2003). 
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Research Gap 
A gap exists in understanding the factors that influence treatment-seeking and 
adherence among Armenians living in LA County. By better understanding the perceived 
barriers to seeking treatment and adhering to it, it is expected that TB health outcomes in 
this susceptible population will be greatly improved both domestically and in their native 
country, where TB-associated morbidity and mortality is high. There are also significant 
public health implications for implementing improved TB prevention efforts in the 
Armenian community, as well as other immigrant populations. 
Problem Statement 
Despite national and statewide efforts to reduce TB, its incidence in California 
remains the highest in the United States (CDC, 2013). Of the 2,169 reported cases in 
California in 2013, 662 cases (30.5%) were located in LA County (County of Los 
Angeles Public Health, 2015). The LA County Department of Public Health’s 
(LACDPH’s) Tuberculosis Control Program actively performs surveillance of TB cases, 
particularly in immigrant populations, and provides treatment throughout the course of 
the disease. The City of Glendale, located within LA County, has experienced the largest 
influx of Armenians nation- and world-wide. There are an estimated 80,000 Armenians 
and their descendants living in Glendale, making it the second largest Armenian 
community on the planet, behind only Yerevan, Armenia (Hayk the Ubiquitous 
Armenian, 2012). Despite the availability of publicly funded TB diagnosis and treatment, 
18% of all new TB cases (118 cases) in LA County in 2013 were found in Glendale and 
surrounding cities within the Service Planning Area (SPA-2) (County of Los Angeles 
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Public Health, 2015). While the number of TB cases within SPA-2 hasn’t been clearly 
defined as Armenian or non-Armenian, the implication that many of these cases are 
attributed to Armenians is based upon their prevalence in the community and the disease 
incidence in their native country. Therefore, the overall purpose of this study was to use 
mixed-methods research to explore differences in barriers to treatment-seeking and 
compliance in Armenians versus non-Armenians, with a potential impact on TB 
prevalence within the local Armenian community. 
Purpose of the Study 
The purpose of this concurrent mixed-methods study was twofold: (a) to explore 
the differences in factors (physical, psychosocial, cultural, or behavioral) relating to TB 
knowledge, treatment-seeking and adherence in Armenians versus non-Armenian 
residing in LA County and (b) how such differences may impact the reduction of TB 
incidence in this susceptible population. For this mixed-methods study, a survey was 
utilized to explore whether such barriers to treatment-seeking and adherence differed 
between Armenian and non-Armenian individuals residing in LA County, with potential 
implications for reduction in disease incidence. This was followed by the qualitative 
component involving in-depth interviews of both Armenians and non-Armenians living 
in LA County to understand general perceptions about TB, along with perceived barriers 
to TB treatment and treatment adherence in both groups. 
The qualitative portion of this concurrent mixed-methods study was an 
ethnography where shared beliefs, behaviors, and knowledge relating to TB treatment-
seeking and adherence among Armenians were explored. The study is also aligned with 
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phenomenology, where Armenians’ individual experiences of TB were described by the 
interviewees and subsequently grouped thematically. In-depth interviews were conducted 
using the social ecological model, SEM (discussed below), and the belief or behavioral 
patterns of the culture-sharing Armenian group in Glendale and surrounding areas, For 
the quantitative portion of the study, the association between the dependent variable—
knowledge about TB treatment seeking and treatment adherence— and the independent 
variables—barriers or factors relating to TB treatment seeking and adherence—were 
explored using a survey questionnaire. Such factors included demographic (Armenian 
versus non-Armenian), socioeconomic, cultural, behavioral, and/or individual beliefs. 
Furthermore, (a) differences in such perceived barriers and (b) characteristics of other 
non-Armenian populations were assessed. 
Research Questions and Hypotheses 
This mixed-methods study addressed the following research questions and tested 
the associated null and alternative hypotheses: 
1. What are the perceived barriers to treatment seeking and adherence for 
tuberculosis in an Armenian population living within the United States? 
2. Is there a difference in barriers to treatment seeking and adherence for 
tuberculosis in Armenian versus non-Armenian populations living in Los Angeles 
County and which factors (e.g., physical, cultural, psychosocial, behavioral) have 
the greatest influence? 
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HA2: There are differences in factors relating to treatment-seeking and 
adherence for tuberculosis in Armenian versus non-Armenian populations 
in Los Angeles County. 
H02: There are no differences in factors relating to treatment-seeking and 
adherence for tuberculosis in Armenian versus non-Armenian populations 
in Los Angeles County. 
In the quantitative study (RQ2), the dependent variable, knowledge about TB 
treatment-seeking and treatment-adherence, was explored in relation to the independent 
variables, barriers, or factors about TB treatment-seeking and treatment-adherence. A 
more detailed discussion of the research questions and associated hypotheses is addressed 
in Chapter 3. 
Theoretical and Conceptual Framework  
Theoretical Framework 
The theoretical framework used for this study was the SEM. SEM is widely used 
in public health and incorporates key principles from community- and individual-based 
approaches of prevention, with emphasis on the environment. Here, four interrelated 
factors are addressed: (a) the individual and risk behaviors, (b) relationships, (c) 
community and environment, and (d) societal /cultural norms. Several studies involving 
TB transmission amongst various populations across the United States have been 
reported (Hawker, Bakhshi, Ali, & Farrington, 1999; Myers et al., 2006). 
Studies involving decreasing the transmission of TB or other infectious diseases 
have also used grounded theory (Daftary, 2012; Daftary & Padayatchi, 2012; de Souza & 
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Guerreiro Vieira da Silva, 2011; Dodor & Kelly, 2010; Johansson & Winkvist, 2002; 
Onifade et al., 2010); the Theory of Social Stigma (Castro & Farmer, 2005); or the  
theory of social determination (de Queiroz, De-La-Torre-Ugarte-Guanilo, Ferreira, & 
Bertolozzi, 2012). However, SEM is a more dynamic and applicable model. TB, in 
particular, is a dynamic disease that involves personal factors (e.g., biology, personal 
competence, resilience), social factors (e.g., family influences, social norms), and 
sociocultural-environmental factors (e.g., socioeconomics, cultural identity, knowledge, 
and motivation), all of which SEM accounts for. 
Conceptual Framework 
The qualitative portion of the mixed-methods study is grounded by ethnography, 
with aspects of phenomenology. Ethnography-based approaches are well-suited for this 
study due to the emphasis on social interactions, behaviors, and perceptions within a 
particular group (Reeves, Kuper, & Hodges, 2008). Phenomenology explores what and 
how something is experienced by a particular population, as individuals, and are then 
universally grouped based on reported experiences (Creswell, 2012, p. 76). For this 
study, in-depth interviews of Armenians and non-Armenians living in LA County were 
conducted to gain insight into perceived barriers to treatment-seeking and treatment-
adherence for TB. Currently, there are no reports in the literature describing this, despite 
the high incidence of TB in Armenia. The current literature discusses psychosocial and 
psychiatric barriers in other ethnicities and groups living in their native country and upon 
immigration to the United States. Such barriers and groups will be discussed in detail in 
Chapter 2. 
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When conducting ethnography, it is important to engage in cultural immersion to 
gain a better understanding of the native language and social norms. Having been raised 
with significant Armenian influences throughout my life, these experiences can be 
leveraged not only for accessing the population but also relating to participants. Further 
immersion involves the ability to converse with participants in their native language, if 
need be, and therefore Armenian language classes were taken concurrent with this study 
in conjunction with assistance from Armenian speaking family and friends. Both were 
critical for preparing the questionnaire and survey, pretesting the questionnaire and 
survey, and conducting final interviews with participants. 
The ethnography approach complements the aforementioned theoretical 
framework guiding the study, SEM. Here, the inter-relationship between intra-personal, 
interpersonal, sociocultural-environmental, and behavioral influences guided the 
framework. When addressing the independent variables of barriers to treatment-seeking 
and treatment-adherence for TB in the Armenian community, cultural influences and 
patterns may play an important role in behaviors and outcomes. Depending on the overall 
outcome of this study, findings may suggest that observed differences in barriers to 
treatment in the Armenian community versus non-Armenian community living in LA 
County are critical for effective disease management and subsequent reduction of TB 
incidence. 
Nature of the Study 
The intent of this concurrent, mixed-methods study was to identify differences in 
perceived barriers or factors (physical, psychosocial, cultural, or behavioral) in 
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Armenians versus non-Armenians (independent variable) for TB treatment-seeking and 
adherence (dependent variable), with potential implications for disease incidence and 
prevalence. In the study, perceived barriers and factors were explored using in-depth 
interviews with Armenians and non-Armenians in the community. The rationale for 
combining both quantitative and qualitative data was to better understand this research 
problem by converging broad numeric trends and detailed interview data in an effort to 
reduce morbidity and mortality associated with TB incidence and prevalence in 
Armenians.  
For the qualitative aspect of this project, ethnography-focused pursuits were 
implemented. Here, interviews were conducted with 10 Armenians and 8 non-Armenians 
in LA County to understand perceived barriers and factors relating to TB treatment and 
adherence. For the quantitative aspect of this project, 200 LA County residents were 
intended to be surveyed for differences in perceived barriers or factors to TB treatment 
and adherence; however, due to challenges in recruiting, only 127 LA County residents 
were ultimately recruited (55 Armenian and 72 non-Armenian). Initially, convenience 
sampling was exercised where Armenian family members and friends acted as 
gatekeepers for gaining access to subjects. Subjects for both parts of the study were both 
women and men, ranging in age from 21 to > 70 years old. Subjects were not current TB 
positive patients; however, patients who underwent treatment and were TB negative were 
not discouraged from participating in the study. 
19 
 
 
Operational Definitions 
Bactericidal: Describes the killing of bacteria; may be achieved by inactivating 
metabolic mechanisms or breakdown of cell wall (Nelson & Williams, 2007, p. 666). 
Bacteriostatic: Describes the non-killing mechanism that controls or stops 
bacterial cell growth or reproduction (Nelson & Williams, 2007, p. 666). 
Congregate Setting: Settings where people meet or gather, including the 
workplace, shelters, schools, social or recreational settings, or places of worship. They 
are treated as high TB-contact areas and special control measures are of interest (New 
Jersey Medical School National Tuberculosis Center, 2004). 
Direct Observed Therapy Short Course (DOTS): Observed treatment by medical 
staff to ensure treatment compliance throughout the required treatment duration, which is 
generally four to twelve months (Naidoo et al., 2009). 
Extensively Drug Resistant Tuberculosis (XDR-TB): TB resistant to 
fluoroquinolone, rifampicin or isoniazid, and any of the three injectables (capreomycin, 
kanamycin, and amikacin) (Velayati et al., 2009). 
First line antituberculosis drugs: Most commonly used treatment for TB. Drugs 
include isoniazid, Rifampicin, Pyrazinamide, Streptomycin, Ethambutol, and 
Thiacetazone (Nelson & Williams, 2007, p. 666). 
Health Insurance Portability and Accountability Act (HIPAA): Patient security 
and privacy act established in 1996 to protect the privacy of individually identifiable 
health information including date of birth, any portion of an address, date(s) of service, 
and diagnosis (Issel, 2009, p. 533). 
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Latent Tuberculosis Infection (LTBI): Asymptomatic form of TB that may 
become active at any time. Detectable using the PPD skin test (Nelson & Williams, 2007, 
p. 660). 
Los Angeles County Department of Public Health (LACDPH): Public Health 
Department serving LA County in California whose mission is “to protect health, prevent 
disease, and promote health and well-being” (County of Los Angeles Public Health, n.d.-
a). 
Multi-Drug Resistant Tuberculosis (MDR-TB): TB strains resistant to multiple 
anti-tuberculin drugs, both first line and second line (Mathema et al., 2006). 
Nontuberculous Mycobacteria (NTM): A group of microorganisms within the 
Mycobacterium genus that cause an array of diseases that include TB-like lung disease, 
lymphatic and systematic diseases, and disease of the bone, skin, or soft tissue. They are 
often misdiagnosed as M. tuberculosis (Raju, Raju, Zhao, & Rubin, 2016). 
Nucleic Acid Testing (NAT): Detection of a pathogen’s nucleic acids (DNA or 
RNA) for the rapid diagnosis of an infectious disease which generally involves sample 
preparation, amplification, and detection methods (Niemz et al., 2011). 
Paucibacillary: A low bacterial load of Mycobacterium tuberculosis bacilli in 
patients which compromises accurate disease diagnosis (Dam & Bose, 2002). 
Purified Protein Derivative (PPD): A solution prepared from cultures of tubercle 
bacilli. It was originally developed by Robert Koch in 1890 as a cure for TB and is now 
used as an intracutaneous injectable diagnostic for the Mantoux tuberculin skin test 
(Nelson & Williams, 2007, p. 661). 
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Second line treatment: Fluoroquinolones or injectable drugs, amikacin, 
kanamycin, or capreomycin (Warren et al., 2009). 
Service Planning Area (SPA): A geographic region within LA County of which 
there are eight. Due to the enormous size of the county, they are broken down to “develop 
and provide more relevant public health and clinical services targeted to the specific 
health needs of the residents in these different areas” (County of Los Angeles Public 
Health, n.d.-b). 
Social Ecological Model (SEM): A prevention framework developed by the CDC 
that accounts for interactions between individual, relationship, community, and societal 
factors (CDC, 2009b). 
Total Drug Resistant Tuberculosis (TDR-TB): Mycobacteria tuberculosis resistant 
to all available treatment (Velayati et al., 2009). 
Tubercle: Segregated region of the lungs produced by the host’s immune system 
for the containment of M .tuberculosis (Beltz, 2011, p. 222). 
Tuberculosis Control Program (TBC): LA County’s Department of Public Health 
TB prevention program launched in 1996 with a mission of preventing the “transmission 
of TB within LA County through early detection of active disease and treatment of latent 
infection” (Nitta & Davidson, 2003). 
Voluntary counseling and testing centers (VCTs): Primary health care facilities in 
high burden low resource settings which administer testing and counseling for HIV/AIDs 
and more recently, TB (African Medical and Research Foundation, 2013; Los Angeles 
County Department of Public Health, n.d.). 
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Assumptions, Scope, Delimitations and Limitations  
Assumptions 
A key assumption of this study was that Armenians residing in LA County, 
particularly in Glendale or SPA-2, are primary contributors to TB incidence in the region 
due to their high population in the area. Further collaboration with LACDPH’s TBC 
program are necessary to fully characterize case ethnicity specifics, without violating 
privacy laws covered by HIPAA, and are recommended for future studies. 
A second key assumption was that barriers to treatment-seeking and treatment-
adherence for Armenians will be different than what has been reported for other 
populations. Current barriers, as discussed previously, include HIV/AIDS status, 
immigration, socioeconomic status, disease co-infection, social networks, molecular co-
factors, and various psychiatric conditions, such as helplessness and depression. Coming 
from a strong Armenian upbringing, it is known that Armenians are a very tight social 
group, bound by traditions and internal social norms, many of them brought over from 
Armenia. Therefore, it is of great interest to see how these factors may influence 
perceptions regarding TB and TB seeking behaviors.  
Scope and Delimitations  
The study examined TB and barriers to treatment-seeking and treatment-
adherence in Armenians in LA County. While LA County houses the largest population 
of Armenians in the country and world—aside from Armenia itself (Hayk the Ubiquitous 
Armenian, 2012)—generalizability may be compromised. It is believed that this study 
involved a representative pool of Armenians living in the United States; however, social 
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and economic factors impacting the study may differ in Armenians living in other parts of 
the nation or world. 
Additionally, assumptions regarding TB incidence in LA County, particularly in 
SPA-2 were made, where case reports are being correlated with Armenian dominance in 
the area and disease trends in native Armenia. Currently, Armenians are classified with 
the White/Caucasian race and thus TB cases in LA County are reported as such. 
Therefore, determining patient ethnicity as Armenian on a case-by-case basis may be 
challenging and may be worth exploring in future studies.  
Limitations 
This study suffered from several limitations; they needed to be addressed and 
interpreted when deriving final conclusions. One key limitation of this study pertains to 
TB case reporting in LA County. While the actual numbers are up to date due to 
extensive reporting mandates by the county, determining patient ethnicity as Armenian 
on a case-by-case basis may be challenging. Currently, Armenians are classified with the 
White/Caucasian race. The current implications of the study rely on the fact that many of 
the cases within SPA-2 are attributed to Armenians based upon their prevalence in the 
community (Hayk the Ubiquitous Armenian, 2012) and disease incidence in Armenia 
(WHO, 2012a). 
Another limitation is that this study focused only on Armenians residing in LA 
County. LA County houses the largest population of Armenians in the country and world, 
aside from Armenia itself (Hayk the Ubiquitous Armenian, 2012); therefore, it is believed 
that the study involved a representative pool. However, the social and economic factors 
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impacting the study may not be generalizable to Armenians living in other parts of the 
world. 
Further limitations involve those factors that may threaten validity and reliability 
when conducting qualitative studies, including recall bias and sampling strategies 
(Creswell & Plano Clark, 2011, p. 211; Frankfort-Nachmias & Nachmias, 2008, p. 150). 
Recall bias may severely impact the study and overall outcomes should be addressed 
through appropriate instrumentation and surveys. Sampling strategies are another concern 
and may severely impact data analysis and results. Surveys and/or in-depth interviews 
with Armenians in the community were accessed through gatekeepers from family, 
church, and community groups to understand perceived barriers to treatment and follow-
up, including current knowledge base about the disease and accessibility from TBC. 
Conducting in-depth interviews also offer challenges including logistics, time, and 
rationalization and coding of responses. 
A final threat to validity and reliability involved instrumentation, which, in this 
case, was a questionnaire. An original questionnaire was generated to ensure cultural 
sensitivity and relevance to the Armenian community. This presented some challenges 
because there were no assurances about its validity and coherence.  Therefore, pretesting 
was required to ensure the questionnaire’s appeal and ease of comprehension. To remove 
some ambiguity, the questionnaire was provided in English and Armenian. The 
questionnaire for the non-Armenian group was also subjected to pretesting to address 
some of the same issues and to ensure clarity. 
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Significance of the Study 
TB morbidity and mortality are highly associated with treatment regimen and 
nonadherence. Varying growth patterns and specialized biological characteristics of M. 
tuberculosis create complex antibiotic treatments and chemotherapy that require up to 12 
months. DOTS was initiated in 1995 and continues to be promoted to improve patients’ 
adherence through the use of supervision by healthcare workers; however, success has 
been inconsistent due to lagging government involvement, available resources, and 
insufficient support systems (Naidoo & Mwaba, 2010). 
A thorough understanding of barriers and factors relating to treatment-seeking and 
adherence is vital for complete disease management and control. Barriers to TB treatment 
and treatment compliance for some immigrant populations have been discussed in the 
literature. Such barriers include gender (Onifade et al., 2010), social stigma (Daftary, 
2012; Dodor & Kelly, 2010), poverty and sub-standard housing, disease coinfection (e.g., 
cardiovascular, HIV, hepatitis), unsupportive social and work environments, 
incarceration, disbelief in the health facility and staff, helplessness, hopelessness, and 
depression (Fry et al., 2005; Kandula et al., 2004; Naidoo et al., 2009; Tupasi et al., 
2016). However, TB prevention studies are severely lacking for Armenians living in the 
United States and Armenia, particularly qualitative studies, which generate firsthand 
accounts of the social situation within the Armenian community.  
Positive Social Change  
This research fills the gap in understanding treatment-seeking barriers in this 
susceptible population, with potential public health implications for other diseases in 
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addition to TB. Implications for social change involve decreasing TB prevalence in the 
Armenian population in the United States—and potentially within native Armenia—
through more effective disease management, resource allocation, and patient care. 
Summary 
This chapter highlighted TB background and current trends relating to disease 
diagnosis, genetic variants, treatment and therapy, susceptible populations, and major 
barriers to treatment-seeking and treatment-compliance, in both developing and 
developed countries. Furthermore, barriers and factors relating to treatment-adherence for 
non-Armenian populations living abroad were discussed. This served to present the 
problem statement, research questions and hypotheses, significance of inquiry within an 
Armenian population, definition of terms, and the assumptions and limitations within the 
literature. 
Chapter 2 provides extensive background information on TB and discusses the 
literature in light of the current study’s research question, hypotheses, problem statement, 
and objectives. Specifically, this chapter will compare the literature on barriers to TB 
treatment-seeking and adherence in immigrant populations, though those specific to 
Armenians are severely lacking. Literature exploring the health system in Armenia, in 
conjunction with studies addressing other infectious diseases in Armenians in their native 
country and the United States, will also be explored in an effort to uncover social and 
behavioral trends that may be useful for the qualitative surveys. 
In Chapter 3, a more detailed discussion of study design, research methodology, 
participant sampling and instrumentation will be presented.  In Chapter 4, the results and 
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statistically-derived findings from the two study components will be presented in detail 
and related back to the research questions and hypotheses.  Finally in Chapter 5, a 
summary and interpretation of the study findings will be detailed, as well as 
recommendations for future research and implications for social change. 
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Chapter 2: Literature Review 
Introduction and Background 
TB is a deadly, yet curable, infectious disease. High morbidity and mortality rates 
are associated with a rigorous treatment regimen, nonadherence, and the emergence of 
resulting drug-resistant strains (Mathema et al., 2006; Sacchettini, Rubin, & Freundlich, 
2008). Highly susceptible populations in both developed and developing countries 
include the homeless, immigrants, HIV/AIDS patients, low socioeconomic populations, 
and those in correctional facilities. Increased susceptibility reflects inadequate medical 
care, poor living conditions, high incidence of multidrug resistance, loss to follow-up, or 
low treatment adherence (Beltz, 2011, pp. 206–207; Mathema et al., 2006; Sacchettini et 
al., 2008). Loss to follow-up and low treatment adherence are of particular interest to 
public health where a variety of approaches and barriers have been investigated in an 
effort to improve TB outcomes and disease surveillance, most notably DOTS (Nelson & 
Williams, 2007, pp. 685–688; WHO, 2010, 2012b), and improved diagnostics (McNerny, 
2011; Program for the Appropriate Technology in Health, 2011; Small & Pai, 2010). 
Armenia suffers from a high incidence of multidrug resistance TB and has 
therefore been by designated by the WHO as one of the 18 highest priority countries for 
TB control in the Europe Region (Hayrapetyan, 2012; WHO, 2012b). Furthermore, it is 
one of the top 27 countries in the world burdened by MDR-TB (Hayrapetyan, 2012). On 
the other hand, the County of Los Angeles in California suffers from relatively high TB-
incidence trends and ranks one of the highest in the country with 30.5% of the cases 
reported in California located in LA County (County of Los Angeles Public Health, 
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2015). Additionally, LA County is home to the highest population of Armenians, aside 
from Yerevan, Armenia’s capital and largest city. While TB data collected by the 
LACDPH’s Tuberculosis Control Program don’t differentiate Armenian as ethnicity, 
implications are such that this cultural group may contribute to the inflated incidence 
rates with LA County. Therefore, the goal of this study was to utilize a mixed-methods 
ethnography approach to explore differences in factors (e.g., physical, psychosocial, 
cultural, or behavioral) relating to TB knowledge, treatment-seeking and adherence in 
Armenians versus non-Armenian residing in LA County and how such differences may 
impact the reduction of TB incidence in this susceptible population. 
TB is a dynamic and historical disease that continues to perplex scientists and 
researchers seeking to reduce morbidity and mortality relating to the causative agent. As 
a result, the body of knowledge is expansive and continues to grow. The literature 
relating to TB covers disease epidemiology, breakthrough in diagnostics, hurdles 
associated with drug resistance, and problems associated with treatment adherence. Much 
of latter is done in the context of general susceptible populations (e.g., HIV positive, 
homeless, poor, immigrants, incarcerated), with little emphasis on specific cultures where 
familial influences and traditions may have a profound impact on TB knowledge and 
treatment adherence behaviors. Armenians, in particular, are a susceptible population 
with strong family influences; however, very few studies have been dedicated to this 
group. Susceptibility within this population relates to high incidence in their native 
country, inadequate health care, poor disease tracking, poor education regarding the 
disease, poverty, migrant workers, and immigration to foreign lands where assimilation 
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by this “hidden minority” may prove to be a challenge (Bakalian, 2011; Truzyan et al., 
2015; Vink et al., 2005). A few studies exist which explore TB-associated problems in 
their native country (Breitscheidel, 2006; Breitscheidel, Stamenitis, & Bosch, 2010; 
Ehlman et al., 2007; Grigoryan et al., 2008; Ministry of Health of Republic of Armenia, 
2007; Truzyan et al., 2015; Vink et al., 2005); however, to the best of my knowledge, no 
studies of Armenians living the United States were uncovered relative to TB or any other 
infectious disease where an ethnography approach was utilized for understanding 
Armenian patient health care seeking behaviors within an unfamiliar health care system.  
The following chapter presents a critical review of the literature in an effort to 
establish an understanding of the current state of TB in the developed and developing 
world, with particular interest in the Armenian community. The literature search strategy 
will be discussed which covers databases and key terms utilized for conducting the 
exhaustive search. Furthermore, support for the theoretical foundation and conceptual 
foundation will be discussed. Key variable and concepts relating to the study specifically 
will also be discussed, including concepts relating to both the qualitative and quantitative 
components of the study. A summarization of key findings in the literature will also be 
highlighted as a transition into the methodological approaches discussed in Chapter 3 is 
made. 
Literature Search Strategy 
Databases, Search Engines, and Keywords 
In conducting this exhaustive literature search, the databases used were Web of 
Science, PubMed/MEDLINE, Google Scholar, and Science Direct. The keywords were 
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as follows: tuberculosis, Armenia, education, epidemiology, theory, social ecological 
model, Eastern Europe, drug resistance, directly observed treatment, disease barrier 
Armenia, Armenia health barriers, Armenia United States disease, Armenia culture 
health, ethnographic study, Armenian culture, prison, tuberculosis HIV, tuberculosis 
immigrant, tuberculosis diagnostic, tuberculosis social determinants, tuberculosis 
stigma, tuberculosis treatment barrier, and tuberculosis behavior. Some common 
abbreviations included TB, MDR-TB, XDR-TB, TDR-TB, DOTS, and TB-HIV. The 
selected literature addressed key research goals, disease epidemiology, and identifying 
gaps in the literature. Documents were obtained via electronic download or interlibrary 
loan. As relevant documents were being downloaded, cataloging and subsequent 
categorization was done using the bibliographic software, Zotero (Roy Rosenweig Center 
for History and New Media, Fairfax, VA), which interfaces directly with word processing 
software to facilitate proper APA citation formatting throughout the writing process. 
Scope of the Literature 
A literature review based on the terms described above was an extensive and 
iterative process. Peer reviewed articles were searched and read, if they explicitly related 
to topics relevant to the scope of the study. Most of the literature searched was very 
current, spanning over the past 10 years. However, primary peer-reviewed articles cited 
numerous times by the more recent publications were also read in order to get a complete 
understanding of the concept addressed. This was particularly true when investigating 
theoretical foundation and conceptual framework. Background relating to TB 
32 
 
 
epidemiology and initial research in theoretical framework was also obtained from books 
addressing infectious diseases and theories in public health, respectively. 
Theoretical Foundation 
The theoretical foundation for this study is based upon the SEM (CDC, 2009b). 
SEM is a dynamic behavioral intervention model which focuses on the individual, 
community, the environment, and interactions thereof. TB is a dynamic disease that is 
influenced by the interplay of many factors including: personal factors (e.g., biology, 
personal competence, resilience), social factors (e.g., family influences, social norms), 
and sociocultural-environmental factors (e.g., socioeconomics, cultural identity, 
knowledge, and motivation). SEM is adaptable to many public health applications and 
has therefore been applied to a variety of public health intervention strategies. 
SEM has been used frequently in infectious disease and sociological 
epidemiology (Green, Lewis, & Bediako, 2005; Hosek, Harper, Lemos, & Martinez, 
2008; Murray, Oxlade, & Lin, 2011; Reifsnider, Gallagher, & Forgione, 2005). SEM 
epitomizes social epidemiology with ecological factors at its core that present integral 
principles that serve as a foundation for explaining potential causal relationships between 
disease and social and biological conditions (Krieger, 2001) and address complex 
community-based problems relating to health disparities (Green et al., 2005; Reifsnider et 
al., 2005). Here, key principles are incorporated from community- and individual-based 
approaches of prevention with an emphasis on the environment. As seen in Figure 1, 
SEM addresses four inter-related factors: the individual and risk behaviors, relationships, 
community and environment, and societal /cultural norms (CDC, 2009b). The individual 
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is central to the model where internal determinants such as knowledge, attitudes, and 
beliefs come into play. The next layer considers external forces attributable to 
interpersonal processes and relationships such as social interactions with family, partners, 
and friends. The next level of community includes individuals, businesses, institutions, or 
organizations that collectively form a social construct or community. Finally, the 
outermost level, social structure / public policy, incorporates environmental and/or 
governmental changes, to effectively influence change (California Department of Public 
Health, n.d.; CDC, 2009b). 
Figure 1. The four levels and main influences involved in the 
social ecological model (SEM).  Adapted from The Social-
Ecological Model: A Framework for Prevention - Violence 
Prevention - Injury Modified, by CDC, 2009b, Retrieved 
February 5, 2013, from 
http://www.cdc.gov/violenceprevention/overview/social-
ecologicalmodel.html. 
SEM has been more widely used for studies addressing many facets of TB 
transmission, treatment and prevention, including health disparities, ethnic differences, 
Societal 
(religion, culture, 
societal norms, 
policy)
Community 
(workplace, 
school, 
neighborhood)
Interpersonal 
Relationship 
(peers, family, 
partners)
Individual 
(biological, 
personal)
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socioeconomics, immigration, and psychosocial factors amongst various populations both 
nationally and internationally. More specifically, one relevant study by Myers et al. 
(2006) explores TB transmission in California using an ecological approach. Using the 
U.S. Census data for California, ecological variables such as racial/ethnic distribution, 
immigration, education level, employment status, poverty, and crowding were 
incorporated and related to new TB cases, using pediatric cases as a measurement of 
transmission. Overall, lower median incomes, racial/ethnic minorities, and immigrants 
were found to have higher rates of pediatric tuberculosis. While extremely relevant to this 
study, there was no differentiation of Armenians as an ethnicity so specific insight into 
this group is not provided. 
Other groups such as Hawker et al. (1999), Harling et al. (2008), Marx et al. 
(2007), Barr et al. (2001), Tupasi et al. (2016), and Holtgrave et al. (2004) have utilized 
SEM to investigate the impact of various ecological factors (namely poverty, SES, and 
ethnic differences) on TB transmission treatment adherence in a variety of populations in 
the United States and abroad. Again, none of these studies explicitly discuss any such 
factors within the Armenian community, either in the United States or Armenia. Murray, 
Oxlade, and Lin (2011) have expanded upon SEM and used mathematical modeling to 
further explore the dynamics associated with social, environmental and biological 
determinants of TB in an effort to improve intervention strategies. While the study has 
some limitations due to the static nature of mathematical modeling, associations between 
TB infection and smoking, indoor air pollution, alcohol use, diabetes, nutrition, 
crowding, migration, aging, and economic trends were projected (Murray et al., 2011). 
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Conceptual Foundation: Armenian Ethnography Elements 
One component of this mixed-methods study involved ethnography in relation to 
the Armenian culture. Distinctive with their shiny black hair, prominent nose, and the 
tell-tale “ian” (or variations thereof) at the termination of their familial name, Armenians 
are rich in close family bonds, cultural quips with ancestral origins, and the strength and 
desire to survive. Despite the Armenian genocide in 1915 by the Turks, the Spitak 
Earthquake of 1988, and the dissolution of the Soviet Union in 1991, Armenians have 
learned to come together in order to survive and move forward. Many of these historical 
events also resulted in the immigration of Armenians to other parts of the world, 
including the United States, Europe (e.g., United Kingdom), and Latin America. With 
immigration comes the desire to assimilate within the host society while also struggling 
to also maintain cultural identity. William Saroyan, a well-known American-Armenian 
author, epitomized Armenians best in a series of short stories in Inhale and Exhale” 
(1936, p. 438): 
I should like to see any power of the world destroy this race, this small tribe of 
unimportant people, whose wars have all been fought and lost, whose structures 
are crumbles, literature is unread, music is unheard, and prayers are no more 
answered. Go ahead, destroy Armenia. See if you can do it. Send them into the 
desert without bread or water. Burn their homes and churches. Then see if they 
will not laugh, sing, and pray again. For when two of them meet anywhere in the 
world, see if they will not create a new Armenia. 
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The Armenian genocide of 1915 not only is a significant part of the Armenian 
history but also contributes to the strong cultural identity and presence of Armenians. 
First-generation Armenians and genocide survivors have openly exercised their ability to 
share their experiences with next generations of family members and friends in an effort 
to keep their stories alive. With these stories and experiences, descendants of the victims 
and survivors have yet another common thread with which to weave their Armenian 
culture together with others regardless of where they live. Also interwoven within these 
stories are traditional beliefs about life, health, happiness, politics, social conduct and 
business that seem to transcend time; some with a scientific basis and others more 
folkloric. Armenians are also a very spiritual, yet superstitious, group of people and 
actively ward off bad or evil throughout their daily events, primarily through the use of 
the kapoot achk (blue eye) which wards off ill fortune brought about from the evil eye 
(Best Country Reports, 2011, p. 17). Regardless of the validity, such beliefs impact 
decisions that are made within their daily lives and must therefore be realized and 
understood when attempting to address or improve health outcomes. If a disease like TB 
is not understood (including symptoms, modes of transmission, and treatment) and an 
explanation is not culturally relevant, Armenians may rely upon the kapoot achk as the 
primary means of fighting the disease and therefore result in poor health outcomes. By 
integrating kapoot achk as part of the education and intervention plan, disease treatment 
seeking and adherence behaviors may improve. 
Several other events central to Armenian history which impact their health in 
particular are the Spitak Earthquake of 1988 and the crumbling of the Soviet Union in 
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1991. In fact, the fall of the Soviet Union is viewed as a major event that lead to the rise 
of TB and MDR-TB in that region (Phillips, 2013). While part of the Soviet Union, 
Armenians had access to free health care, though access for women was sparse. Once the 
Soviet Union dissolved, resources for the delivery of adequate health care in Armenia 
also suffered where much of the burden fell on limited and underpaid physicians and 
nurses (Amoros, Callister, & Sarkisyan, 2010). Therefore, the overall health of 
Armenians suffered and health-seeking behaviors also changed. In 2002, the Center for 
Health Services Research and Development of the American University of Armenia 
conducted an assessment to identify vulnerable population groups and specific health 
education needs. Four main highly susceptible populations included children under the 
age of 5, the elderly, pregnant women, and adolescents. Afflictions ranged from acute 
respiratory disease (including TB), poor nutrition, poor reproductive health, poor dental 
health, dangers from alcohol and passive smoking, physical inactivity, poor hygiene, poor 
mental health, accidents, cardiovascular disease, and cancer (Center for Health Services 
Research and Development, American University of Armenia, 2002).  
Economic uncertainty following the breakup of the Soviet Union also forced 
many Armenians to seek seasonal work in neighboring TB-burdened countries and then 
return to Armenia following work completion. As a result, migrant workers have been 
found to have higher incidence of TB (particularly MDR), HIV co-infection, delayed 
treatment initiation, and increased loss to treatment follow-up due to migration between 
affected countries, with inadequate reporting systems to track them (Truzyan et al., 
2015). Poor economic status has also seen a rise in injection drug use in Armenia. 
38 
 
 
Injection drug users (IDUs) have a higher incidence of HIV, which is problematic for the 
activation of latent TB. According to Ghukasyan (1999), IDUs in Armenia are 
misinformed about their TB status, uninformed about TB-HIV synergy, and tend to avoid 
TB health clinics for fear of incarceration or involuntary detention. 
The earthquake of 1988 also hampered the country’s health status, despite still 
being part of the Soviet Union. Significant lives were lost, people were displaced, and 
infrastructure was severely destroyed (Doarn & Merrell, 2011). Furthermore, the 
aftermath of the earthquake resulted in an increase in post-traumatic stress disorder, 
anxiety, depression (Goenjian et al., 2000), along with a breakdown in overall healthcare 
services (Doarn & Merrell, 2011). 
A major consequence of the aforementioned tragedies in recent Armenian history 
is the immigration of Armenians to distant lands. As Armenians flee from their native 
country in the hope of a better life, issues and sensitivities relating to assimilation and 
maintaining cultural identity surface (Bakalian, 2011). Many immigrant populations such 
as Armenians are misunderstood or viewed as clannish and are targeted as being 
problematic. The ability to assimilate and assume anonymity may appear to be 
advantageous in terms of escaping stereotypes and social stigma, as demonstrated by 
Armenians living in London (Talai, 1986). However, Armenian pride and the desire to 
preserve their culture seem to supersede taking the easy path where ancestral value 
systems, language, food, and religious ideologies are incorporated into their daily lives 
and communities.  First-generation Armenian parents have to make the decision as to 
whether they should raise their children according to Armenian customs and teach them 
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their native language or to completely submerge them in English-American lifestyle in 
order to simplify their assimilation (Imbens-Bailey, 1996; Phinney, Ong, & Madden, 
2000). However, the decision to adopt non-Armenian values and norms may prove to be 
challenging when making general life decisions involving community socialization, 
education, and workplace policies. Many explanations, or lack thereof, of social norms 
may be misconstrued or misinterpreted, thereby compromising the social balance 
between cultural beliefs and superstitions and local norms. Such conflict contributes to 
the appeal of conducting an ethnographic study in relation to disease and disease 
outcomes in the American-Armenian community where ambiguities in health seeking 
behaviors and knowledge may exist. 
Armenians living in the United States are a rarely studied group and considered to 
be a hidden minority. More specifically, studies involving American-Armenians in the 
social sciences are quite limited (Bakalian, 2011). Therefore, the ethnographic 
component of this study could fill the gap in gaining insight into perceived barriers to 
treatment-seeking and treatment-adherence for tuberculosis, particularly those that are 
specific to cultural attitudes, influences, and behaviors. Furthermore, studies 
incorporating ethnography and TB are limited. Park and Littleton (2008) conducted an 
ethnography in New Zealand to explore the impact of immigration on TB incidence 
influxes within the country. Overall, it was found that immigrants were responsible for 
the increase in active and latent cases of TB within the country. Therefore, the 
investigators proposed the use of such information to incorporate social support programs 
specific for such groups into their healthcare system. They also found the results to be a 
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threat to their national health and have proposed modifications in their immigration 
policies. Investigations into barriers to treatment-seeking behaviors in such groups were 
not discussed. This study may also set precedence in this area of TB research as well.  
Key Variables and Concepts 
The causative agent of tuberculosis, M. tuberculosis, is a complicated micro-
organism that contributes to the complexity of the disease and disease outcomes. Disease 
epidemiology, rigorous treatment regimen, insufficient health care and treatment support, 
and a variety of social determinants are all dynamic contributors to poor health outcomes 
related to the disease. Many of these contributors translate across country borders while 
others are unique to specific races or cultures. The studies described herein will highlight 
many of these areas in general terms and more specifically as they relate to the Armenian 
community, albeit limited. 
Disease Epidemiology, Diagnosis, and Treatment 
M. tuberculosis is a slow-growing obligate aerobic bacillus with a thick waxy cell 
envelope that primarily targets the lungs and respiratory tract (Beltz, 2011, p. 212; 
Mathema et al., 2006; Nelson & Williams, 2007, p. 654). The thick waxy cell envelope 
presents challenges for TB diagnosis and treatment (Velayati et al., 2009), which will be 
also be discussed in detail below. M. tuberculosis is readily transmissible through 
aerosolization of only a few viable tubercle bacilli resulting from coughing, sneezing, 
laughing, talking, or singing (CDC, 2012a). Upon inhalation of released mycobacteria, 
active (primary) or latent (LTBI) infection may result, with one-third of those exposed 
becoming infected and 10% eventually becoming active and symptomatic (Mathema et 
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al., 2006). Most active cases take several weeks from time of exposure; however 
immuno-compromised individuals may experience rapid progressive primary 
tuberculosis. If left untreated, active TB can be quite deadly with mortality rates of up to 
50% (Beltz, 2011, p. 211). With latent TB, mycobacteria are dormant and individuals are 
asymptomatic (CDC, 2012a). LTBI can reactivate years following primary infection; 
which may be triggered by the weakening of the immune system as with HIV co-
infection, age, malnutrition, poor living conditions, and poor hygiene.  
Disease diagnosis varies, depending upon the country, available resources, 
infrastructure, and extent of infection. Such variability and potential inadequacies can 
prove to be problematic due to the nature and potential lethality of the disease. 
Traditional diagnosis of active pulmonary TB is performed using smear microscopy, 
culture-based methods of sputum specimens, or chest x-ray (Beltz, 2011, pp. 214–216; 
Nelson & Williams, 2007, p. 664; Niemz & Boyle, 2012). Though outdated, these 
technologies are amenable to high burden low resource settings due to simplicity and low 
cost; however, they suffer from insufficient sensitivity and specificity, inadequate speed, 
and inconsistent availability in health clinics or VCTs where many patients first seek care 
(Niemz & Boyle, 2012; Niemz et al., 2011; Small & Pai, 2010). Patients are also 
requested to produce multiple sputum specimens to confirm a positive result, which may 
result in loss to follow-up if the patient does not return due to logistical challenges (Lawn 
et al., 2013; Niemz & Boyle, 2012; Niemz et al., 2011). In Armenia, the standard mode 
of TB diagnosis is chest x-ray due to the inaccessibility of sputum microscopy. This trend 
is attributed to the lack of involvement by health practitioners and nurses, quality 
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microscopes, reagent and supply procurement, and adequately trained personnel (Vink et 
al., 2005). According to a recent WHO Global TB report, in Armenia there are only 26 
laboratories performing smear microscopy with only 4% using LED microscopes, 1 
laboratory performing culture and drug susceptibility testing, and 2 performing NAT via 
Cephied’s GeneXpert® MTB/RIF (WHO, 2015). 
The implementation of NAT is moving to the forefront of TB diagnostics. NAT 
has been found to be more sensitive, specific, and rapid than current methods and also 
facilitates the diagnosis of multidrug resistant TB, thereby positively impacting patient 
outcomes (Niemz & Boyle, 2012; Niemz et al., 2011; Schumacher et al., 2016; Small & 
Pai, 2010). While highly advantageous, worldwide implementation of TB NAT is 
hampered by complicated cell physiology, specimen type, patient age, HIV-1 
comorbidity, expense, and complexity of systems. The waxy bacterial wall makes the 
pathogen very difficult to lyse which limits the amount of DNA template liberated for 
amplification. Furthermore, HIV-1 co-infected individuals and young children may 
produce insufficient volumes of sputum and therefore paucibacillary, which may limit 
target yield (Niemz & Boyle, 2012). Current NAT may involve the polymerase chain 
reaction (reviewed by Ling et al., 2008) or isothermal amplification schemes such as 
loop-mediated isothermal amplification (Boehme et al., 2007, 2010), helicase-dependent 
amplification (Ao et al., 2012; Motré et al., 2011; Torres-Chavolla & Alocilja, 2011), 
transcription-mediated amplification (Pfyffer et al., 1994), or cross-priming amplification 
(Fang et al., 2009). The most prominent and highly endorsed system by the WHO, 
StopTB, FIND, and local health ministries is Cepheid’s GeneXpert® MDR/RIF. The 
43 
 
 
GeneXpert® MDR/RIF is fully integrated assay system that incorporates TB diagnosis 
and rifampin resistance testing. The WHO has recommended its use in areas where rates 
of MDR-TB is high and serve as a replacement for smear microscopy, particularly in 
district and sub-district level laboratories of developing countries (Lawn et al., 2013). 
The adoption of the GeneXpert® MDR/RIF has revolutionized TB NAT testing, with 
next generation systems moving toward the patient bedside or point-of-care. This will 
further improve patient health outcomes, where diagnosis and treatment can be 
implemented in a single visit which is particularly important in areas where patients live 
remotely and have to travel great distances to obtain results and receive treatment 
(McNerny, 2011; Niemz & Boyle, 2012; Niemz et al., 2011). 
Historically, effective TB treatment has proven to be a challenge even when 
antibiotics were first introduced in the 1940s. Even then, the emergence of initial 
antibiotic resistance was seen almost immediately. The use of a first-line drug regimen of 
isoniazid or rifampicin was developed over the subsequent 30 years; however resistance 
to both drugs was not labeled as MDR until the early 1990’s (Sullivan & Amor, 2013). 
Contributing factors to the complexity of TB treatment include the emergence of multi-
drug resistant strains (MDR, XDR, and TDR-TB) and biological factors, such as its thick 
waxy cell envelope, slow growth, and disease-causing nontuberculous mycobacteria 
(NTM). Such characteristics are key contributors to the high morbidity and mortality 
rates associated with the disease. The thick waxy coat makes the pathogen highly 
impermeable to antibiotics and in conjunction with its slow growth rate, several classes of 
antimicrobials are used to target various stages of growth (Nelson & Williams, 2007, p. 
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666). Furthermore, the treatment must be adhered to for 6 - 12 months, depending upon 
patient treatment compliance, drug resistance status, and HIV status. This may be further 
complicated by the improper diagnosis of diseases caused by NTMs as TB, which leads 
to the unnecessary and improper treatment administration of TB drugs further selecting 
for MDR-TB strains (Raju et al., 2016). The incidence of multidrug resistant TB (MDR, 
XDR, or TDR) varies depending upon the region. In 2011, 9.5% of all new TB cases in 
Armenia were estimated to be MDR (WHO, 2012b); whereas 1.3% of new cases in the 
United States were estimated to be MDR (CDC, 2012d). 
Recent challenges in the administration of adequate treatment involve shortages 
of first- and second-line drugs and the lack of new anti-tubercule drugs in the 
pharmaceutical pipeline. In the United States, there have been recent reports of shortages 
of the commonly used first-line drugs, isoniazid and rifampin, and second-line drugs used 
to treat MDR. In late 2012, shortages of isoniazid were reported by the CDC and many 
state public health departments (CDC, 2012f, p. 13); whereas in early 2013, rifampin 
shortages were reported (“Rifampin for Tuberculosis in Short Supply,” 2013). Most of 
the shortages have been attributed to failed manufacturing lots and priority given to 
global markets. Shortages for second-line drugs in the United States have been reported 
since 2005, primarily due to high demand and priorities internationally and 
manufacturing problems by major pharmaceutical manufacturers (McNamara, 2013). 
Manufacturing problems, in conjunction with very few new developed and FDA 
approved drugs, are another hurdle for effective treatment. In the past decade, only 10 
potential viable drugs have progressed into the clinical development pipeline, with only 6 
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specific to TB (Ma, Lienhardt, McIlleron, Nunn, & Wang, 2010). In late 2012, Johnson 
& Johnson received FDA approval for a new class of anti-tubercule, Sirturo or 
bedaquiline, which has been shown to be effective against drug-resistant TB strains; 
however, it has been shown to work better with combined with other TB therapeutics and 
mortality rates from drug toxicity appear to be roughly five times higher than standard 
regimens (Thomas, 2012). Furthermore, Sutezolid (Sequella) is also in late stage clinical 
trials and continue to show promise, though faces similar hurdles (Maxmen, 2013; “New 
TB drug offers glimmer of hope in S.Africa,” 2015). With the help of Doctors Without 
Borders, the introduction of bedaquiline to MDR patients in Armenia is bringing hope to 
patients who had previously been unsuccessful on other therapies (Al Jazeera, 2014). 
While TB diagnostics continue to advance and improve rapid disease diagnosis, treatment 
shortages may prove to be yet another hurdle in effective TB disease management. 
Current global health systems are not able to effectively diagnose and treat TB, 
particularly MDR-TB, primarily due to the inability to prevent treatment interruption 
during immigration (Tschampl, Garnick, Zuroweste, Razavi, & Shepard, 2016). 
Therefore, national and international surveillance of TB cases has been made top priority 
by national health ministries and the WHO. Within the United States, all 50 states and 
territories have TB control programs that report to national surveillance systems, Online 
Tuberculosis Information System (OTIS) and National Prevention Information Network 
(NPIN). Individual counties within the states also have TB control programs that serve to 
complement statewide and national systems. In an effort to improve international 
surveillance and treatment programs, the WHO has created subgroups or regions to 
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facilitate global case reporting. The WHO subgroups include the African Region, Region 
of the Americas, Eastern Mediterranean Region, European Region, South-East Asia 
Region, and the Western Pacific Region (WHO, 2012b). The Country of Armenia falls 
within the European Region. In 2012, there were a total of 182 Member states and 204 
countries and territories actively collecting more than 99% of the world’s TB cases 
reported data (WHO, 2012b). In 2003 to 2004, the CDC conducted a study on TB 
surveillance efforts in the Republics of Armenia and Georgia to investigate the impact of 
the fall of the Soviet Union on disease surveillance efforts. Overall, major improvements 
in TB public health efforts for both countries were needed; however, it was noted that in 
2007 Armenia’s National Tuberculosis Programme (NTP) was receptive to critique and 
stopped charging for TB services (Ehlman et al., 2007). This supersedes when Armenia’s 
Ministry of Health began working in conjunction with Stop TB to reduce TB incidence, 
which occurred in 2010 (WHO, 2013). Furthermore, Armenia’s MOH has been taking a 
more proactive approach by joining other at-risk Eastern European nations and 
establishing symposia to discuss TB-related issues. In 2015, Armenia hosted a TB 
symposium entitled “New treatments and approaches to Tuberculosis” (Medecins Sans 
Frontieres, n.d.). 
Also incorporated into the WHO global surveillance program and the Millennium 
Development Goal (MDG) are Direct Observed Therapy Short Course DOTS and DOTs 
Plus programs in order to ensure treatment adherence. DOTS was first initiated in 1995 
by the WHO and StopTB to improve treatment adherence by incorporating a supervisory 
healthcare worker to monitor patients taking the prescribed dosage of the treatment 
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regimen (Naidoo et al., 2009). Key components of an effective DOTS program include: 
(a) governmental commitment to controlling TB, (b) microscopic detection of 
symptomatic patients, particularly those seeking care, (c) short-course therapy with 
supervised treatment for at least the first 2 months, (d) systematic tracking of cases and 
outcomes, and (e) a reliable supply of anti-TB drugs (Nelson & Williams, 2007, pp. 666–
667). While DOTS was initially viewed as an effective means to manage patient 
compliance with 20 million lives saved (WHO, 2012b), it is now viewed as being flawed 
with improvements needed. Much of the inconsistencies in success may be attributed to 
lagging government involvement, insufficient resources, and insufficient support systems 
(Naidoo & Mwaba, 2010).  
DOTs Plus was initiated in 1999 by the WHO and its partners to monitor, 
manage, and improve outcomes for MDR-TB (WHO & StopTB, 2006). One of the main 
hindrances with DOTs Plus is the overall expense of the treatment regimen. Unless 
medications are supplied for free or at a severely discounted rate, there is no guarantee 
that a patient will comply with treatment. In Armenia, those with confirmed MDR or 
chronic cases that failed according to DOTS, receive DOTS-Plus. However, due to a 
shortage of state funds and anti-TB medications to complete the treatment regimen, 
individuals are forced to pay out-of-pocket and may not be able to do so because they are 
too expensive (Breitscheidel, 2006). In a pilot study looking into the benefits of DOTS 
implementation in Armenia, Georgia, and Azerbaijan in 1999, results looked promising 
where TB incidence significantly decreased after 3 months of treatment implementation 
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(Zalesky et al., 1999). However, similar studies have not been conducted recently, 
particularly after StopTB stepped in to assist Armenia’s NTP in 2010. 
With the advent of new virtual technological advances that allow for real-time 
communication, such as live streaming and Facetime, and the global availability of 
mobile devices, improvements in DOTs is possible. Mobile Direct Observation of 
Treatment (MDOT) and Virtually (video) Observed Therapy (VOT) are showing marked 
improvements in TB treatment adherence by bridging the gap between patient and 
caregiver interactions. Costs associated with travel and work absenteeism, along with the 
ability of the healthcare worker to visibly watch the patient take their medication shows 
some real promise in combating attrition (Hoffman et al., 2010; Story et al., 2016). While 
studies are still in their early phases, the WHO is beginning to incorporate digital product 
specifications into their diagnostics profiling requirements. 
TB Susceptible Populations 
Key populations that are highly susceptible to TB transmission, infection, and 
complications with treatment in both developed and developing countries include: 
HIV/AIDS patients, immigrants, the homeless, drug users, those in correctional facilities, 
and those low socioeconomic populations, of which the latter will be discussed in more 
detail in the qualitative and quantitative components below. 
Those individuals co-infected with HIV present one of the largest challenges 
when trying to reduce TB transmission, morbidity, and mortality. Of the 9.6 million new 
TB cases in 2014, 13% were co-infected with HIV. Of the 1.2 million HIV-attributed 
deaths, 400,000 were co-infected with TB (WHO, 2015). Furthermore, infected 
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individuals with latent TB and HIV are more likely to develop active TB than those who 
are HIV negative due to a compromised immune system (CDC, 2012d). Aside from 
increasing the possibility of TB transmission, treatment is compromised. For individuals 
with drug susceptible TB, a minimum treatment of 6 months of first-line anti-tubercule 
drugs is recommended; however rifampicin has been shown to adversely interact with 
many anti-retroviral drugs (CDC, 2012c; Maartens & Wilkinson, 2007). Furthermore, 
concurrent treatments require a large amount of pills to be taken on a daily basis. Pill 
count was found to be a deterrent when complying with treatment for both diseases 
(Gebremariam, Bjune, & Frich, 2011).Therefore, DOTS is highly recommended for 
disease management for such cases. In an effort to reduce HIV and other co-infections of 
opportunistic infectious diseases (e.g., TB, Hepatitis, syphilis), many countries attempted 
to restrict travel of HIV positive individuals, Armenia being one of them. Here there were 
no restrictions for travelling within the country; however those foreign HIV positive 
travelers requesting visas for long term stays were denied visas. Proof of HIV-negative 
status was also required for granting of a visa. While the WHO found that such a policy 
had no significant impact on disease spread, such policies have remained in place though 
Armenia is reportedly working on changing such regulations (Lazarus, Curth, Weait, & 
Matic, 2010).  
Aside from HIV co-infected individuals, immigrant populations are responsible 
for many of the TB cases, particularly in the United States. In 2011, immigrants within 
the United States were responsible for 62% of all TB cases with a case rate 11.5 times 
higher than U.S. born individuals (CDC, 2012d). This is primarily attributed to 
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reactivation of latent TB (CDC, 2012e; Mathema, Kurepina, Bifani, & Kreiswirth, 2006). 
Upon reactivation, they have no or insufficient health care to take care of the extensive 
treatment regimen. An altered short course rifampin and pyrazinamide is available for 
this group but problems with hepatotoxicity and adherence results in no real 
improvement. Because of problems associated with hepatotoxicity, there is also a large 
distrust of the American medical system for TB care (Kandula et al., 2004). As a result, 
the CDC, state and local health departments have mandatory domestic TB screening of 
refugees which not only identifies positive LTBI cases but also facilitates effective 
treatment for those immigrants directly affected and their family members (CDC, 2012e; 
Los Angeles County Department of Public Health, n.d.). 
The homeless population also present challenges for controlling TB transmission 
rates. The homeless tend to suffer from poor mental and physical health, substance abuse 
problems, and insufficient health care that exacerbate the problem of TB transmission. At 
the beginning of 2013, spikes in TB were experienced in LA County’s homeless 
population, Skid Row (“Tuberculosis Outbreak Among Homeless In Los Angeles, Calif. 
[VIDEO],” 2013). Furthermore, as a means of controlling the homeless population, law 
enforcement often times incarcerate them with deleterious effects on disease transmission 
rates. In a 2004 study by the CDC, the source of a TB infection in Kansas was linked to a 
homeless man, whom had presented with bloody sputum to a shelter’s physician. There 
was no follow-up by the patient and was subsequently jailed in multiple facilities in 
Kansas. While still presenting with bloody sputum in these facilities, a tuberculin test or 
chest x-ray was not administered and he was eventually released back into the public 
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while still infected with TB. Contact investigations were conducted and two of his 
cellmates had active infections and 19% were diagnosed with latent TB (CDC, 2004). 
In the United States and abroad, inmates in correctional facilities rank high among 
sources of TB within the infected population. Correctional facilities can be viewed as 
“incubators” for disease, where environmental and behavioral conditions contribute to 
high TB incidence (Beckwith, Zaller, & Rich, 2006). People from diverse backgrounds 
(e.g., immigrants, homeless, drug users, and HIV infected) live in close proximity for 
extended periods of time, participate in high risk behaviors, and have poor medical care, 
all of which facilitate rapid TB transmission (Dara et al., 2013). As a consequence, 
inmates are estimated to have a 17 times higher rate of TB than the general U.S. 
population (Lobato, Roberts, Bazerman, & Hammett, 2004). Reported barriers to 
treatment adherence among the incarcerated include unemployment, co-morbidity, 
malnutrition, and substance abuse and desired incentives for treatment compliance 
include financial, food, and employment (Fry et al., 2005). Following an inmate’s release, 
there is also great potential for TB to be brought into the general population and 
community, particularly when left undiagnosed and untreated. Similarly, workers at 
correctional facilities are also at risk for infection and can become vectors for bringing 
the infection out into the general population. 
Similar trends are seen among incarcerates as compared to the general population 
worldwide (Dara et al., 2013). In the former Soviet Union, MDR-TB rates have been 
reported to be significantly higher in correctional facilities than the general population 
(Stuckler, Basu, McKee, & King, 2008). In an effort to reduce this alarming statistic, the 
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investigators proposed that the implementation of PCR-based detection systems, albeit 
more expensive, was better in the long run for effectively diagnosing and treating the 
disease (Winetsky et al., 2012). In Armenia specifically, TB and MDR-TB rates are 
reportedly higher in the incarcerated and former incarcerates (Breitscheidel, 2006; 
Grigoryan et al., 2008). This is attributed to poor living conditions, malnutrition, poor 
general health and hygiene, and lack of coverage by DOTS. Furthermore, prisoners with 
TB enter into the general community and may later be re-incarcerated again, contributing 
to the transmission cycle (Figure 2). Family, visitors, and prison staff are also at risk for 
developing active pulmonary TB (Breitscheidel, 2006). 
 
Figure 2. TB transmission cycle in Armenia, relative to the incarcerated 
and general population. Adapted from “Tuberculosis in Armenia: still an 
open question,” by L. Breitscheidel, 2006. The Internet Journal of 
Infectious Diseases, 5(2). 
Qualitative Component 
The qualitative aspect of this mixed-methods study explored perceived barriers to 
treatment-seeking and adherence for TB in an Armenian population living within the 
• Penitentiary 
Facility
• Pre-trial 
Detention 
Center
• Military• TB Hospital
Patients
Staff
Visitors
Recruits
Staff
Inmates
Staff
Visitors
Detainees
Staff
Visitors
Gen 
Population
Neighboring countriesNe
igh
bo
rin
g 
co
un
tri
es
53 
 
 
United States. While several systematic reviews have been conducted on qualitative 
studies addressing barriers and facilitators to TB treatment adherence, literature specific 
to Armenians living in the United States and their native country is severely lacking. 
Barriers to treatment-seeking and adherence in other populations, particularly 
immigrants, will be discussed in the next section, quantitative components.  
A systematic review of current qualitative research investigating patient 
adherence to TB treatment was conducted by Munro et al. (2007) in order get a 
comprehensive understanding of the dynamics relating to barriers to and drivers of TB 
treatment adherence. Of the over 7800 citations screened for, 44 were analyzed based on 
a set of established criteria. Reported factors by patients, caregivers, and health care 
providers were considered. Key factors and their interactions were broken down as 
structural (e.g., poverty and gender discrimination), social, health service, and personal 
factors. The investigators were not able to substantially identify a single factor effecting 
treatment adherence, but rather interactions thereof where it was recommended that new 
improved approaches should be patient centered with all influential factors being taken 
into account (Munro et al., 2007). Such an approach falls in line with the theoretical 
framework of the study, SEM, which is a dynamic model. 
A second systematic review of qualitative research investigating the effectiveness 
of DOTS and TB management was conducted by Noyes and Popay (2007). A total of 58 
studies were reviewed to address two main questions: (1) What does qualitative research 
tell us about the facilitators and barriers to accessing and complying with TB treatment? 
and (2) What does qualitative research tell us about the diverse results and effect sizes of 
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the randomized control trials included in the Cochrane Review?  Overall, five themes 
were established: (a) socio-economic and material resources; (b) explanatory and 
knowledge systems; (c) stigma and public discourse; (d) sanctions, incentives, and 
support; and (e) social organizations and relationships (Noyes & Popay, 2007). 
Furthermore, DOTS was found to be no more effective for ensuring treatment adherence 
than self-supervised drug administration which also suggests that more personalized 
treatment delivery systems need to be implemented. 
In a study conducted by Tupasi et al. (2016), factors associated with loss to 
follow-up during MDR-TB treatment in a population in the Philippines were explored. In 
the case-control study of 273 adult patients, a five-level SEM model was used. It was 
found that two individual factors (alcohol abuse and general TB knowledge), two factors 
related to the healthcare setting (trust and support from staff, lack of assistance), and 1 
factor relating to adverse reactions from treatment, particularly vomiting, were the most 
significant (Tupasi et al., 2016). 
TB is debilitating to Armenia as a whole. In 2006, Breitscheidel, Stamenitis, and 
Bosch (2010) conducted an economic impact analysis of adult TB on the Armenian 
government. Based on yearly treatment costs of $359 for smear positive and $239 for 
smear negative individuals, the overall cost estimate for TB control in adults was $1.41 
million (USD). For a developing country like Armenia, this is prohibitively high resulting 
in insufficient resources to adequately treat and manage the disease and possibly 
contributing to the worsening of the epidemic in this country.  
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In a study looking into reasons for delayed TB treatment in Armenia, Schneider et 
al. (2010) interviewed 240 TB patients in two Armenian TB reference hospitals where 
questions regarding symptom recognition, time to seek medical attention after system 
onset, outcomes following their first medical visit, and when treatment was initiated 
following diagnosis. Significant factors associated with delayed medical attention 
included weight loss and fatigue, inability to recognize the symptoms as being TB, and 
inadequate diagnosis and/or referral after the first visit to the doctor (Schneider et al., 
2010). Such findings suggest that enhanced knowledge regarding recognizing signs and 
symptoms of TB, along with improved medical care and staff would dramatically 
improve disease outcomes in Armenia. 
In a 2008 report by Grigoryan et al. (2008) on behalf of the Center for Health 
Services Research and Development, American University of Armenia, a full assessment 
of the TB in Armenia was conducted. The assessment involved the investigation of the 
extent of disease burden, highly susceptible populations within the country, disease 
perceptions, diagnostic and treatment challenges, and methods of disease management 
improvement. The report found that highly susceptible populations included the homeless 
and the poor, migrant populations (particularly refugees), HIV co-infected, the 
incarcerated (current and former), orphans, those living in hospices and psychiatry 
hospitals, those with medical co-morbidities (e.g., pulmonary disease, diabetes, immuno-
compromised), those in close contact with TB infected individuals (e.g., school workers, 
municipal workers, health care, and public transportation), and drug users. Knowledge 
and attitudes regarding TB was very telling. In one survey, 91% could identify TB but 
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only half of those interviewed knew its mode of transmission. In another survey, the vast 
majority did not realize that TB was a public health problem, could not identify 
symptoms, and believed that they and their loved ones were not at risk. Social stigma is 
also high, where roughly 20% keep their family’s TB status a secret. Furthermore, TB 
patients were ill-informed about the duration of treatment and the consequences 
regarding non-compliance or interrupted treatment (Grigoryan et al., 2008). All of these 
themes, in conjunction with an inadequate and burdened national TB control program, 
severely impact national TB management. 
More specifically, Truzyan et al. (2015) looked at factors associated with TB 
incidence in Armenian migrants, who have shown a significant rise since the fall of the 
Soviet Union. Of the 95 migratory adults surveyed, 28.3% of respondents had MDR TB 
and 5.3% were co-infected with TB. Because many of the respondents were abroad when 
first diagnosed, time to treatment initiation and loss to follow-up upon returning to 
Armenia was significantly higher (Truzyan et al., 2015). Due to the increased potential 
for this group to spread the disease, as well as receive incomplete or inadequate 
treatment, the need for a global reporting and tracking system is clearly apparent and 
urged for by the researchers. 
As can be seen from the few studies done on TB in Armenia, many of the 
inadequacies and barriers to treatment are associated with the lack of resources and 
funding allocated to the disease and the national health care system. While the Armenian 
National Tuberculosis Control Program has made great strides, much more needs to be 
done. However, studies regarding Armenians residing in their United States and their 
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perceptions regarding TB and access to health care could not be found in the literature. 
Therefore, this study can address this gap. 
Quantitative Component 
A thorough understanding of barriers to treatment adherence is vital for complete 
disease management and control, regardless of the country afflicted. Reported psychiatric 
and psychosocial factors effecting treatment adherence include poverty, disease co-
infection (e.g., cardiovascular, HIV, hepatitis), social stigma, unsupportive social and 
work environments, disbelief in the health facility and staff, helplessness, hopelessness, 
and depression (Fry et al., 2005; Kandula et al., 2004; Naidoo et al., 2009). Molecular 
factors also play a role, where genetic variation in both the host and the pathogen are 
highly influential in the efficacy of disease transmission (Mathema et al., 2006). All 
factors must be taken into account in order to achieve success. Individual or population-
wide dynamics should be incorporated into a standardized basic model to see an impact 
on disease incidence. Therefore, a multifaceted approach will need to be implemented in 
order to achieve successful disease management and patient care. 
The quantitative aspect of this mixed-method study sought to explore whether 
there are differences in barriers to treatment-seeking and adherence for TB in Armenian 
versus non-Armenian populations living in LA County and which factors (physical, 
cultural, psychosocial, behavioral) have the greatest influence. Here, the dependent 
variable, knowledge regarding TB treatment-seeking and treatment-adherence will be 
explored in relation to the independent variables, barriers or factors relating to TB 
treatment seeking and treatment adherence. As previously discussed, perceived barriers to 
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treatment in Armenians have been minimally explored in their native country but not in 
the United States. However, barriers to treatment in other populations, both in the United 
States and their native country, have been reported and will be discussed in order to 
ground the quantitative portion of the study. 
TB burden has been shown to a have a strong correlation with socio-economics: 
as socio-economics decline, TB burden increases. This is true within developed and 
developing countries, with the poorest countries having an even greater risk. In a study by 
Holtgrave and Crosby (2004), poverty, income inequality, and social capital had 
significant correlations with TB case rates in the United States. The CDC revealed similar 
findings in relation to TB, HIV, and hepatitis, and sexually transmitted diseases in an 
effort to improve interventions and bring these diseases to the forefront of public policy. 
Furthermore, TB rates among Hispanics and black populations is eight to nine times than 
that of white populations (Sharpe, Harrison, & Dean, 2010). Similarly, as previously 
mentioned, immigrant populations are major contributors to increased TB incidence in 
the United States (CDC, 2012b; CDC, 2012d) and tend to fall within lower 
socioeconomic populations in the United States (Ho, 2004). Aside from monetary 
resources, social deprivation amongst many of the at risk populations (homeless, 
incarcerated, some immigrant populations) has been shown. However, the causal links 
between poverty, low socio-economics, and TB risk have not been pinpointed with 
certainty (Lönnroth, Jaramillo, Williams, Dye, & Raviglione, 2009). As sequencing 
technologies continue to evolve, more molecular factors and genetic variations in the host 
and the pathogen may fill this sociobiological gap. 
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For studies investigating psychological factors for TB treatment non-adherence, 
self-reporting of helplessness, anxiety, depression, social support, and quality of life were 
of primary concern. According to Carney and Freedland (2000, p. 200), depression has 
been found to have a profound impact on treatment adherence for many illnesses and 
therefore, such explorations are quite worthwhile and necessary. Severity of depression 
has been found to be related to duration of illness, disease severity, and response to 
therapy. Furthermore, it was found that in the presence of a great social support system 
(mainly comprised of family and friends), depressive symptoms were found to be 
decreased and/or relatively mild (Guo, Marra, & Marra, 2009; Naidoo et al., 2009; 
Naidoo & Mwaba, 2010). Some of the main causes of depression in TB patients which 
result in treatment non-adherence include altered social relationships, social stigma, 
financial burden and loss of income, lack of social support, and persistent cough and 
severity of symptoms (Issa, Yussuf, & Kuranga, 2009; Naidoo et al., 2009; Naidoo & 
Mwaba, 2010; Sulehri et al., 2010). Depression has also been reported in family members 
of those afflicted with the disease, which impacts social support for the patient (Ige & 
Lasebikan, 2011). 
Perceived social stigma in particular, has been shown to have a significant effect 
on treatment initiation and adherence. Many investigators have reported that perceived 
stigma results in early defaulting on treatment (Liefooghe & Muynck, 2001; Munro et al., 
2007; Naidoo et al., 2009; Naidoo & Mwaba, 2010). This may be further exacerbated by 
HIV co-infection where further stigma may be associated with the disease. Such feelings 
may be felt not only in the community but in the workplace and therefore feelings of 
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depression and the lack of desire to continue working may take place. As a consequence, 
it becomes imperative to educate the general public and those within the inner circle of 
the patient to improve general understanding about the disease and promote treatment 
adherence. 
Summary and Conclusions 
The preceding literature review provides a detailed representation of TB 
epidemiology, current problems relating to TB diagnosis, treatment, and patient 
management, vulnerable populations, and specific problems pertaining to the disease in 
Armenian populations. The extensive discussion relating to these topics reveals the 
dynamics surrounding the disease and how such interactions are central themes relating 
to the problem being investigated: barriers to treatment seeking and treatment adherence 
in a specific population, Armenians living in LA County in the United States. Such an 
understanding has significant public health implications for effective treatment 
management in this vulnerable population. 
The theoretical framework and foundation explored further support the need for a 
dynamic approach for effective disease management. The social ecological model uses a 
multi-tiered approach for intervention where personal, social, and environmental 
influences are utilized. These play in nicely with current reported barriers to TB treatment 
seeking and adherence behaviors, which include psychological, psychosocial, physical, 
biological, and cultural factors. The latter becomes a central element to this study, where 
ethnography will serve as the theoretical foundation. Armenians are a proud group of 
people, rich in family ties, influences, and ancestral adages. An understanding of TB 
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knowledge and the interplay of cultural influences in the Armenian community will 
complement current understandings of perceived TB treatment barriers reported for other 
susceptible populations and groups. 
The body of knowledge regarding TB epidemiology is vast and continues to grow 
due to the enormity and severity of the disease at a global level. A smaller subset of TB 
studies explores perceived barriers to treatment-seeking and adherence relative to 
susceptible populations. However, a serious gap exists in the body of knowledge relating 
to the Armenian community, both living in the United States and in Armenia. To the best 
of my knowledge, there are no studies of Armenians living in the United States with 
respect to TB or any other infectious disease behaviors or interventions. TB studies of 
Armenians living in Armenia exist, but are limited. Those addressing perceived barriers 
to treatment and knowledge are even narrower in scope.  
In Chapter 3, the study design will be discussed, along with methodologies that 
will be used to effectively address such gaps. Chapter 3 includes the methodology 
utilized in this study to investigate the barriers to treatment-seeking and adherence in 
Armenian versus non-Armenian populations. Included in this chapter will also be a 
description of research design and approach, an understanding of the sample population 
with justification of the sample size used, diagnostic measures and instruments used to 
confirm disease prevalence and coding for barriers to TB treatment. 
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Chapter 3: Research Methods 
Introduction 
As identified in the literature review, there is a gap in knowledge about the 
perceived barriers to TB treatment-seeking and adherence of Armenians living in the 
United States— a susceptible population. Therefore, a mixed-methods study was 
conducted and focused on Armenians living in LA County. This chapter details the 
qualitative and quantitative methodological approaches that were used to investigate the 
TB knowledge, TB treatment-seeking and TB-adherence behaviors of Armenians versus 
non-Armenians living in LA County. This chapter will include specifics on participant 
selection and recruitment, the research setting, instrumentation, the pilot study, and data 
analysis. 
Setting 
Several settings were employed for this study until the proper sample size was 
met for each study. This was highly contingent on the success of recruitment for any 
given setting. All recruiting was done in LA County, with emphasis on SPA-2. 
Candidates were invited via social media and flyers, initially targeting local churches, 
church groups, and community centers located within the county. Quantitative surveys 
were administered online. More details on sampling and recruitment procedures are 
provided in the next sections. 
Research Design and Rationale 
The goal of this mixed-methods study was to explore the differences in factors 
relating to TB knowledge, such as (a) physical, psychosocial, cultural, or behavioral; (b) 
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treatment-seeking and adherence among Armenians and non-Armenian living in LA 
County; and (c) how such differences may impact the reduction of TB incidence in this 
susceptible population. The purpose of this concurrent mixed-methods study was to 
address the following research questions and hypotheses:  
1. What are the perceived barriers to treatment seeking and adherence for 
tuberculosis in an Armenian population living within the United States? 
2. Is there a difference in barriers to treatment seeking and adherence for 
tuberculosis in Armenian versus non-Armenian populations living in Los Angeles 
County and which factors (e.g., physical, cultural, psychosocial, behavioral) have 
the greatest influence? 
HA2: There are differences in factors relating to treatment seeking and 
adherence for tuberculosis in Armenian versus non-Armenian populations 
in Los Angeles County. 
H02: There are no differences in factors relating to treatment seeking and 
adherence for tuberculosis in Armenian versus non-Armenian populations 
in Los Angeles County. 
Ethnography was one aspect of this study. Ethnography involves full immersion 
in the culture under study in order to get a clear picture of daily life events, family 
dynamics, and social interactions to enhance the observer’s ability to describe such 
events and perceptions in detail (Robson, 2011, p. 142). Due to the extensiveness of 
ethnography studies, they typically take a long time to conduct (Robson, 2011, p. 143); 
however, having had significant Armenian influences throughout my life, these 
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experiences were leveraged not only for expediently accessing the population but also 
relating to participants. Further immersion on my part as the researcher involved the 
ability to converse with participants in their native language, if need be. Therefore, 
Armenian language courses were pursued in conjunction with assistance from Armenian 
speaking family and friends. This was critical when preparing the questionnaire, 
pretesting the questionnaire, and conducting final interviews of participants. 
The mixed-methods study is a convergent parallel design. This design is an 
intuitive and efficient approach whereby two different methods are utilized to obtain 
triangulated results about a singular topic (Creswell & Plano Clark, 2011, pp. 77–78). In 
this study qualitative and quantitative data were collected concurrently, analyzed, and 
then merged during interpretation of the data (Figure 3). The rationale for combining both 
quantitative and qualitative data is to better understand this research problem by 
converging numeric trends and detailed data in an effort to reduce morbidity and 
mortality associated with TB incidence and prevalence in Armenians. Such an approach 
is common when the researcher is interested in triangulating methods by making direct 
comparisons and contrasts between quantitative statistical results with qualitative 
findings for validation purposes (Creswell & Plano Clark, 2011, p. 77). Furthermore, a 
more complete understanding of the ethnographic influences may be achieved with such 
an approach. 
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Figure 3. Basic schematic for this mixed-methods convergent parallel 
design study. Adapted from Designing and Conducting Mixed 
Methods Research (p. 118), by J. Creswell and V. Plano Clark, 2011, 
Los Angeles, CA: SAGE Publications, Inc.. Copyright 2011. 
The qualitative aspect entailed conducting in-depth interviews of Armenians and 
non-Armenians living in LA County to understand general perceptions about TB, along 
with perceived barriers to TB treatment and treatment adherence. Ethnography was 
emphasized here where shared beliefs, behaviors, and knowledge relating to TB 
treatment-seeking and adherence among Armenians and non-Armenians were explored. 
Using SEM as the foundation for the theoretical framework and belief or behavioral 
patterns of the culture-sharing Armenian group in Glendale and surrounding areas, 
appropriate interviews and questionnaires were administered for data collection. The 
quantitative aspect of this study used a survey to explore whether such barriers to 
treatment-seeking and adherence differ in Armenian versus non-Armenian individuals 
residing in LA County, with potential implications for reducing disease incidence. Here, 
Mixed-methods Convergent Parallel Design
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Data Collection: In-
depth interviews
• Data analysis: coding, 
themes, relationships
Quantitative 
Data collection: Survey
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Univariate, bivariate 
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an association between the dependent variable, knowledge regarding TB treatment-
seeking and treatment adherence, and the independent variables, barriers or factors 
relating to TB treatment-seeking and adherence was explored. Such factors included 
demographics (Armenian versus non-Armenian), socioeconomic, cultural, behavioral, 
and/or individual beliefs. Furthermore, differences in such perceived barriers and 
characteristics from other non-Armenian populations have been assessed. 
In concurrent mixed-methods studies data collected from the qualitative study and 
quantitative study are analyzed separately and then merged. The merged results from data 
analysis are then related back to the research questions (Creswell & Plano Clark, 2011, p. 
221). Data analysis strategies will be described in detail later in this chapter. 
Role of the Researcher 
In ethnography, researcher involvement can vary depending upon the level of 
immersion desired. Generally, both observation and participation within the group’s 
natural setting is required (Robson, 2011, p. 144); therefore, my role was an observer-
participant with more emphasis on being a participant particularly during the qualitative 
portion of the study where in-depth interviews were conducted. 
Personal and/or professional relationships were avoided. For those in the local 
Armenian community in particular, there was the possibility that the researcher might be 
familiar with the participant; however, those who have been in close contact with the 
researcher throughout the years were strictly avoided in order to prevent bias or ethical 
dilemmas. 
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Methodology 
Participant Selection 
The participants involved with this study were Armenians and non-Armenians 
living in LA County. The goal of the study is not to make generalizations but to get an in 
depth and comprehensive understanding of potential treatment-seeking and adherence 
behaviors and factors in Armenians versus non-Armenians living in LA County. For the 
qualitative portion of the study, sampling was purposeful and non-probabilistic where 
individuals were selected based upon proximity, availability, and ethnicity, following 
Walden’s IRB approval (number 04-24-14-0230517). With respect to proximity, 
individuals had to reside in LA County. Furthermore, ethnicity designation is an 
important selection criterion where both Armenians and non-Armenians living in the area 
are necessary. Aside from ethnicity, efforts were made to match participants closely 
based upon other characteristics such as gender, age group, and zip code or city of 
residence. 
The primary method of purposive sampling involved snowball sampling. This 
approach may be implemented when one or more individual from the population of 
interest is identified and once interviewed, they are asked to identify other potential 
members of the population (Robson, 2011, p. 275). Primary access was gained through 
local Armenian churches, church groups, community centers and businesses in LA 
County (primarily SPA-2). A similar approach was used for selecting non-Armenian 
participants.  
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For the quantitative element, both Armenian and non-Armenian participants were 
selected based upon convenience sampling. Here, the closest and most convenient 
persons were recruited in a continual manner until the appropriate sample size was 
reached (Robson, 2011, p. 275). Ethnicity was the principal factor for recruiting potential 
participants: Armenian or non-Armenian. LA County has a diverse racial make-up where 
71.6% are White, 9.3% Black, 14.5% Asian, 1.5% American Indian, 0.4% Native 
Hawaiian/Pacific Islander, and 2.8% multiple races. Of the White population, 48.2% are 
classified as Hispanic or Latino and 27.3% as White alone, including Armenians  (U.S. 
Department of Commerce, 2013). Therefore, racial breakdown was selected for with 
further stratification of “White” to differentiate Armenians from non-Armenians. For the 
data analysis, further stratification of race may be required to determine if there are 
significant differences among specific races, such Armenians versus Hispanics. 
For both studies, ethnicity was the primary selection criterion, although 
participants had to speak and read English or Armenian fluently. Participants were not 
excluded based on gender and were adults, and therefore ≥ 18 years of age. Current TB 
positive patients and those with latent TB were excluded; however, patients who had 
undergone treatment and were TB negative were not discouraged from participating. For 
data analysis, stratification based upon previous TB history may be required. Participants 
were required to live in LA County, which was verified with proper identification and 
compared to a list of zip codes or city names in LA County (County of Los Angeles, 
2011). Zip codes within SPA-2 (County of Los Angeles Public Health, n.d.-b), which 
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includes the city of Glendale, were preferred. Participants were pre-screened to ensure 
that these criteria were met. 
To facilitate recruitment for both studies, invitations were provided via social 
media, flyers, or in the case of snowball sampling, were given to participants following 
participation to explain the study to potential future participants. For social media, a 
Facebook page was set-up specifically for the studies. Linked-In and Reddit (Reddit.com) 
were also utilized, with a link to the Facebook site provided. For other recruitment 
approaches utilizing flyers, the invitation was posted in public areas in the region of 
interest, upon permission from the proprietor or from other participants in the case of 
snowball sampling. For continuity, the Facebook page and flyer were similar in 
appearance and content (see Appendices H, I, J, and K). The researcher could be 
contacted via personal e-mail or through a personalized Quick Response (QR) code that 
was scannable with a smart device, such as a cell phone or tablet. 
For the qualitative part of the study, 10 Armenians and 8 non-Armenians 
participated in the in-depth interviews addressing TB knowledge and perceived barriers 
to treatmen- seeking and treatment adherence. With qualitative studies, there appears to 
be more ambiguity when determining appropriate sample size. According to Rudestam 
and Newton (2007, p. 107), 20 to 30 participants may be regarded as a sufficient sample 
size, though others whom are representatives of grounded theory believe 5 to 6 
participants are sufficient. An important factor for determining an appropriate sample size 
in qualitative studies is saturation in order to fully develop a model or concept (Creswell, 
2012, pp. 88–89). Here saturation is desirable where all possible answers or trends have 
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been revealed and there is no added benefit in interviewing additional participants 
(Robson, 2011, p. 148). This was taken into account when conducting interviews for the 
qualitative study, though original proposed numbers were found to be suitable. Due to the 
implementation of a convergent parallel design for this study, those who participated in 
the qualitative study were not eligible to participate in the quantitative study. Following 
the completion of the qualitative interview process, participants were given a $10 Target 
gift card to extend appreciation for their involvement in the study. 
For the quantitative component, the recruitment of 200 participants was proposed: 
100 Armenians and 100 non-Armenians living in LA County. Participants were recruited 
using social media and flyers, as described previously. Surveys were administered online 
using the online survey tool, SurveyGizmo (www.surveygizmo.com).  
Calculation of sample size was done a priori using correlations reported in the 
literature regarding reported barriers to treatment in various populations and social 
determinants effecting TB incidence in the United States. In a study by Holtgrave and 
Crosby (2004), correlations between societal predictor variables and TB cases were 
calculated using Pearson’s correlation coefficient (r). From this, coefficients of 
determination (r2) were calculated, which were used to determine effect size for this 
study. Coefficients ranged from 0.132 to 0.485, depending upon the variable. No such 
information was available in the literature for Armenians living in Armenia or in the 
United States. Therefore, using G* Power 3 calculator software (http://www.psycho.uni-
duesseldorf.de/abteilungen/aap/gpower3/) and Exact test parameters of bivariate normal 
mode and an alpha level of 0.05, effect sizes range from 0.363 to 0.696, with resulting 
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sample sizes of 92 and 20, respectively. Since information on this population is less 
defined in the literature, an effect size of 0.363 was used and thus, roughly 100 
Armenians and 100 non-Armenians were desired for surveying. 
Instrumentation: Qualitative 
The qualitative study involved in-depth interviews with Armenians and non-
Armenians to get a thorough understanding of TB knowledge and perceptions relating to 
the disease and treatment. Since this study was relatively unique, the interview guide with 
open-ended questions was generated by the researcher; however, several pre-tested 
questionnaires were used to generate some of the reference questions (Bakalian, 2011, 
pp. 476–494; Jakubowiak et al., 2008; Xu et al., 2009). Interviews were tape recorded, 
with permission from the participants, and were referenced when any questions or 
ambiguities in response scripts arose.  
Data triangulation was exercised to establish validity. Here, more than one 
method of data collection was utilized (Creswell & Plano Clark, 2011, pp. 209–210; 
Robson, 2011, p. 158) where transcripts were cross-checked with interview recordings. 
Furthermore, the dissertation supervisor (V.M.) examined accuracy of transcription, 
coding, and resulting common themes and conclusions. Proper coding and subsequent 
interpretation is important for integrating themes with quantitative study results. 
Questionnaires were administered in English and Armenian, with pretesting serving as a 
means to validate the translation of the questions. Furthermore, someone fluent in 
Armenian was available to administer or clarify questions to native Armenian speaking 
participants. 
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For the culturally relevant questions pertaining to Armenians, Bakalian (2011) 
provided many pertinent questions relating to the study topic. In this study, the author 
was interested in learning about challenges with assimilation faced by Native Armenians 
as they immigrated to the United States. The questionnaire was mailed to Armenians 
living in the New York and New Jersey area as part of the author’s dissertation at 
Columbia University in the field of Sociology. Furthermore, in a study by Xu et al. 
(2009), a mixed-methods approach was used for studying TB treatment adherence and 
barriers to adherence in China. Insight from healthcare workers was also solicited, which 
was a consideration for this study. Some examples of the open-ended questions in the 
interview guide are the following (See Appendix B for Armenian translation): 
Basic background information – Armenian participants 
1. Did you emigrate from Armenia? 
a. How long have you lived in the United States? 
b. In what city are you currently residing? 
2. Do you read/write Armenian? How well? 
3. Is Armenian spoke in your household? If so, how often? 
4. Do you read Armenian literature, watch Armenian TV programs (e.g., 
Armenian Teletime), or listen to Armenian radio? 
a. If yes, which ones? 
b. How often? 
5. Do you patronize businesses or seek professional assistance (e.g., medical 
doctors) because they are Armenian? 
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6. Are you involved with community activities or organizations (e.g., 
Armenian Church, Massis Guild, Ararat Home)? Which ones? 
7. Do you have kapoot ach (blue eye) in your residence? 
Basic background information – non-Armenian participants 
1. Did you emigrate from another country? 
a. If yes, which country? 
b. How long have you lived in the United States? 
c. In what city are you currently residing? 
2. Do you read/write in another language? Which one? 
3. Is English the primary language spoken in your household? If no, what 
other language is spoken? 
4. Are you involved with community activities or organizations? Which 
ones? 
General Background questions - all 
1. What year were you born? 
2. What is your marital status? 
3. Please describe your residence type. Do you own or rent? 
4. How many people are living in your household? 
a. Please describe relation to you. 
b. Please describe gender and ages of each. 
5. What is your highest level of education? 
6. What is your occupation? 
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7. What is your total annual household income (pre-tax)? 
8. Do you have health insurance? 
9. How frequently do you visit a local physician annually?  Do you trust 
your local physician? 
10. When either you or family/friends are diagnosed with any disease, do you 
seek spiritual guidance? 
11. When you are feeling sick, do you use home remedies such as massages, 
herbs, oils, drink herbal or spiced teas? Which ones specifically? 
a. If yes, do you practice this prior to seeking help from a physician? 
b. Upon visiting a physician, do you continue the use of home remedies 
while under a physician’s care? 
TB specific questions - all 
1. Are you familiar with the disease, tuberculosis (TB)? If yes, please 
describe what you know about it, including modes of transmission. 
2. Is TB infectious to others? Please describe. 
3. Have you heard about recent reports of tuberculosis cases in the news? 
a. In the United States? 
b. In other countries? Which ones?  
4. Is TB a treatable disease? 
a. What do you know about the treatment? 
b. Are any of these factors a deterrent for seeking or adhering to 
treatment?  Which ones? 
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5. If TB is mentioned by family, friends, or news reports, what are your 
initial reactions and feelings? 
6. If you re diagnosed with TB in the future (or have been diagnosed in the 
past), what will be/have been your feelings towards this event? 
7. If someone in your family, close friends, or colleague mention that he/she 
has TB, what will be your feelings towards this event? 
8. Has anyone in your family been diagnosed with TB?  
a. If yes, did your behavior toward him/her change? 
b. Describe how you felt when you learned of the diagnosis. 
9. Are you aware of TB treatment facilities in Los Angeles County and the 
services provided? 
a. If no, if information was made available, (perhaps in Armenian for 
Armenians only), would you be more inclined to read about the 
disease? 
b. Would you inform others in your community? 
10. Are you aware of any social or community support groups for dealing 
with the disease? If yes, please describe. 
Instrumentation: Quantitative 
Pilot Study 
In order to determine comprehensibility and appropriateness of the quantitative 
survey, a pilot study was conducted. According to Creswell (2012, p. 165), pilot testing is 
advisable for refining questions and research instruments, assess bias, and adapt research 
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procedures. For this study, the preliminary quantitative research instrument was 
distributed to a panel of experts with qualifying credentials (e.g., PhD for at least five 
years in academia or research within the scientific community). The instrument was 
administered in paper form and through the online forum, SurveyGizmo, in order to also 
assess the test-taking environment. Revisions to the instrument were made according to 
recommendations and feedback by the panel. Subsequently, a small sample (15 to 20 
people) was selected to pilot test the revised survey. Participants for the pilot study were 
both Armenian and non-Armenians living in LA County and were recruited in the same 
fashion as the main study (flyers, consent forms etc.). This was also conducted in the 
same online test-taking environment as the officially launched study. 
Survey 
For the quantitative portion of this mixed-methods study, a pre-tested survey 
questionnaire was administered to roughly 200 participants, approximately100 Armenian 
and 100 non-Armenian, to further understand TB knowledge in the two populations and 
to determine if there are differences among the two groups. Questions were similarly 
phrased as in the qualitative study; however, questions were closed-ended and options 
were provided in more of a Likert scale format to facilitate quantitation and data analysis. 
Some questions allowed for the participant to fill-in a response as well as select multiple 
options. 
A key threat to validity and reliability for quantitative studies involves 
instrumentation, which in this case was the survey questionnaire. An original 
questionnaire was generated in order to ensure cultural sensitivity and relevance to the 
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Armenian community. This presented some challenges because, as an original 
questionnaire, assurances regarding its validity and cohesiveness may be lacking. 
Therefore, pretesting was required to ensure questionnaire appeal and ease of 
comprehension. To remove some ambiguity, the questionnaire was provided in English 
and Armenian. Pretesting also ensured that all translations were comprehensible and 
accurate. 
Questions included in the survey questionnaire were (See Appendix C for 
Armenian translation):  
Basic background information 
1. How old are you? 
a. 18-20, b. 21-30 c. 31-40, d. 41-50, e. 51-60, f. 61-70, g. > 70 years old 
2. What is your gender? 
a. Male b. Female 
3. What is your race? 
a. White, non-Hispanic or Latino, b. White, Armenian, c. White, Hispanic or 
Latino, d. Black / African American, e. Asian, f. American Indian / 
Alaskan native, g. Native Hawaiian or Pacific Islander, h. two or more 
races, Armenian i. two or more races, non-Armenian 
4. What is your ethnicity? 
a. Non-Hispanic, Latino, or Spanish origin, b. Mexican, Mexican-American, 
Chicano, c. Puerto Rican, d. Cuban, e. other Hispanic, Latino, or Spanish 
origin (e.g., Argentinian, Columbian, Dominican, Salvadoran) 
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5. What is your country of origin (fill in)? ______________ 
6. How many years have you been living in United States? 
a. a. less than 1 year b. 1-5 years c. 6-10 years d. 11-20 years e. > 20 years 
7. What city do you currently reside in? 
a. Glendale, b. Pasadena/South Pasadena, c. Burbank, d. San Fernando, e. 
Santa Monica/West Los Angeles, f. Downey/Montebello/South Gate, g. 
other _______________ 
8. What is your marital status? 
a. Single, never married, b. married, c. divorced, d. widowed, e. separated 
9. How many people are living in your household (excluding yourself)? 
a. 0, b. 1 c. 2-4, c. 5-6, d. > 6 
10. Describe their relationship to you? (select all that apply) 
a. Spouse or partner, b. child, c. sibling, d. elderly parents or grandparents, e. 
other _______________ 
11. Is English the primary language spoken in your household? a. yes b. no 
12. What other languages are spoken in your household? 
a. Armenian, b. Spanish, c. none, d. other______________ 
13. What is your highest level of education? 
a. High school, b. some college, c. bachelor’s degree, d. graduate / 
professional degree 
14. What is your occupation? 
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a. Unemployed, b. retired, c. homemaker, d. student, e. professional (doctor, 
lawyer, teacher), f. manual laborer (skilled or unskilled worker) 
15. What is your total annual household income (pre-tax)? 
a. 0-$25,000, b. $25,001-$40,000, c. $40,001-$60,000, d. $60,001-$80,000, 
e. $80,001-$100,000 f. > $100,000  
16. Do you have health insurance? a. yes, b. no 
17. Do you trust your primary care physician? a. yes, b. no, c. I don’t have one 
18. Do you seek spiritual guidance upon diagnosis of any disease, either for you 
or family/friends? a. yes, b. no 
19. When feeling sick, do you use home remedies (e.g., massages, herbs, oils, 
drink herbal or spiced teas)? A. yes, b. no 
TB specific questions 
1. Have you heard of the disease tuberculosis (TB)? a. yes, b. no  
2. How have you heard about TB? (check all that apply) 
a. TV, b. Internet, c. family or friends, d. newspaper/magazine e. 
other________ 
3. Do you believe that TB is a modern day health problem in the US? a. yes, b. 
no 
4. Do you believe that TB is a modern day health problem internationally?         
a. yes, b. no 
5. How is TB transmitted? 
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a. Coughing, sneezing, b. touching, c. sexual contact, d. food/water 
ingestion, e. smoking, f. imbalance of hot and cold, g. do not know 
6. What is the most common symptom of TB? 
a. Coughing, b. sneezing, c. loss of appetite, d. tiredness/fatigue, e. bleeding, 
e. do not know 
7. Are you aware of treatment available for treating TB? a. yes, b. no 
8. How long is the treatment regimen? 
a. 3 days, b. 1 week, c. 1 month, d. > 6 months, e. do not know 
9. Is TB treatment 100% effective? a. yes, b. no, c. do not know 
10. Is TB a curable disease? a. yes, b. no, c. do not know 
11. If TB is mentioned by family, friends, or news reports, what are your initial 
reactions and feelings? 
a. Frightened, b. informed, c. indifferent, d. helplessness 
12. Have you or anyone in your family been diagnosed with TB? a. yes, b. no 
13. If yes, how did you feel? (select any that apply) 
a. Frightened, b. informed, c. indifferent, d. helpless, e. depressed 
14. What factors do you associate with TB? (select any that apply) 
a. Poverty, b. foreign-born, c. HIV status, d. drug history, e. low social class, 
f. sexual orientation, g. mental illness, h. religion, i. a common disease, k. 
a curable disease, l. smoking, m. imbalance of hot and cold, n. 
incarceration 
15. If someone has TB, you think that (select any that apply): 
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a. he/she probably did something wrong, for example use of drugs, b. it’s a 
punishment given by the God, c. he/she has the disease because of his/her racial 
background, d. it could happen to anyone 
16. 
If you had TB, would you: 
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a. 
Trust doctors to cure it?      
b. 
Be compliant with doctors’ instructions 
regarding treatment? 
     
c. 
Seek treatment outside the hospital/ 
private practice setting 
     
17. If you would seek treatment outside of a hospital/ private practice setting, 
where would you go? (select any that apply) 
a. Chiropractor, b. Acupuncturist, c. Homeopathic doctor/nutritionist, d. 
Religious/ church leader, e. massage therapist, f. home remedies (herbs, 
oils, teas), g. I wouldn’t. 
18. Are you aware of TB treatment facilities in Los Angeles County and the 
services provided? a. yes, b. no 
19. If no, if information was made readily available, would you be more inclined 
to read about the disease and inform others in your community?  a. yes, b. no 
20. Are you aware of social support groups in your community for dealing with 
the disease? a. yes b. no 
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Recruitment, Participation, and Data Collection  
All participants were recruited using social media and flyers in public places such 
as local churches, church groups, community centers and businesses located within LA 
County. Participant recruitment for the qualitative study also involved snowball 
sampling, as described earlier, in order to gain access to Armenians and non-Armenian 
living in LA County, primarily SPA-2. The project goals were outlined and informed 
consent was obtained in order to move forward with the in-depth interviews as well as 
with the completion of the surveys. Furthermore, participants were alerted to the fact that 
a follow-up may be required if there are ambiguities in responses or if something required 
clarification. An Armenian speaker was present for Armenian participants to ensure that 
all intentions and goals were understood, and also provided a signed confidentiality 
agreement in order to be included in the study.  
For those who responded positively to the invitation, an email and phone number 
of the researcher was made available to all interested parties. A separate email and phone 
number was set-up by the researcher to maintain professionalism and exclusivity to the 
study. For those completing the quantitative survey online, the letter of consent 
(Appendices D, E, F, and G) was checked to reflect participant willingness to agree to 
study terms and participate. They were available in English or Armenian, depending upon 
participant preference. Upon completion, a thank you was generated. A $10 Target gift 
card was also provided as compensation for those who participated in the qualitative 
component of the study. 
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All data have been stored electronically, with backups on a separate password 
protected computer. Furthermore, recordings for the qualitative interviews were copied 
and serve as a backup in case the original becomes compromised from overuse or 
researcher error during transcription. 
Data Analysis 
In the study, perceived barriers and factors were explored using in-depth 
interviews and surveys with Armenians and non-Armenians in the community. For the 
qualitative component, data and coding were divided based upon key words or phrases 
for each question, with the use of Microsoft Excel and Word software. Also, these data 
were analyzed thematically. Microsoft Word can be used for “coding and retrieving, 
semi-automated coding and inspection, creating hierarchies of code categories via 
indexing, global editing of theme codes, coding of ‘face sheet’ data, exploring 
relationships between face-sheet codes and conceptual codes, quantifying the frequency 
of code instances, and annotating text” (LaPelle, 2004). Further, thematic analysis was 
selected since it is a widely used approach for detecting, analyzing and reporting themes 
within qualitative data (Braun & Clarke, 2006). The six phases of analysis were the 
following: familiarizing with the data, generating initial codes, searching for themes, 
reviewing themes, defining and naming themes and finally producing a scholarly report 
of the analysis (Braun & Clarke, 2006).  
For the quantitative component, the goal is to explore whether there are 
differences in barriers to treatment-seeking and adherence for TB in Armenian versus 
non-Armenian populations living in LA County and which factors (e.g., physical, 
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cultural, psychosocial, behavioral) have the greatest influence (Table 1). First, all data was 
entered into Statistical Program for Social Sciences (SPSS; IBM Corporation, version 
21). Then, since all variables of the study were categorical, frequencies were calculated 
and reported. Second, bivariate analysis (chi-square test) was used to test the strength of 
associations between independent (barriers or factors relating to TB treatment seeking 
and adherence, such as ethnicity, demographics, cultural beliefs etc.) and dependent 
variables (knowledge regarding TB treatment seeking and treatment adherence). Finally, 
the estimates of the relative risks of the dependent variable were reported by calculating 
the odds ratios (ORs) and the corresponding 95% confidence intervals (CIs), using 
multinomial logistic regression analysis (for more details on the statistical procedures, see 
Table 2). The dependent variable was knowledge regarding TB treatment seeking and 
treatment adherence and predictors were all the aforementioned independent variables. 
Significant confounders, as well as interactions were retained in the models. Deviance 
residuals were calculated to evaluate the model's goodness-of-fit. All reported probability 
values (p-values) were compared to a significance level of 5%.  
In order to integrate the data from the qualitative and quantitative studies, the data 
were analyzed separately and then merged. The merged results from data analysis were 
then related back to the research questions. 
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Table 1 
Variables, Research Questions, and Items on Surveys 
Research Question Variable Item number(s) in Survey 
1. What are the perceived 
barriers to treatment 
seeking and adherence for 
Tuberculosis in an 
Armenian population 
living within the United 
States? 
1. Ethnicity/race 
(IV) 
“TB Specific” #14, 15 
2. Cultural beliefs 
(IV) 
“TB Specific” #14, 15 
3. Demographics 
(IV) 
“TB Specific” #14, 15 
4. Religion (IV) “TB Specific” #15, 17 
5. Knowledge (DV) “TB Specific” # 1-13, 16, 18,19 
2. Is there a difference in 
barriers to treatment 
seeking and adherence for 
Tuberculosis in Armenian 
versus non-Armenian 
populations living in LA 
County and which factors 
(e.g., physical, cultural, 
psychosocial, behavioral) 
have the greatest 
influence? 
1. Ethnicity/race 
(IV) 
“Basic background information” # 3, 4; 
“TB Specific” #14, 15 
2. Cultural beliefs 
(IV) 
“Basic background information” #17, 19; 
“TB Specific” #5, 14, 15 
3. Demographic (IV) “Basic background information” # 1, 2, 5-
15, “TB Specific” #14, 15 
4. Religion (IV) “Basic background information” # 16, 18; 
“TB Specific” #15, 17 
5. Knowledge (DV) “TB Specific” # 1-13, 16, 18, 19 
Note. IV = independent variable; DV = dependent variable 
Table 2 
Statistical Procedures Per Research Question and Hypothesis 
Research Question Hypothesis (Ha) Variables Statistical Procedure/ 
Analysis 
RQ2: Is there a difference 
in barriers to treatment 
seeking and adherence for 
TB in Armenian versus non-
Armenian populations 
living in LA County and 
which factors (e.g., physical, 
cultural, psychosocial, 
behavioral) have the 
greatest influence? 
There are 
differences in 
factors relating to 
treatment seeking 
and adherence for 
TB in Armenian 
versus non-
Armenian 
populations in LA 
County 
IV: 
barriers / 
factors  
1. Univariate: Frequency 
DV: TB 
knowledge 
2. Bivariate: Chi-square test 
(χ2) 
 3. Multivariate: 
Multinomial Logistic 
Regression (Odds Ratios 
(ORs) and Confidence 
Intervals (CIs)) 
 
 
Threats to Validity 
When a study is tailored to a specific population, threats to external validity occur 
through generalizability (McKenzie, Neiger, & Thackeray, 2009, p. 369). With this 
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particular study, the focus was on Armenians residing in LA County.  LA County is 
home to the second largest population of Armenians in the country and world (Hayk the 
Ubiquitous Armenian, 2012), and therefore it is believed that it the study involves a 
representative pool. However, the social and economic factors impacting the study may 
not be generalizable to Armenians living in other parts of the world. Furthermore, 
cultural elements will be specific only to Armenians, and possibly those living the former 
Soviet Union, and may therefore lack generalizability to other populations. However, the 
goal of this study was to address the gap in developing suitable public health intervention 
TB programs specific for this at-risk population. 
Sampling validity is also a potential concern. Here, the concern is whether the 
target population is adequately sampled by the instrument being used to measure or 
address the question. This is a problem when investigators construct and employ 
instruments for the first time (Frankfort-Nachmias & Nachmias, 2008, p. 150). Due to the 
specificity of this study design as it relates to a specific population, sampling validity 
may have become a threat. However, pilot testing was conducted ahead of time to ensure 
that the questionnaires were adequately measuring what they were intended to measure. 
Trustworthiness 
This mixed-methods study addresses the issue of credibility through the use of 
triangulation and peer review. Triangulation, the use of multiple methods of data 
collection to test hypotheses and measure variables (in this case qualitative and 
quantitative data, using convergent parallel design), is a useful strategy for limiting the 
validity of scope and minimizing specificity relating to a particular method of data 
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collection (Frankfort-Nachmias & Nachmias, 2008, p. 189). In this study, both in-depth 
interviews and questionnaire surveys were utilized. The in-depth interviews allowed for 
observation of participant as well as verbal content to each question. At the end of both 
studies, analyzed data were merged. If the findings obtained from the two collection 
methods concur, then the validity of findings are increased (Frankfort-Nachmias & 
Nachmias, 2008, pp. 189–190). Triangulation further established dependability of the 
study. Furthermore, the dissertation supervisor (V.M.) was incorporated to serve as a 
peer-reviewer to ensure proper interpretation of responses and results. This also serves as 
a means to improve dependability of the findings. 
Transferability is similar to generalizability in that it can threat the validity of a 
study if the population is too limited. Again, one component of this study was an 
ethnography focusing on Armenians living in LA County. Should other researchers 
attempt to replicate these finding, alterations may need to be made to accommodate 
specific attributes of the population being studied. 
Ethical Considerations 
This study was conducted in accordance with guidelines established by Walden 
University’s IRB, approval number 04-24-14-0230517. All necessary IRB documentation 
is shown in Appendix A, which addresses access to participants, appropriate treatment of 
participants, and institutional permissions. 
With research involving human subjects, ethics must always be considered and 
addressed in order to protect participant’s basic human rights. Robson (2011, p. 200) has 
88 
 
 
highlighted ten questionable practices in social research that will be avoided and 
addressed in this study (Table 3). 
Table 3 
Ten Questionable Practices in Social Research 
1 Involving people without their knowledge or consent 
2 Coercing them to participate 
3 Withholding information about the true nature of the research 
4 Otherwise deceiving the participant 
5 Inducing them to commit acts that may diminish self-esteem 
6 Violating rights of self-determination 
7 Exposing participants to physical or mental stress 
8 Invading their privacy 
9 Withholding benefits from some participants 
10 Not treating participants fairly, or with consideration, or with respect 
 
When recruiting and enrolling participants, the project was explained clearly both 
verbally and in writing. For Armenian participants, an Armenian translator was made 
available during the qualitative component. All questionnaires were made available in 
Armenian. Upon acceptance, participants were required to read and sign the letter of 
consent form (Appendices D and E), reflecting their understanding of the project and 
their involvement. Confidentiality was ensured for the qualitative component; whereas 
anonymity and confidentiality was ensured for the quantitative component. Each 
participant was given a randomized code, which were used throughout the entire process, 
including data analysis. The peer-reviewer was not privy to any participant’s name or 
information. 
Data, including coding logs, were stored in a locked file cabinet, off-premises 
from the researcher for 5 years. Subsequent to this, all data, including transcripts and 
coding logs, will be destroyed. 
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Summary 
This concurrent mixed-methods study is designed to address the gap that exists in 
the body of knowledge regarding perceived barriers to TB treatment-seeking and 
adherence relative to a susceptible population, Armenians living in the United States, 
namely LA County, and in Armenia. This was achieved through in-depth interviews and 
surveys designed to assess TB knowledge and treatment-seeking and adherence behaviors 
in Armenian versus non-Armenians living in LA County, using the convergent parallel 
design. Measures to ensure internal and external validity in the study, along with ethical 
concerns, were also addressed. Data analysis and interpretation of the two studies were 
conducted and then merged.  
Chapter 4 will detail the results and findings from the two components of the 
study. 
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Chapter 4: Results 
Introduction 
The purpose of this mixed-methods study was to explore factors (physical, 
psychosocial, cultural, or behavioral) relating to TB knowledge, treatment-seeking and 
adherence among Armenians living in LA County and compare them to non-Armenian 
living in LA County. Such differences may impact the reduction of TB incidence in the 
highly susceptible Armenian population. To understand the general perceptions about 
TB, along with perceived barriers to TB treatment and treatment adherence in both 
groups, the qualitative component of this study used in-depth interviews of both 
Armenians and non-Armenians living in LA County. A survey was used with the 
quantitative component to explore whether such barriers to treatment-seeking and 
adherence differ between Armenians and non-Armenians living in LA County, which 
have implications for reduction in the incidence of disease. Both survey instruments were 
original and required pretesting or pilot testing prior to administration. 
Research question 1 (RQ1) was a descriptive inquiry whereas Research question 2 
(RQ2) was inferential in nature: 
RQ1. What are the perceived barriers to treatment seeking and adherence for 
tuberculosis in an Armenian population living within the United States? 
RQ2. Is there a difference in barriers to treatment seeking and adherence for 
tuberculosis in Armenian versus non-Armenian populations living in Los Angeles 
County and which factors (e.g., physical, cultural, psychosocial, behavioral) have 
the greatest influence? 
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HA2: There are differences in factors relating to treatment seeking and 
adherence for tuberculosis in Armenian versus non-Armenian populations 
in Los Angeles County. 
H02: There are no differences in factors relating to treatment seeking and 
adherence for tuberculosis in Armenian versus non-Armenian populations 
in Los Angeles County. 
This chapter details the data collection methods and data analyses from both the 
qualitative and quantitative components. For the qualitative element, responses were 
tabulated using Excel and common themes extracted and organized Word. For the 
quantitative element, SPSS, version 21, software was used to conduct univariate, 
bivariate, and multivariate analyses of the data. The findings from both study components 
were further triangulated and themes merged and related back to the research questions. 
Pilot Study 
A pilot study was conducted for the quantitative survey to ensure 
comprehensiveness, appropriateness, and lack of bias of the questions, invitation, and 
testing forum. The preliminary quantitative research instrument was distributed in paper 
form and through the online forum to a panel of experts with qualifying credentials (e.g., 
PhD for at least five years in academia or research within the scientific community). 
Once feedback was provided by the expert panel, minor revisions were made to the 
survey instrument which included minor wording of question to remove ambiguities. 
Subsequently, a small sampling of 35 people comprised of 17 Armenians and 18 non-
Armenians living in LA County were recruited in the same fashion as the main study 
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(flyers, consent forms etc.). Of the 35 recruited participants, 23 completed either the 
paper version, online version, or both. All participants were asked to keep track of time to 
completion and the invitation was adjusted to reflect the average time. Criticisms relating 
to the questions as originally proposed or the test taking environment were minimal. 
Some changes that were made included allowing participants to specify/ fill-in responses 
for the “other” option for background question SQ7 and tuberculosis-specific questions 
SQ2 and SQ13. This helped in further clarifying and stratifying answers for data analysis. 
Upon incorporating the suggested changes, the official study was launched in the online 
forum, SurveyGizmo. 
Setting 
For both the qualitative and quantitative component, Armenian translated 
questionnaires and surveys were made available to Armenian participants. Furthermore, 
an Armenian translator was available for all Armenian participant interviews. Initial 
questionnaire and survey questions were translated by a fluent Armenian speaker, whom 
is also employed as an English-Armenian translator. The questionnaires and surveys were 
translated into Western Armenian, as opposed to Eastern Armenian, because the primary 
dialect spoken in LA County is Western Armenian. While the two dialects have many 
similarities, any participants whom were more familiar with Eastern may have 
encountered minimal confusion. All of the translations were then back-translated to 
verify validity and accuracy of the questions by an unrelated Armenian speaker, whom is 
fluent in both Eastern and Western dialects. This individual also served as the translator 
for the face-to-face interviews. As recommended by Walden’s IRB committee, a 
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confidentiality agreement and NIH Human Subjects training were completed by the 
translator. 
Demographics 
For both the qualitative and quantitative study, participants living in LA County 
were recruited and classified as either Armenian or non-Armenian. A participant was 
classified as Armenian if they were born in Armenia, emigrated from Armenia, were two 
or more races (one of which being Armenian), and/or were born in the United States and 
speak Armenian in their household. All such information was extracted from various 
questions on both surveys and questionnaires. Furthermore, participants were required to 
live in LA County and be at least 18 years of age. Several participants from the 
quantitative study were removed post-participation due to the lack of fulfillment of these 
requirements. 
Data Collection 
Qualitative Component 
For the qualitative study, the goal was to recruit 15-25 participants over 18 years 
of age living in LA County, with relative equal distribution between classifications of 
Armenian and non-Armenian. Ultimately, 10 Armenians and 8 non-Armenians met the 
specified criteria and were interviewed face-to-face. Table 4 summarizes the overall 
demographics of the Armenian and non-Armenian participants. The Armenian contingent 
has spent fewer years living in the United States than the non-Armenian group, though 
the age distribution is relatively the same among groups. This suggests that the 
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Armenians are likely more first and second generation where cultural traditions may be 
more influential. 
 
Table 4 
Characteristics of Individuals  Interviewed about Tuberculosis Knowledge and 
Perceptions (n = 18) 
Characteristics No. of 
Individuals,
Armenians 
(%) 
No. of 
Individuals, 
Non-Armenian 
(%) 
Classification 10 8 
Gender 
Male 
Female 
 
2 (20) 
8 (80) 
 
3 (37.5) 
5 (62.5) 
Age 
18-30 
31-40 
41-50 
51-60 
>60 
 
3 (30) 
0 
1 (10) 
3 (30) 
3 (30) 
 
1 (12.5) 
2 (25) 
2 (25) 
0 
3 (37.5) 
Country of Origin 
Iran 
Iraq 
Lebanon 
Mexico 
Romania 
United States 
 
5 (50) 
3 (30) 
1 (10) 
0 
0 
1 (10) 
 
1 (12.5) 
0 
0 
1 (12.5) 
1 (12.5) 
5 (62.5) 
Years in United States 
≤ 20 years 
> 20 years 
 
6 (60) 
4 (40) 
 
1 (12.5) 
7 (87.5) 
City Residing In LA County 
Altadena / Pasadena 
Glendale 
Granada Hills 
Rancho Cucamonga 
 
2 (20) 
8 (80) 
0 
0 
 
5 (62.5) 
1 (12.5) 
1 (12.5) 
1 (12.5) 
Marital Status 
Single, never married 
Married 
Divorced 
 
3 (30) 
3 (30) 
1 (10) 
 
1 (12.5) 
5 (62.5) 
2 (25) 
(table continues) 
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Widowed 
Separated 
3 (30) 
0 
0 
0 
Residence Type 
Apartment, rent 
Condominium, own 
House, own 
House, rent 
 
0 
1 (10) 
6 (60) 
3 (30) 
 
1 (12.5) 
0 
5 (62.5) 
2 (25) 
Number of People in Household (excluding self) 
0 
1 
2-4 
5-6 
 
2 (20) 
0 
6 (60) 
2 (20) 
 
1 (12.5) 
1 (12.5) 
5 (62.5) 
1 (12.5) 
 Primary Language Spoken in Household 
Armenian 
English 
Spanish 
Other 
 
10 (100) 
0 
0 
0 
 
0 
5 (62.5) 
2 (25) 
1 (12.5) 
Educational Level 
High School 
Some College 
Bachelor’s Degree 
Graduate/Professional Degree 
 
2 (20) 
0 
6 (60) 
2 (20) 
 
3 (37.5) 
0 
4 (50) 
1 (12.5) 
Occupation 
Unemployed 
Retired 
Homemaker 
Student 
Professional 
Manual Laborer 
 
0 
1 (10) 
3 (30) 
1 (10) 
5 (50) 
0 
 
0 
3 (37.5) 
0 
0 
4 (50) 
1 (12.5) 
Annual Household Income 
$0-$40,000 
$40,001-$100,000 
>$100,000 
 
6 (60) 
3 (30) 
1 (10) 
 
1 (12.5) 
4 (50) 
3 (37.5) 
Health Insurance 
Yes 
No 
 
7 (70) 
3 (30) 
 
7 (87.5) 
1 (12.5) 
Trust Primary Care Physician 
Yes 
No 
Don’t have one 
 
7 (70) 
2 (20) 
1 (10) 
 
7 (87.5) 
1 (12.5) 
0 
Annual visits to Physician 
0-1 
2-4 
 
7 (70) 
1 (10) 
 
2 (25) 
5 (62.5) 
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5-6 
>6 
1 (10) 
1 (10) 
1 (12.5) 
0 
Use Home Remedies 
Yes 
No 
 
10 (100) 
0 
 
8 (100) 
0 
Seek Spiritual Guidance 
Yes 
No 
 
6 (60) 
4 (40) 
 
4 (50) 
4 (50) 
 
Recruitment for the qualitative component was purposive and relied primarily on 
snowball sampling, as proposed. Overall, recruitment spanned over a period of two 
months, from February through the end of March of 2015. Many of the face-to-face 
interviews were conducted at the participant’s residence or a friend’s residence. This may 
have contributed to the participant’s willingness to consent and conduct the interviews 
and therefore be open with their responses due to their increased comfort level. All 
interviews were recorded, with prior knowledge and consent by the interviewee. On 
average, each interview took ten minutes. Following the recorded interview, time was 
taken to explain tuberculosis, its history, and relevance to today in more detail. All 
participants appeared quite interested and appreciated this extra effort in order to 
understand that TB remains a public health threat, particularly among the Armenian 
community living locally and in their native country. 
Quantitative Component 
For the quantitative study, it was proposed to recruit 200 participants over 18 
years of age living in LA County, half of which were Armenian and half non-Armenian. 
Overall, a total of 130 participants completed the survey; however, three were removed 
97 
 
 
from the study due to residing outside of LA County. This resulted in a final tally of 72 
non-Armenians (56.7%) and 55 Armenians (43.3%) qualified participants. The resulting 
post-hoc power analysis was satisfactory > 0.90. This was determined using G* Power 3 
calculator software (version 3.1.4) and logistic regression test, an alpha level of 0.05, and 
an odds ratio of 0.347 (for “TB route of Transmission” as the dependent variable, with  
the weakest obtained significant p value, 0.05) as determined below in data analysis 
(Table 12).  
Table 5 provides a summary of the demographics pertaining to both participant 
populations. More females participated in the survey than males (62.2% vs 37.8%), with 
the majority of participants living in the United States more than 20 years (89%). The 
latter observation is a more skewed than in the qualitative study where the populations 
were more even evenly distributed, with the Armenians having spent less time in the 
United States (< 20 years). Furthermore, 67.7% of participants were classified as 
professional (e.g., doctor, lawyer, teacher) and 50.4% have an annual household income 
> $100,000, potentially impacting socioeconomic implications. While the majority of 
respondents trust their primary care physician (86.6%), 66.1% also rely on home 
remedies for personal medicinal therapy and 70.9% do not seek spiritual guidance upon 
receiving diagnosis of a disease for themselves or close family/friends. 
Table 5 
Descriptive Statistics – Demographic Variables (n = 127) 
Demographic Frequency (ƒ) Percent (%) 
Classification 
Armenian 
Non-Armenian 
127 
55 
72 
 
43.3 
56.7 
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Gender 
Male 
Female 
 
48 
79 
 
37.8 
62.2 
Age 
18-30 
31-40 
41-50 
>50 
 
32 
49 
28 
18 
 
25.2 
38.6 
22.0 
14.2 
Race 
White, Non-Hispanic/Latino 
White, Armenian 
White, Hispanic/Latino 
Black, African American 
Asian 
2 or more, Armenian 
2 or more, non-Armenian 
 
55 
37 
10 
1 
8 
12 
4 
 
43.3 
29.1 
7.9 
0.8 
6.3 
9.4 
3.1 
Ethnicity 
Non-Hispanic, Latino, or Spanish Origin 
Mexican, Mexican American, Chicano 
Cuban 
Other Hispanic, Latino, or Spanish Origin (e.g., 
Argentinian, Columbian, Salvadoran, 
Dominican) 
 
109 
9 
1 
8 
 
85.8 
7.1 
0.8 
6.3 
Country of Origin 
Armenia 
Canada 
Egypt 
El Salvador 
European Countries 
Hong Kong 
Iran 
Japan 
Lebanon 
Mexico 
Philippines 
Turkey 
United States 
 
4 
1 
1 
1 
2 
1 
3 
1 
9 
1 
2 
1 
100 
 
3.1 
0.8 
0.8 
0.8 
1.6 
0.8 
2.4 
0.8 
7.1 
0.8 
1.6 
0.8 
78.7 
Years in United States 
≤ 20 years 
> 20 years 
 
140 
113 
 
11.0 
89.0 
City Residing In (LA County) 
Glendale 
Pasadena/South Pasadena 
 
9 
31 
 
7.1 
24.4 
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Burbank 
San Fernando 
Santa Monica/ West Los Angeles 
Downey / Montebello / South Gate 
Other 
Alhambra 
Altadena 
Azusa 
Canoga Park 
Cerritos 
Claremont 
Glendora 
Hollywood 
La Crescenta 
La Habra 
La Verne 
Long Beach 
Los Angeles 
Monrovia 
North East LA 
Northridge 
Norwalk 
Pomona 
Porter Ranch 
Reseda 
San Dimas 
San Gabriel 
Santa Clarita 
Shadow Hills 
South Bay 
Sun Valley 
Sunland 
Tujunga 
Upland 
Venice 
Winnetka 
5 
2 
8 
4 
68 
4 
3 
1 
1 
2 
5 
3 
2 
1 
1 
1 
5 
10 
1 
1 
4 
1 
4 
3 
1 
2 
1 
1 
1 
1 
1 
2 
2 
1 
1 
1 
3.9 
1.6 
6.3 
3.1 
53.5 
3.1 
2.4 
0.8 
0.8 
1.6 
3.9 
2.4 
1.6 
0.8 
0.8 
0.8 
3.9 
7.8 
0.8 
0.8 
3.1 
0.8 
3.1 
2.4 
0.8 
1.6 
0.8 
0.8 
0.8 
0.8 
0.8 
1.6 
1.6 
0.8 
0.8 
0.8 
Marital Status 
Single, never married 
Married 
Divorced 
Widowed 
Separated 
 
53 
67 
4 
1 
2 
 
41.7 
52.8 
3.1 
0.8 
1.6 
Number of People in Household (excluding self)   
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0 
1 
2-4 
5-6 
>6 
15 
25 
81 
5 
1 
11.8 
19.7 
63.8 
3.9 
0.8 
Household Relation 
Spouse/ Partner 
Spouse/Partner, Child 
Spouse/Partner, Child, Elderly parent/ 
grandparent 
Spouse/Partner, Child, Other 
Spouse/Partner, Elderly parent/ grandparent, 
other 
Spouse/Partner, other 
Child 
Child, Elderly parent/grandparent 
Sibling 
Sibling, Elderly Parent / grandparent 
Elderly Parent / grandparent 
Other 
Friend 
Housemate / Roommate 
Niece 
Whole family 
 
37 
39 
1 
 
1 
2 
 
1 
6 
1 
3 
11 
5 
5 
3 
4 
1 
1 
 
29.1 
30.7 
0.8 
 
0.8 
1.6 
 
0.8 
4.7 
0.8 
2.4 
8.7 
3.9 
3.9 
2.4 
3.1 
0.8 
0.8 
English Primary Spoken Household Language 
Yes 
No 
 
106 
21 
 
83.5 
16.5 
Primary Household Language (non-English) 
Armenian 
Spanish 
None 
Other 
Arabic 
Armenian, Russian 
German 
Korean 
Mandarin 
Russian, Turkish 
Turkish, Arabic 
 
40 
8 
72 
7 
1 
1 
1 
1 
1 
1 
1 
 
31.5 
6.3 
56.7 
5.5 
0.8 
0.8 
0.8 
0.8 
0.8 
0.8 
0.8 
Educational Level 
High School 
Some College 
Bachelor’s Degree 
 
7 
26 
46 
 
5.5 
20.5 
36.2 
(table continues) 
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Graduate/Professional Degree 48 37.8 
Occupation 
Unemployed 
Retired 
Homemaker 
Student 
Professional (e.g., lawyer, doctor, teacher) 
Manual Laborer 
 
4 
4 
9 
18 
86 
6 
 
3.1 
3.1 
7.1 
14.2 
67.7 
4.7 
Annual Household Income 
$0-$40,000 
$40,001-$100,000 
>$100,000 
 
21 
42 
64 
 
16.5 
33.1 
50.4 
Health Insurance 
Yes 
No 
 
120 
7 
 
94.5 
5.5 
Trust Primary Care Physician 
Yes 
No 
Don’t have one 
 
110 
3 
14 
 
86.6 
2.4 
11.0 
Seek Spiritual Guidance 
Yes 
No 
 
37 
90 
 
29.1 
70.9 
Use Home Remedies (herbs, teas, etc.) 
Yes 
No 
 
84 
43 
 
66.1 
33.9 
 
The survey was administered online through SurveyGizmo over the span of 8 
months, from July 2014 to February 2015. Recruitment was again purposive where 
snowball sampling was the primary mode, relying on social media and paper flyers 
distributed in local businesses in the community to initiate awareness regarding the study. 
Recruitment proved to be challenging overall, which is likely due to the vastness of LA 
County despite extensive efforts by the investigator using the aforementioned avenues. 
Recruitment of the Armenian population proved to be particularly challenging as 
compared to non-Armenians despite the flyers and survey being made available in 
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Armenian. An additional fourteen participants, the majority being Armenian, failed to 
complete the survey and were thus eliminated from the participant response pool and 
subsequent data analysis. Here, all of the questions relating to demographics were 
completed with attrition occurring once tuberculosis-related questions were encountered.  
Data Analysis 
Qualitative Component 
During each of the face-to-face interviews, a paper interview guide (Chapter 3 
and Appendix B) was used for each individual to direct the flow of the interview 
questions and allow for note-taking, while everything was being voice recorded. This was 
also the case for those requiring the Armenian translator. Once all of the face-to-face 
interviews were completed, the recorded interviews were played repeatedly until every 
word was transcribed verbatim. The researcher also met with the Armenian translator on 
a separate occasion to transcribe all of the Armenian respondents verbatim. Copies of the 
written transcripts were de-identified and provided to the peer reviewer. 
To facilitate finding themes, the responses to each question by each respondent 
were tabulated in an Excel spreadsheet. From there common themes and subthemes were 
identified and coded in Microsoft Word. Key themes and sub-themes relating to disease 
transmission and infectivity, incidence (national and international), treatment, and feeling 
and reactions to the disease were identified and tabulated for each population, see Tables 
6 and 7 (Armenian and non-Armenian, respectively). 
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Quantitative Component 
The quantitative survey was administered using SurveyGizmo which facilitated 
data analysis as all question results can be exported directly to Excel or SPSS. Also, 
outside of SurveyGizmo, a codebook was generated based on responses for each question 
(Appendix L). Some glitches relating to coding when exporting directly from 
SurveyGizmo to SPSS were discovered, so Excel was used as an intermediary. Once all 
of the responses from completed surveys were exported into Excel, they were first 
checked for qualifications (resident of LA County and 18 years or older). Three 
participants were disqualified based on these criteria. The responses were then coded 
using the codebook for each question and respondent using extensive “if-then” statements 
in Excel. All of the coded data were then input into SPSS to check for errors. Any 
missing values were designated as “999”. These coded data were cross checked by the 
peer-reviewer to ensure that no errors were present and that data analysis could proceed. 
Results 
Qualitative Component 
Following the face-to-face interviews, the oral responses from the 10 Armenian 
(A) and 8 non-Armenian (NA) participants were transcribed verbatim. Two of the 
Armenian participants required the translator to be present during the interview and the 
translator subsequently assisted in translating the responses for the researcher. 
Furthermore, one of the Armenian participants (A10) had limited English skills, 
unbeknownst to the researcher. The translator was not present at the time of the 
interview; however, a family member was able to provide some assistance. Therefore, 
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information gathered from this respondent was limited. Following this, all responses were 
tabulated using Microsoft Excel. Themes and subthemes for each population were then 
analyzed in more detail using Microsoft Word (LaPelle, 2004). 
RQ2 addresses factors relating to TB knowledge and perceptions (e.g., physical, 
cultural, psychosocial, behavioral) in Armenians and non-Armenians living in LA 
County, and to determine differences among the populations. TB-related responses were 
broken down and grouped based on disease knowledge and awareness, and disease 
perceptions. Knowledge- and awareness-based questions explored mode of transmission, 
incidence, ability to treat, and familiarity with treatment facilities and support programs. 
Perception-based questions explored personal reactions to hearing about the disease, 
either on the news, by a close family member or friend, or if they were to hypothetically 
personally contract the disease. 
As can be seen in Tables 6 and 7, there are some similarities and differences in 
responses between the two populations. Both populations had general vague knowledge 
as to how TB is transmitted, its molecular properties, degree of infectivity, and national 
and international incidence. Both also felt like there “should be” a treatment available but 
didn’t have any details on regimen; however, only the Armenian population 
acknowledged the availability of a vaccine. When it came to perceptions and feelings 
about the disease, the Armenian population expressed more empathy, an overt 
willingness to help someone with the disease, desire to seek treatment or urge others to 
seek treatment, and seek spiritual guidance and outside education for themselves or 
others. When asked, all of the Armenian respondents had kapoot ach (blue eye) in their 
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homes, with A9 responding “Yes, it’s all around. It’s something an Armenian family has 
to have!” The non-Armenian population appeared more trepid, less willing to help others 
and urge them to seek treatment, and less open to seek spiritual guidance; however, they 
were very willing to educate themselves about the disease. 
Table 6 
Thematic Analysis of Tuberculosis Knowledge and Perceptions by 10 Armenian Adults 
Theme / 
category 
Subcategory Selected Extract(s) 
TB Mode of 
transmission 
Variable 
routes of 
transmission 
“Not so familiar with TB, think it’s airborne.” (A2) 
“Transmits, I think it’s a virus. Transmitted through 
bodily fluids.” (A6) 
“Transferred through mouth, cough, and close relations 
or contact.” (A7) 
 Awareness of infectivity 
“Contagious, in my time growing up TB patients weren’t 
allowed to stay inside at home. They were taken outside 
because very contagious or go to private hospital and 
stay there for years.” (A4) 
TB incidence Unfamiliar with reports 
“Couple of incidence in the U.S. I didn’t follow-up but 
heard of that there were such things in different states.” 
(A1) 
“No, just Ebola!” (A9) 
TB treatable Ignorance if curable 
“Should be treatable because it is bacterial. Like every 
other disease, depends upon level of how far you are and 
how damaged.” (A3) 
“For preliminary stages, yes, otherwise no.” (A5) 
 Ignorance of treatment 
“I think there is a medicine or pill for it. When I got my 
skin test, I was told not to go into the sun but I did 
anyway and it changed color. Therefore, I was given a 
prescription for medicine but never took it.” (A8) 
 Vaccine availability 
“There was an outbreak a long time ago and they 
couldn’t control it. They found vaccine for it, I think 
there is a vaccine for it.” (A6) 
Reaction if 
TB 
mentioned or 
contracted by 
others 
Empathetic 
initial 
reaction 
“Going to be sad because person will endure a lot.” (A4) 
“Sad because it is a dangerous disease and try to prevent 
getting contaminated by using masks.” (A5)  
“Initially feel that they could be going through a lot of 
stress and pain, but would want to comfort them even 
though that is not really my personality.” (A6) 
(table continues) 
106 
 
 
 
Overt 
willingness 
to help 
“Go visit and help. I’m not afraid of getting sick.” (A3) 
“I would try to help the person and support them and be 
there for them and comfort them.” (A8) 
 Spiritually influenced 
“Going to be careful around person and pray for them.” 
(A4) 
 
Pro-active in 
providing 
advice for 
seeking 
treatment 
“I would feel sorry for them and make them seek 
treatment.” (A1) 
 
 
Desire to 
improve 
disease 
knowledge 
“I would be curious as to how I could get it (e.g., from a 
person coughing). How is it transmitted? I would read 
about it more and inform myself.” (A8) 
Reaction if 
diagnosed 
with TB 
Varied Initial 
reactions 
“I would be immediately angered but family would help 
me relax but I would still think about it.” (A6) 
“If I knew it was deadly, I would try hard to not let it kill 
me.” (A9) 
 Eager to seek treatment 
“I would stay away from everybody as soon as possible 
and start treatment as soon as possible.” (A1) 
“I would stay away from everybody and get complete 
treatment before going back into society.” (A5) 
 
Seek outside 
knowledge or 
spiritual 
guidance 
“I would try to gain as much knowledge about the 
disease, read day and night in order to break it down and 
analyze it more as a physician. Secondly, try to use 
personal logic gained to see if maybe herbal medicine 
will help or maybe change environmental for a limited 
time.” (A3) 
Awareness of 
TB treatment 
facilities or 
support 
groups in LA 
County 
Completely 
unaware 
“Aware of groups for drugs and all that, but not for TB 
unfortunately.” (A1)  
“Not specifically for TB but aware of clinics that offer 
but can’t tell for certain if only TB but assuming that 
there a lot clinics available for diagnosing or testing.” 
(A3) 
TB 
information 
seeking 
Majority 
interested in 
information 
and 
informing 
others 
“No, not interested unless it becomes personal and am 
able to help them but would not seek in general.” (A3) 
“Yes, would love to hear more to know what’s going on 
and happening with the disease.” (A4) 
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Table 7 
Thematic Analysis of Tuberculosis Knowledge and Perceptions by 8 Non-Armenian 
adults 
Theme / 
category 
Subcategory Selected Extract(s) 
TB Mode of 
transmission 
Variable routes 
of transmission 
“TB is a blood disease or immune disease. Maybe 
sexually transmitted”. (NA1) 
“Disease that starts in the lungs, transmitted by viral, 
air, coughing. Transmitted using things that were in 
contacted with person that carries the disease, like 
drinking from same cup.” (NA5) 
“I don’t really know much about it. I’m assuming it is 
transmitted through moisture, saliva, sneezing, and 
maybe blood transfusions.” (NA7) 
 Awareness of infectivity 
“My understanding that it was a communicable 
disease and they had sanitariums for it.” (NA4) 
“Highly infectious. I have to be tested regularly as a 
public servant who works with children.” (NA6) 
TB incidence Unfamiliar with reports 
“Don’t recall in the past few years, but measles has. 
There’s more incidence of cancer than TB.” (NA6) 
“It’s prevalent in poor countries that don’t have 
resources.” (NA7) 
TB treatable Ignorance if curable 
“My assumption is that it’s treatable (and treatment is 
available) based on the fact that most diseases are, but 
don’t know if is life-saving or just prolong death.” 
(NA1) 
“Once you get it and don’t get medical attention, it’s 
very seldom that you thrive from it.” (NA3) 
 Ignorance of treatment 
“Don’t know specifics about treatment.” (NA7) 
“Treatable now but years ago it wasn’t.” (NA8) 
 Vaccine availability Vaccine not mentioned by any NA participant. 
Reaction if 
TB 
mentioned or 
contracted by 
others 
Trepid initial 
reaction 
“Afraid to come in contact with person.” (NA3) 
“Concerned, if a family member. If in the news, then it 
could start an epidemic, so I would be concerned.” 
(NA5) 
 
Covert 
willingness to 
help 
“It depends upon how close to me is in the 
neighborhood, then would be leery about going 
around and visiting or making contact.” (A3) 
“I would probably stay clear and would suggest that 
(table continues) 
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they make everything possible so they don’t 
contaminate other people.” (NA5) 
 Non-spiritually influenced 
There was no mention of praying for others or seeking 
outside spiritual guidance by any NA participants. 
 
Non-proactive 
in emphasizing 
treatment 
seeking 
activities 
There was no mention of advising others to seek 
treatment upon mention of a diagnosis amongst NA 
participants. 
 
Desire to 
improve disease 
knowledge 
“I would start researching from many different sources 
(e.g., colleges and doctors) and compile my own 
thoughts.” (NA1) 
“I would educate myself on what I can or cannot do 
around them to know how the possibility of 
transmission.” (NA7) 
Reaction if 
diagnosed 
with TB 
Trepid Initial 
reaction 
“I would be scared. Am I going to live? Could I give it 
to my kids?” (NA1) 
“I’ve never been diagnosed, but if I were I would be 
shocked.” (NA5) 
 Willing to seek treatment 
“I would definitely seek medical treatment.” (NA5) 
“I wouldn’t be scared. It’s just like any other disease 
and would go to doctor.” (NA8) 
 
Seek outside 
knowledge or 
guidance 
“I would immediately research to see exactly how 
scared I would be and how transmissible it is.” (NA1) 
Awareness of 
TB treatment 
facilities or 
support 
groups in LA 
County 
Completely 
unaware 
“Not aware but feel like there is because there are 
support groups for everything (e.g., drug abusers, 
sexual abusers, cancer, death). Don’t know specifics 
on location. Don’t know anyone who would seek it 
out unless had the disease.” (N1) 
“Used to have a sanitarium in the Foothills many years 
ago (~50 years ago).” (N4) 
TB 
information 
seeking 
Concordant 
interest in 
information and 
informing 
others 
“Yes, love educating self. Knowledge is power.” 
(NA1). 
“If it were brief and not a book, yes would want to 
know if it was existing.” (NA4) 
 
Some of the questions not relating to TB yielded similar responses in regards to 
doctor trust, the use of home remedies, and spiritual guidance, with positive outlooks on 
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most accounts (Tables 4 and 8). For both groups, the majority (> 80%) expressed great 
trust in the ability of their doctor to effectively diagnose and treat any given disease; 
however, a minority (≤ 20%) expressed a harsh distrust. Both groups had a similar 
distribution of individuals who seek spiritual guidance upon receiving news of a disease 
diagnosis for either themselves or close family/friends and those who don’t. Overall, all 
participants opted for the use of home remedies, either prior to seeking a doctor’s 
consultation and/or most continued taking the home remedy following prescription of 
treatment by a doctor. 
Table 8 
Thematic Analysis of Non-tuberculosis Perceptions by 10 Armenian and 8 Non-Armenian Adults 
Theme / 
category 
Subcategory Selected Extract(s) 
Doctor Trust Positive Outlook 
A1: “I don’t have a particular one, but I should trust who I 
get.” 
NA1: “Yes, but all are prone to error and some tests don’t 
find things, for example cancer, heart condition, etc. Once 
see a physician, I trust them enough to ask for advice.” 
 Negative Outlook 
A3: “Absolutely not!” 
NA5: “No!” 
Spirituality Highly Spiritual 
A6: “Yes, the first thing I and my family does is seek 
spiritual guidance.” 
NA1: “I’m a spiritual person but not religious, I do self-
prayer but wouldn’t physically seek it at a church or 
mosque. I would seek the best doctors in the world first.” 
 Non-Spiritual 
A7: “No, goes to the doctor.” 
NA7: “No, but some family might pray but not me 
personally.” 
Use home 
remedies 
Teas most 
preferred 
A4: “Yes, mint tea and Turkish tea.” 
NA3: “Yes, it depends upon what it is at the time. There are 
certain herbs and teas that grow in yard (mint and mint 
bark).” 
 Alternative remedies 
A6: “My family and I give each other massages and I stay in 
bed.” 
A4: “Massages on occasion.”  
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Quantitative Component 
RQ1 identifies the perceived barriers to TB treatment-seeking and adherence 
within the Armenian population surveyed in LA County. The independent variables (IV) 
include ethnicity/race, cultural beliefs, demographics, and religion, with knowledge being 
the dependent variable (DV). To address this, a univariate analysis was performed by 
comparing frequencies of responses for each question for those participants classified as 
Armenian. The responses were subsequently tabulated, including associating each 
question to specific independent variables to facilitate data interpretation (Table 9). 
Questions relating to TB knowledge reveal that 98.2% of Armenians have heard 
of TB, with a singular source of knowledge coming from family and friends (27.8%) or 
school (12.7%) or a combination of sources such as TV, Internet, family/friends, and 
newspaper/magazines (11.1%). Armenian respondents believe it is a modern day health 
problem in the U.S. (63.6%) and internationally (89.1%), with coughing and sneezing as 
the primary mode of transmission (63.6%). While 54.5% believe there is a treatment 
available for TB, the majority of respondents are unaware of the duration of treatment 
regimen (61.8%), whether it is 100% effective (54.5%), or if the disease is curable 
(30.9%). 94.5% of the Armenian participants have never been diagnosed or know 
someone who has been diagnosed with TB and 41.8% feel informed at the mention of the 
disease. Factors associated with TB were found to be vast, with 20.9% believing it is a 
curable disease and 90.9% believing that contracting the disease could happen to anyone. 
If contracted, 92.7% trust their physician to cure it (58.2% strongly agree and 34.5% 
agree), 80% would comply with treatment recommendations (67.3% strongly agree and 
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12.7% agree), and 50.9% would not seek treatment outside of a hospital setting (23.6% 
strongly agree, 27.3% agree), though 76.4% also utilize home remedies. 
 
Table 9 
RQ1. What are the Perceived Barriers to Treatment-seeking and Adherence for 
Tuberculosis in an Armenian Population Living within the United States? (n = 55) 
Survey Question Frequency 
(ƒ) 
Percent 
(%) 
Associated 
Variable(s) 
1 Heard of Tuberculosis 
Yes 
No 
 
54 
1 
 
98.2 
1.8 
Knowledge 
2 How have you heard about TB? 
TV 
Internet 
Family or friends 
Newspaper/magazine 
TV and Internet 
TV and newspaper/magazine 
Internet and family/friends 
Internet and newspaper/magazine 
Family/friends and other 
Newspaper/magazine and other 
TV, Internet, family/friends 
Internet, family/friends, 
newspaper/mag 
Internet, family/friends, other 
TV, Internet, family/friends, 
newspaper/magazine 
Other 
Common Knowledge 
Doctor 
Health Center 
Health Industry 
Research 
School 
Required TB test 
Work 
 
5 
2 
15 
0 
1 
1 
1 
1 
4 
1 
5 
1 
 
1 
6 
 
10 
1 
2 
1 
1 
1 
7 
1 
1 
 
9.3 
3.7 
27.8 
0 
1.9 
1.9 
1.9 
1.9 
7.4 
1.9 
9.3 
1.9 
 
1.9 
11.1 
 
18.5 
1.8 
3.6 
1.8 
1.8 
1.8 
12.7 
1.8 
1.8 
Knowledge 
3 Modern day health problem in the US? 
Yes 
 
35 
 
63.6 Knowledge 
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No 20 36.4 
4 Modern day problem internationally? 
Yes 
No 
 
49 
6 
 
89.1 
10.9 
Knowledge 
5 Mode of transmission 
Coughing, sneezing 
Touching 
Sexual contact 
Food/water ingestion 
Smoking 
Imbalance of hot and cold 
Do not know 
 
35 
0 
0 
2 
0 
0 
18 
 
63.6 
0 
0 
3.6 
0 
0 
32.7 
Knowledge 
6 Most common symptom 
Coughing  
Sneezing  
Loss of appetite 
Tiredness/fatigue 
Bleeding 
Do not know 
 
34 
1 
1 
8 
1 
10 
 
61.8 
1.8 
1.8 
14.5 
1.8 
18.2 
Knowledge 
7 Treatment available? 
Yes 
No 
 
30 
25 
 
54.5 
45.5 
Knowledge 
8 Length of treatment 
3 days 
1 week 
1 month 
> 6 months 
Do not know 
 
1 
4 
5 
11 
34 
 
1.8 
7.3 
9.1 
20.0 
61.8 
Knowledge 
9 Treatment 100% effective? 
Yes 
No 
Do not know 
 
12 
13 
30 
 
21.8 
23.6 
54.5 
Knowledge 
10 A curable disease? 
Yes 
No 
Do not know 
 
33 
5 
17 
 
60 
9.1 
30.9 
Knowledge 
11 Initial reactions and feelings when 
mentioned by family, friends, or news? 
Frightened 
Informed 
Indifferent  
Helplessness 
 
 
15 
23 
16 
1 
 
 
27.3 
41.8 
29.1 
1.8 
Knowledge 
12 You or anyone in family diagnosed?   Knowledge 
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Yes 
No 
3 
52 
5.5 
94.5 
13 If yes, how did you feel? 
Frightened 
Informed 
Indifferent 
Helpless 
Depressed 
Informed & Indifferent 
 
1 
1 
0 
0 
0 
1 
 
33.3 
33.3 
0 
0 
0 
33.3 
Knowledge 
14 Factors associated with TB: 
Poverty 
Foreign-born 
HIV status 
Drug history 
Low social class 
Sexual orientation 
Mental illness 
Religion 
A common disease 
A curable disease 
Smoking 
Imbalance of hot and cold 
Incarceration 
Poverty and low social class 
Poverty and a common disease 
Poverty and a curable disease 
Poverty, foreign-born, and low social 
class 
Foreign-born and a curable disease 
A common disease and a curable 
disease 
A common disease and smoking 
Poverty, foreign-born, a curable 
disease 
Poverty, HIV status, and a curable 
disease 
Poverty, drug history, and 
incarceration 
Poverty, sexual orientation, religion, 
incarceration 
Foreign-born, low social class, 
common disease, incarceration 
A common disease, curable disease, 
 
2 
1 
0 
0 
0 
0 
0 
0 
6 
11 
2 
4 
1 
1 
1 
2 
3 
 
2 
2 
 
1 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
 
3.6 
1.8 
0 
0 
0 
0 
0 
0 
10.9 
20.0 
3.6 
7.3 
1.8 
1.8 
1.8 
3.6 
5.5 
 
3.6 
3.6 
 
1.8 
5.5 
 
1.8 
 
1.8 
 
1.8 
 
1.8 
 
1.8 
Ethnicity/ 
Race 
Cultural 
Belief 
Demographics 
Religion 
Knowledge 
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and smoking 
A curable disease, smoking, imbalance 
of hot and cold 
Poverty, foreign-born, curable disease, 
incarceration 
Poverty, foreign-born, low social 
class, common disease, curable disease 
Poverty, HIV status, drug history, 
common disease, smoking 
Poverty, drug history, smoking, and 
imbalance of hot and cold 
Poverty, foreign-born, low social 
class, curable disease, and 
incarceration 
Poverty, foreign-born, low social 
class, curable and common disease,  
incarceration 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
 
1 
 
1.8 
 
1.8 
 
1.8 
 
1.8 
 
1.8 
 
1.8 
 
 
1.8 
 
15 If someone has TB, you think that: 
Did something wrong (e.g., drug use) 
A punishment given by the God 
Due to racial background 
It could happen to anyone 
Did something wrong and it could 
happen to anyone 
Due to racial background and it could 
happen to anyone 
 
0 
1 
2 
50 
1 
 
1 
 
0 
1.8 
3.6 
90.9 
1.8 
 
1.8 
Ethnicity/ 
Race 
Cultural 
Belief 
Demographics 
Religion 
16a If you had TB, would you trust doctors 
to cure it? 
1. Strongly agree 
2. Agree 
3. No Opinion 
4. Disagree 
5. Strongly disagree 
 
 
32 
19 
4 
0 
0 
 
 
58.2 
34.5 
7.3 
0 
0 
Cultural 
Belief 
Demographics 
Religion 
16b If you had TB, would you be compliant 
with doctors’ instructions regarding 
treatment? 
1. Strongly agree 
2. Agree 
3. No Opinion 
4. Disagree 
5. Strongly disagree 
 
 
 
37 
7 
6 
2 
3 
 
 
 
67.3 
12.7 
10.9 
3.6 
5.5 
Cultural 
Belief 
Demographics 
Religion 
16c If you had TB, would you seek 
treatment outside a hospital/ private 
 
 
 
 
Cultural 
Belief 
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practice setting? 
1. Strongly agree 
2. Agree 
3. No Opinion 
4. Disagree 
5. Strongly disagree 
 
5 
8 
14 
15 
13 
 
9.1 
14.5 
25.5 
27.3 
23.6 
Demographics 
Religion 
17 If seeking outside treatment, where 
would you go? 
Chiropractor 
Acupuncturist 
Homeopathic doctor/nutritionist 
Religious/ church leader 
Massage therapist 
Home remedies (herbs, oils, teas) 
I wouldn’t 
Acupuncturist and homeopathic doctor 
Homeopathic doctor and home 
remedies 
Chiropractor, religious leader, home 
remedies 
Acupuncturist, homeopathic doctor, 
home remedies 
Homeopathic doctor, religious leader, 
home remedies 
Chiropractor, Acupuncturist, 
Homeopathic doctor, and massage 
therapist 
Chiropractor, Acupuncturist, 
Homeopathic doctor, and home 
remedies 
Chiropractor, Acupuncturist, 
Homeopathic doctor, massage 
therapist, home remedies 
Chiropractor, Acupuncturist, 
Homeopathic doctor, religious leader, 
massage therapist, home remedies 
 
 
0 
0 
4 
2 
0 
3 
35 
2 
1 
 
1 
 
1 
 
1 
 
1 
 
 
1 
 
 
1 
 
 
2 
 
 
0 
0 
4.3 
3.6 
0 
5.5 
63.6 
3.6 
1.8 
 
1.8 
 
1.8 
 
1.8 
 
1.8 
 
 
1.8 
 
 
1.8 
 
 
3.6 
Cultural 
Belief 
Religion 
18a Aware of TB treatment facilities in LA 
County and the services provided? 
Yes 
No 
 
 
8 
47 
 
 
14.5 
85.5 
Demographics 
Knowledge 
18b If no, if information was made readily 
available, would you be more inclined 
to read about the disease and inform 
 
 
 
 
 
 
Cultural 
Belief 
Knowledge 
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others in your community? 
Yes 
No 
 
32 
15 
 
68.1 
31.9 
19 Aware of community social support 
groups for dealing with the disease? 
Yes 
No 
 
 
5 
50 
 
 
9.1 
90.9 
Knowledge 
Basic Background Information 
18 Seek Spiritual Guidance 
Yes 
No 
 
24 
31 
 
43.6 
56.4 
Religion 
19 Use Home Remedies (herbs, teas, etc.) 
Yes 
No 
 
42 
13 
 
76.4 
23.6 
Cultural 
Belief 
 
RQ2 identifies which factors (e.g. physical, cultural, psychosocial, behavioral), if 
any, contribute to differences in knowledge (DV) relating to TB between Armenians and 
non-Armenians living in LA County. To explore this, bivariate chi-square (χ2) analyses 
were performed with classification of populations (Armenian or non-Armenian) servings 
as the independent variable (IV). Table 10 summarizes all of the χ2 results, highlighting 
significant factors (p <0.05) and the effect size associated with these variables.  
 
Table 10 
RQ2. Bivariate Analysis (n = 127) 
Dependent 
Variable 
Independent 
Variable 
χ2 p Interpretation Effect Size 
(Cramer’s V) 
Heard of TB Armenian- 
non 
Armenian  
1.319 ns Arm/Non-Arm status 
does not affect heard of 
TB 
NA 
Source of TB 
Knowledge 
Armenian- 
non 
Armenian  
40.213 0.037 There is a significant 
difference in TB 
knowledge source in 
Arm (9.3% TV, 3.7% 
Internet, 27.8% 
family/friends, 0% 
0.565 
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printed media, 10% 
other) as compared to 
non-Arm (1.4%, 0%, 
11.1%, 2.8% 13.9%, 
resp) 
TB US 
Problem 
Armenian- 
non 
Armenian 
0.085 ns Arm/Non-Arm status 
does not affect TB 
national awareness 
NA 
TB 
International 
Problem 
Armenian- 
non 
Armenian 
0.048 ns Arm/Non-Arm status 
does not affect TB 
international awareness 
NA 
TB route of 
Transmission 
Armenian- 
non 
Armenian 
8.203 ns Arm/Non-Arm status 
does not affect route of 
TB transmission 
knowledge 
NA 
TB 
Symptoms 
Armenian- 
non 
Armenian 
5.631 ns Arm/Non-Arm status 
does not affect route of 
TB symptom 
knowledge 
NA 
TB 
Treatment 
Available 
Armenian- 
non 
Armenian 
0.073 ns Arm/Non-Arm status 
does not affect TB 
treatment availability 
knowledge 
NA 
TB 
Treatment 
Length 
Armenian- 
non 
Armenian 
6.913 ns Arm/Non-Arm status 
does not affect TB 
treatment duration 
knowledge 
NA 
TB 
Treatment 
Effectiveness 
Armenian- 
non 
Armenian 
1.279 ns Arm/Non-Arm status 
does not affect TB 
treatment effectiveness 
knowledge 
NA 
TB Curable 
Disease 
Armenian- 
non 
Armenian 
0.883 ns Arm/Non-Arm status 
does not affect TB 
disease status 
knowledge 
NA 
TB reactions Armenian- 
non 
Armenian 
2.212 ns Arm/Non-Arm status 
does not affect 
reactions to TB 
diagnosis 
NA 
TB Diagnose 
family/friend 
Armenian- 
non 
Armenian 
0.392 ns Arm/Non-Arm status 
does not affect personal 
TB diagnosis  
NA 
TB Diagnosis Armenian- 5.625 ns Arm/Non-Arm status NA 
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Feelings non 
Armenian 
does not affect feelings 
toward TB positive 
individual 
Factors 
Associated 
with TB 
Armenian- 
non 
Armenian 
52.321 ns Arm/Non-Arm status 
does not affect TB 
factors knowledge 
NA 
Trust Doctor 
to treat TB 
Armenian- 
non 
Armenian 
5.631 ns Arm/Non-Arm status 
does not affect trust in 
physician’s ability to 
treat TB 
NA 
Compliant 
with doctors’ 
instructions 
regarding 
treatment 
Armenian- 
non 
Armenian  
11.630 0.020 Non-Arm significantly 
more compliant 
(strongly agree/agree) 
as compared to Arm 
(97.2% vs. 80%) 
0.303 
Seek 
treatment 
outside of 
doctor’s care 
Armenian- 
non 
Armenian 
1.549 ns Arm/Non-Arm status 
does not affect desire to 
seek outside treatment 
for TB 
NA 
Alternative 
Treatment 
types 
Armenian- 
non 
Armenian 
18.286 ns Arm/Non-Arm status 
does not affect 
alternative treatment 
sought 
NA 
Aware of LA 
County TB 
treatment 
facility 
Armenian- 
non 
Armenian 
0.278 ns Arm/Non-Arm status 
does not affect LA 
County TB treatment 
facility awareness 
NA 
Read about 
TB, if 
provided 
Armenian- 
non 
Armenian 
0.864 ns Arm/Non-Arm status 
does not affect desire to 
read about TB if 
provided 
NA 
Aware of 
community 
TB support 
groups 
Armenian- 
non 
Armenian 
0.369 ns Arm/Non-Arm status 
does not affect TB 
community support 
group awareness 
NA 
Seek spiritual 
guidance 
Armenian- 
non 
Armenian 
9.8883 0.002 Significantly more Arm 
seek spiritual guidance 
(43.6%) as compared to 
non-Arm (18.1%) 
0.279 
Use Home 
Remedies 
Armenian- 
non 
Armenian 
4.526 0.033 Significantly more Arm 
use home remedies 
(76.4%) as compared to 
non-Arm (58.3%) 
0.189 
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Trust 
Primary 
Physician 
Armenian- 
non 
Armenian 
2.889 ns Arm/Non-Arm status 
does not affect trust of 
primary care physician 
NA 
Have Health 
Insurance 
Armenian- 
non 
Armenian 
0.578 ns Arm/Non-Arm status 
does not affect health 
care insurance 
procurement 
NA 
Gender Armenian- 
non 
Armenian 
0.201 ns Arm/Non-Arm status is 
not affected by gender 
NA 
Years in US Armenian- 
non 
Armenian 
7.970 0.005 Arms have 
significantly fewer 
years in US (80% ≥ 20 
years) as compared to 
non-Arm (95.8%) 
0.251 
Marital 
Status 
Armenian- 
non 
Armenian 
1.405 ns Arm/Non-Arm status is 
not affected by marital 
status 
NA 
Number of 
People in 
household 
(excluding 
self) 
Armenian- 
non 
Armenian 
13.138 0.011 Arm have significantly 
more people per 
household (83.6% ≥ 2) 
as compared to non-
Arm (56.9%) 
0.322 
English  
primary 
language 
spoken 
Armenian- 
non 
Armenian 
27.636 0.000 Arm have a 
significantly lower 
level of English as their 
primary language 
(63.6%) as compared to 
non-Arm (98.6%) 
0.466 
Level of 
Education 
Armenian- 
non 
Armenian 
12.755 0.005 Arm have a 
significantly lower 
level of education 
(12.7% High school, 
25.5% some college, 
27.3% Bachelor’s, 
34.5% 
Graduate/Professional) 
as compared to non-
Arm (0%, 16,7%, 
43.1%, 40.3% resp) 
0.317 
Occupation Armenian- 
non 
Armenian 
8.742 ns Arm/Non-Arm status is 
not affected by 
occupation 
NA 
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Annual 
Household 
Income 
Armenian- 
non 
Armenian 
3.565 ns Arm/Non-Arm status is 
not affected by annual 
household income 
NA 
 
The effect size was calculated using the 2-sided Pearson’s chi-square value where 
p-values ≤ 0.05 were considered to be significant. Of those factors with significance, a 
Cramer’s V scale was used to evaluate the strength of the effect size (d.f. ≥ 3): < ± 0.06, 
small; ± 0.17 medium, and  ≥ ± 0.29, large (Zaiontz, 2016). For this study, the effect size 
was calculated using only those factors relating to TB-specific questions. Other factors 
relating to background of the two populations also showed some significant differences 
with strength (Table 10) and will be discussed later in Chapter 5.  
As seen in Table 11, those factors with the greatest significance and strength 
relate to how the two populations learned about the disease (“TBHearSource”) and how 
compliant with a doctor’s instructions would they would be if diagnosed (“TBWhatifB”). 
From these, the average Cramer’s value was calculated, resulting in an effect size of 
0.434. 
Table 11 
Effect Size Determination: TB-Specific Questions (n = 127) 
Variable Pearson’s  Cramer’s V 
TBHearSource 0.037 0.565 large 
TBWhatifB 0.020 0.303 large 
    
Average  0.434  
 
For RQ2, multinomial logistic regression was used to explore interactions 
between the nominal, multi-categorical dependent variables for any of the independent 
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variables. The dependent variables explored were those with large effect sizes and 
significant chi-square values (0.1 > p < 0.05) from the bivariate analysis, which included 
“TBHearSource, TBWhatifB (compliance), and TBTransmit” (p = 0.084, Cramer’s V 
0.254). These variables were tested against predictor factors relating to demographics, 
religion, and cultural beliefs, focusing on those that were found to be significant in the 
bivariate analysis (Table 10).  
Table 12 summarizes the significant findings and predictors, where the full model 
predicts significantly better than the null model. Overall, it was found that for the 
dependent variable, Source of TB knowledge (TBHearSource), classification (Armenian 
versus non-Armenian) and the use of home remedies were significant factors with the 
latter having a number of combinations of factors that are good predictors. For the 
dependent variable TB Route of Transmission (TBTransmit), classification and age were 
found to be significant, with “coughing and sneezing” representing a good predictor (OR 
0.347; CI 0.134-0.838). For the question addressing compliance (TBWhatifB), 
classification, English spoken in household, and education were significant. However, in 
some cases there were limitations in the models where there were singularities with some 
of the predictor variables, suggesting they should be removed or merged (see notation a). 
Proposed mitigations will be discussed further in Chapter 5. 
Table 12 
RQ2. Multivariate Analysis (n=127) 
Dependent 
Variable 
Factor p Parameter Estimates 95% Confidence 
Interval (CI) 
Predictor p Odds 
Ratio 
Lower Upper 
Source of TB Classification < 0.05 a     
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Knowledge 
(TBHear 
Source) 
(Armenian/ 
non-
Armenian) 
Use of Home 
Remedies 
< 0.05 Family/friends 
Internet  + 
Newspaper/ 
Magazine 
Internet  + 
other 
Family/friends 
+ other 
Newspaper/ 
Magazine + 
other 
TV + Internet 
+ Newspaper/ 
Magazine 
TV + Family/ 
friends + 
Newspaper/ 
Magazine 
Internet  + 
Family/friends
+ Newspaper/ 
Magazine 
Internet + 
Family/friends
+ other 
Family/friends
+ Newspaper/ 
Magazine  + 
other 
TV + Internet 
+ Family/ 
friends + other 
Internet  + 
Family/friends 
+ Newspaper/ 
Magazine + 
other 
< 0.05 
0.00 
 
 
0.00 
 
< 0.05 
 
0.00 
 
 
0.00 
 
 
0.00 
 
 
 
0.00 
 
 
 
0.00 
 
 
0.00 
 
 
 
0.00 
 
 
0.00 
 
 
14.25 
3. 50e8 
 
 
3. 50e8 
 
33.00 
 
3. 50e8 
 
 
3. 50e8 
 
 
3. 50e8 
 
 
 
3.50e8 
 
 
 
3.50e8 
 
 
3.50e8 
 
 
 
3.50e8 
 
 
3.50e8 
 
 
1.16 
3. 50e8 
 
 
3.50e8 
 
1.56 
 
3.50e8 
 
 
3.50e8 
 
 
3.50e8 
 
 
 
3.50e8 
 
 
 
3.50e8 
 
 
3.50e8 
 
 
 
3.50e8 
 
 
3.50e8 
 
 
174.80 
3.50e8 
 
 
3.50e8 
 
697.96 
 
3.50e8 
 
 
3. 50e8 
 
 
3.50e8 
 
 
 
3.50e8 
 
 
 
3.50e8 
 
 
3.50e8 
 
 
 
3.50e8 
 
 
3.50e8 
 
 
TB route of 
Transmission 
Classification 
(Armenian/ 
non-
Armenian) 
0.05 Coughing/ 
sneezing 
< 0.05 
 
0.35 0.13 0.84 
Age < 0.05 a     
Compliance 
if Diagnosed 
Classification 
(Armenian/ 
< 0.05 Strongly 
Agree 
0.00 
 
5.70e-9 
 
1.09e-9 
 
2.98e-8 
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with TB 
(TBWhatifB) 
non-
Armenian) 
Strongly 
Disagree 
No Opinion 
0.00 
 
0.00 
3.64e-9 
 
2. 50e-8 
5.39e-10 
 
2. 50e-8 
2.27e-9 
 
2.50e-8 
Years in US < 0.05 Strongly 
Agree 
Strongly 
Disagree 
No Opinion 
0.00 
 
0.00 
 
0.00 
3.28e7 
 
6.97e7 
 
4.64e8 
1.82e6 
 
3.38e6 
 
2.09e7 
5.91e8 
 
1.44e9 
 
1.03e10 
English 
spoken in 
household 
< 0.05 b     
Education < 0.05 a     
a Unexpected singularities in the Hessian matrix encountered, indicating that either some 
predictor variables should be excluded or some categories should be merged 
b low logistic coefficients 
 
Summary of RQ1 Results  
RQ1 is a descriptive inquiry that investigates the perceived barriers to treatment 
seeking and adherence for TB in an Armenian population living within the United States. 
The quantitative study utilized a series of online survey questions addressing knowledge-, 
cultural-, religious-, demographic-, and ethnicity-based inquiries (Table 9). Univariate 
analyses of the 55 Armenian respondents revealed themes relating to all independent 
variables. Some of the knowledge-based inquiries revealed that 98.2% of Armenians 
have heard of TB, with a singular source of knowledge coming from family and friends 
or school, or a combination of sources such as TV, Internet, family/friends, and 
newspaper/magazines. Furthermore, Armenian respondents believe TB is a modern day 
health problem both in the U.S. and internationally, with coughing and sneezing as the 
primary mode of transmission. While just over 50% believe there is a treatment available, 
the majority of respondents are unaware of the duration of treatment regimen, whether it 
is 100% effective, or if the disease is curable. Almost all of the Armenian participants 
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have never been diagnosed or know someone who has been diagnosed with TB, with less 
than 50% feeling informed at the mention of the disease. Factors associated with TB were 
found to be vast, with 20.9% believing it is a curable disease and 90.9% believing that 
contracting the disease could happen to anyone. If contracted, 92.7% trust their physician 
to cure it, 80% would comply with treatment recommendations, and just over half of 
respondents would not seek treatment outside of a hospital setting, though 76.4% also use 
home remedies. 
Further support was achieved through the face-to-face interviews of 10 Armenian 
participants in the qualitative study, with some ambiguities. Here knowledge of TB 
existed but mode of transmission, incidence, and treatment characteristics (e.g., duration, 
type, and effectiveness) was more uncertain. The majority of Armenians expressed great 
trust in the ability of their doctor to effectively diagnose and treat any given disease; 
however, a minority expressed a harsh distrust. All of the respondents also opted for the 
use of home remedies, either prior to seeking a doctor’s consultation and/or most 
continued taking the home remedy following prescription of treatment by a doctor. The 
culturally-based inquiry regarding the presence of kapoot ach in their house revealed that 
all of them had at least one, with one (A9) responding “Yes, it’s all around. It’s 
something an Armenian family has to have!” 
Summary of RQ2 Results 
RQ2 is inferential and explores differences in barriers to treatment seeking and 
adherence for Tuberculosis in Armenian versus non-Armenian populations living in LA 
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County and determines which factors (e.g., physical, cultural, psychosocial, behavioral) 
have the greatest influence?  The alternative and null hypotheses are:  
HA2: There are differences in factors relating to treatment seeking and adherence 
for tuberculosis in Armenian versus non-Armenian populations in Los 
Angeles County. 
H02: There are no differences in factors relating to treatment seeking and 
adherence for tuberculosis in Armenian versus non-Armenian populations in 
Los Angeles County. 
The quantitative element of the study involved surveying 55 Armenians and 72 
non-Armenians residing in LA County. To determine significant differences, if any, 
between the two populations in regards to barriers to treatment-seeking and adherence for 
TB, bivariate chi-square (χ2) analyses were performed with classification of populations 
(Armenian or non-Armenian) servings as the independent variable (IV)  As can be seen 
in Tables 10 and 11, significant factors (p <0.05) with medium to large effect sizes relate 
to how the two populations learned about the disease (“TBHearSource”) and how 
compliant with a doctor’s instructions would they would be if diagnosed (“TBWhatifB”). 
From these, the average Cramer’s V value was calculated, resulting in an effect size of 
0.434.  
Multinomial logistic regression was then used to explore interactions between 
these nominal, multi-categorical dependent variables for any of the independent 
variables. “TBHearSource”, “TBWhatifB” (compliance), and “TBTransmit” (p = 0.084, 
Cramer’s V 0.254) were tested against predictor factors relating to demographics, 
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religion, and cultural beliefs, focusing on those that were found to be significant in the 
bivariate analysis (Table 10). For the dependent variable, Source of TB knowledge 
(TBHearSource), classification (Armenian versus non-Armenian) and the use of home 
remedies were significant factors with the latter having a number of combinations of 
factors that are good predictors. For the dependent variable TB Route of Transmission 
(TBTransmit), classification and age were found to be significant, with “coughing and 
sneezing” representing a good predictor (OR 0.347; CI 0.134 - 0.838). For the question 
addressing compliance (TBWhatifB), classification, English spoken in household, and 
education were significant. However, in some cases there were limitations in the models 
where there were singularities with some of the predictor variables, suggesting they 
should be removed or merged. 
The qualitative component of the study where 10 Armenians and 8 non-
Armenians were interviewed face-to-face, found some similarities and differences in 
responses between the two populations. Both populations had general vague knowledge 
relating to route of transmission, degree of infectivity, molecular properties, and 
incidence. Both also felt like there “should be” a treatment available but didn’t have any 
details on regimen; however, only the Armenian population acknowledged vaccine 
availability. When it came to perceptions and feelings, the Armenian population 
expressed more empathy, an overt willingness to help someone with the disease, desire to 
seek treatment or urge others to seek treatment, and seek spiritual guidance and outside 
education for themselves or others. The non-Armenian population appeared more trepid, 
less willing to help others and urge them to seek treatment, and less open to seek spiritual 
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guidance; however, they were very willing to educate themselves about the disease. Both 
groups had a similar distribution of individuals who seek spiritual guidance upon 
receiving news of a disease diagnosis for either themselves or close family/friends and 
those who don’t. Overall, all participants opted for the use of home remedies, either prior 
to seeking a doctor’s consultation and/or most continued taking the home remedy 
following a physician’s prescription of treatment. 
Trustworthiness 
When conducting a mixed-methods study, there are many important aspects that 
need to be considered to guarantee credibility and dependability. For this concurrent 
mixed-methods study, data triangulation was utilized to address these concerns. By 
utilizing multiple modes of data collection, e.g., observational from the face-to-face 
interviews of the qualitative study and online survey research from the quantitative study, 
specificity and validity concerns relating to a particular approach is minimized. For this 
study, data from the qualitative study and quantitative study were collected in parallel, 
analyzed separately, and then converged following data analysis. From this convergence, 
it was found that the findings from both studies are primarily in agreement, with some 
minor diverging trends. These are likely due to differences in survey environment (face-
to-face versus remote and online), where the online participants appeared to be more 
informed about the disease overall irrespective of classification. 
To further address potential issues relating to credibility and dependability, peer 
review was utilized as a mechanism for external checking the research process, remove 
threats of bias, provide analytical direction, and confirm results. For these studies, the 
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dissertation supervisor, V.M., served as the peer reviewer throughout the process by 
looking over all of the results (pilot study and final studies) and confirming appropriate 
implementation and analysis of all statistical tests used. 
For an ethnography in particular, transferability or generalizability is a concern. 
Not only did this study focus on a particular population, Armenians, but was even more 
selective for those living in LA County. If other researchers attempt to replicate this 
study, it is likely that alterations may need to be made to account for attributes specific to 
the population being studied (e.g., demographics). 
Data validity and reliability are serious concerns for any researcher. They can be 
threatened by the instrumentation used to conduct the study, particularly when developed 
by the researcher, as well as from data coding methods following data collection but prior 
to analysis. For the quantitative portion of the study, pilot testing was conducted to 
validate the instrumentation. The recommendations were incorporated into the final 
survey prior to recruitment and implementation online. Furthermore, a codebook was 
generated for each research question (Appendix L). This was approved by the peer 
reviewer V.M. prior to data analysis. All of the responses from completed online surveys 
were exported from SurveyGizmo into Excel, where the researcher manually coded all of 
the responses based on the approved codebook. This was transferred into SPSS and 
checked externally for errors by V.M.  
Coding for qualitative studies may be more subjective which can offer challenges 
relating to reliability. For the qualitative component of this study, written transcripts were 
generated from the voice recordings. The data were then analyzed for key words and 
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phrases that relate back to the research questions. For these key themes, sub-themes were 
also formulated and indexed. These were cross-checked by the peer reviewer for errors. 
Summary 
The purpose of this mixed-methods study was to explore factors (physical, 
psychosocial, cultural, or behavioral) relating to TB knowledge, treatment-seeking and 
adherence in Armenians versus non-Armenian residing in LA County and whether 
differences exist between the populations. Univariate (frequencies), bivariate (chi-
square), and multivariate (multinomial logistic regression) statistical analyses were 
implemented to determine factors and relationships. The qualitative component utilized 
face-to-face interviews with coded and grouped responses to address concerns relating to 
specificity and validity. Data from both study components were collected in parallel, 
analyzed separately, and then converged post-analysis. 
The null hypothesis (H0) for RQ2 is rejected in favor of the alternative hypothesis 
(HA), “there are differences in factors relating to treatmen- seeking and adherence for TB 
in Armenian versus non-Armenian populations in Los Angeles County”. The resulting 
post-hoc power analysis was satisfactory > 0.90. Bivariate analysis determined that there 
are two factors that are significantly different between Armenian and non-Armenian 
populations: (a) the source of TB knowledge and (b) compliance with a doctor’s 
instructions if a TB diagnosis is received. The multivariate analysis found factors that 
were good predictors for each of these variables, though some limitations were found 
with the model (further discussed in Chapter 5). Some factors with significance include 
the use of home remedies (with many combinations of predictors), age, years residing in 
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the United States, education, and English as the primary language in the household. 
Analysis of the responses from the qualitative component revealed that both populations 
were in general uninformed about TB (e.g., transmission, treatment, curability, and 
incidence). The Armenian population appeared to be more willing to help others, while 
using caution, if diagnosed and trust their physician for diagnosing and treating; whereas, 
non-Armenians were less willing to help others and jeopardize their health and expressed 
less trust in their physician’s ability to effectively treat the disease. 
The results of the study will be summarized and interpreted further in Chapter 5. 
Furthermore study limitations, as well as recommendations for future research, social 
implications, the theoretical foundation (SEM), and conclusions of the study will be 
discussed. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
TB continues to be a global public health problem and has been made a top 
priority disease for control and eradication by the WHO and national health ministries 
(WHO, 2015). Armenians, in particular, are a susceptible population due to high national 
incidence of MDR-TB, inadequate health care, poor disease surveillance, poor disease 
education, poverty, and emigration/immigration (Bakalian, 2011; Hayrapetyan, 2012; 
Truzyan et al., 2015; Vink et al., 2005); however, very few epidemiological or prevention 
studies have been dedicated to this group. 
The purpose of this study was to explore differences in factors (physical, 
psychosocial, cultural, or behavioral) relating to TB knowledge, treatment-seeking and 
adherence in Armenians as compared to non-Armenians in LA County to determine 
which factors have the greatest potential impact on reducing TB incidence in this 
susceptible population. To do this, a mixed-methods study design was implemented using 
concurrent quantitative components, an online survey, followed by qualitative face-to-
face interviews. Resulting data were analyzed separately and merged during the 
interpretation phase of the study. 
For the quantitative component, 55 Armenians residing in LA County were 
surveyed through the online platform SurveyGizmo. Here, knowledge-, cultural-, 
religious-, demographic-, and ethnicity-based inquiries were investigated. Among the 
surveyed Armenian population, perceived barriers to treatment-seeking and adherence for 
TB were explored and analyzed for (Table 9). Knowledge-based inquiries revealed that 
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98.2% of Armenians have heard of TB, with knowledge coming from family and friends 
or school, or a combination of sources such as TV, Internet, family/friends, and 
newspaper/magazines. Furthermore, Armenian respondents believe TB is a global health 
problem, with the primary mode of transmission being coughing and sneezing. Factors 
associated with TB were found to be vast, with 20.9% believing it is a curable disease 
and 90.9% believing that contracting the disease could happen to anyone. While just over 
50% believe that treatment is available, the majority were unsure of treatment details 
such as duration and effectiveness. Almost all of the Armenian participants have never 
been diagnosed or know someone who has been diagnosed with TB, with less than 50% 
feeling informed at the mention of the disease. 
The qualitative component further supported the quantitative findings among the 
Armenian population. Here, 10 Armenian participants were interviewed face-to-face. 
Analysis of responses revealed awareness of TB; however, knowledge of the mode of 
transmission, incidence, and treatment characteristics (e.g., duration, type, and 
effectiveness) was absent. The culturally based inquiry on the presence of kapoot ach in 
their residence revealed all of them had at least one.  
Differences in barriers to treatment-seeking and adherence for TB in Armenian 
and non-Armenian populations in LA County were identified using bivariate chi-square 
(χ2) and multivariate multinomial logistic regression analyses of the online survey data. 
When comparing data from the 55 Armenians and 72 non-Armenians surveyed, 
significant factors with medium to large effect sizes were: (a) how the two populations 
learned about the disease (“TBHearSource”) and (b) how compliant with a doctor’s 
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instructions would they would be if diagnosed (“TBWhatifB”). Using Cramer’s V 
calculations, the resulting effect size was 0.434 (see Tables 10 and 11). Multivariate 
analyses of these factors, along with an additional factor of how TB is transmitted 
(TBTtransmit, p = 0.084), revealed predictor factors such as classification, the use of 
home remedies, age, education, and English as the primary household language to be 
significant. The null hypothesis (H0) for RQ2 is rejected in favor of the alternative 
hypothesis (HA), “there are differences in factors relating to treatment seeking and 
adherence for TB in Armenian versus non-Armenian populations in LA County”. 
When exploring differences in the two populations, the qualitative component 
revealed some similarities and differences in responses. Amongst the 10 Armenians and 8 
non-Armenians interviewed, both populations had vague knowledge relating to route of 
transmission, degree of infectivity, molecular properties, and incidence. Both also 
believed that there “should be” a treatment available but didn’t have any details on 
regimen; however, only the Armenian population acknowledged vaccine availability. 
When exploring perceptions and feelings, the Armenian population expressed more 
empathy, an overt willingness to help someone with the disease, desire to seek treatment 
or urge others to seek treatment, and seek spiritual guidance and outside education for 
themselves or others. The non-Armenian population appeared more trepid, less willing to 
help others and urge them to seek treatment, and less open to seek spiritual guidance; 
however, they were very willing to educate themselves about the disease. Both groups 
had a similar distribution of individuals who seek spiritual guidance upon receiving news 
of a disease diagnosis for either themselves or close family/friends and those who don’t.  
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Interpretation of the Findings 
Results from this study confirm, and extend, the very limited knowledge relating 
to TB awareness and barriers to treatment seeking and adherence in an Armenian 
population. In an extensive report by Grigoryan et al. (2008), TB knowledge and attitudes 
of Armenians living in Armenia were assessed. Of those interviewed, 91% could identify 
TB but only half knew how it was transmitted. Additionally, the vast majority did not 
realize that TB was a public health problem, could not identify symptoms, and believed 
that they and their loved ones were not at risk. Social stigma was also high, where 
roughly 20% keep their family’s TB status a secret. Furthermore, TB patients were ill-
informed about the duration of treatment and the consequences regarding non-compliance 
or interrupted treatment (Grigoryan et al., 2008). 
In both the quantitative and qualitative components of this study, > 90% of 
respondents were aware of TB; with the qualitative component revealing that majority of 
the participants were uninformed regarding transmission, and 63.6% of the quantitative 
participants aware that coughing and sneezing are the primary mode of transmission. In 
regards to treatment, 61.8% of respondents from the quantitative component had no idea 
about duration of treatment and 54.5% didn’t know if the treatment was effective. The 
lack of familiarity regarding treatment was also supported by the qualitative study, 
though similar trends were also seen in the non-Armenian counterparts. 
Fears relating to social stigma didn’t seem as apparent in either the quantitative or 
qualitative components of this study; however, very few respondents either had the 
disease or knew of someone who had it. In the quantitative component, 90.9% felt if 
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someone had TB, it could happen to anyone and was not attributable to race or was a 
punishment by God. In the qualitative study, most Armenians would be empathetic to 
those with TB, would be eager to help, and would urge the patient to seek treatment 
immediately; however, the non-Armenian contingent were more trepid, less eager to help, 
and would stay isolated from the patient. The proactive response in Armenians is contrary 
to what was reported by Ige and Lasebikan (2011) where family members of patients 
reported increased depression and helplessness. 
Schneider et al. (2010) explored reasons for delaying TB treatment in patients in 
Armenia where significant factors included weight loss and fatigue, the inability to 
recognize TB symptoms, and referral after the first doctor’s visit. In the qualitative 
component of this study, the majority of Armenian respondents reported that they would 
immediately seek treatment upon receiving a positive diagnosis and would urge close 
family and friends to do the same; however, their inability to recognize symptoms as TB 
or utilize home remedies first may in actuality result in delays in seeking treatment. In the 
quantitative aspect of this study, 61.8% of Armenians identified coughing as the most 
common symptom of TB; however, other characteristics such as bleeding, loss of 
appetite, and fatigue were far less recognizable. Because coughing is a common symptom 
of many diseases and 76.4% also utilize home remedies, individuals may delay 
consulting with a physician for proper diagnosis and treatment. Therefore, the findings by 
Schneider et al. (2010) and this study suggest that enhanced knowledge regarding 
recognizing signs and symptoms of TB, along with improved medical care and staff 
would dramatically improve disease outcomes in the Armenians living in the United 
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States and Armenia. Furthermore, it is evident that the lack of studies relating to TB in 
Armenian populations perpetuates the problem of poor disease outcomes. 
The social ecological model serves as a strong theoretical foundation in social 
epidemiology, particularly for improving infectious disease outcomes, by explaining 
potential causal relationships between disease and social and biological conditions 
(Krieger, 2001) and addressing complex community-based problems relating to health 
disparities (Green et al., 2005; Reifsnider et al., 2005). As depicted in Figure 1, SEM 
addresses four inter-related factors: (a) the individual and risk behaviors (e.g., 
knowledge, attitudes, beliefs); and (b-d) interpersonal relationships, community and 
environment, and societal /cultural norms, such as social interactions, social constructs, 
social structure, and public policy (California Department of Public Health, n.d.; CDC, 
2009b). All levels constructively work together to positively influence change.  
SEM has been widely used in TB studies addressing transmission, treatment and 
prevention, including health disparities, ethnic differences, socioeconomics, immigration, 
and psychosocial factors amongst various populations both nationally and internationally. 
Myers et al. (2006) utilized an ecological approach for exploring TB transmission in 
California by focusing on racial/ethnic distribution, immigration, education level, 
employment status, poverty, and crowding obtained from U.S. Census data and related 
them to new TB cases. Using pediatric cases as a measurement of transmission, it was 
found that pediatric TB cases were elevated in lower median incomes, racial/ethnic 
minorities, and immigrants. While this study explored such factors in an Armenian 
population, the ability to find causation and link them to new TB cases in LA County is 
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difficult and beyond the scope of this study due to the classification of Armenians as 
White/Caucasian for census data. Due to Armenians’ declared willingness to help others 
in the qualitative component as compared to non-Armenians, this would be interesting to 
explore how it may impact population-specific treatment adherence efforts. 
Other groups have utilized SEM to investigate the impact of various ecological 
factors (particularly poverty, SES, knowledge, and ethnic differences) on TB treatment 
adherence in a variety of populations in the United States and abroad (Barr et al., 2001; 
Harling et al., 2008; Hawker et al., 1999; Holtgrave & Crosby, 2004; Marx et al., 2007; 
Tupasi et al., 2016). Murray et al. (2011) incorporated mathematical modeling with SEM 
to further explore the dynamics associated with social, environmental and biological 
determinants of TB in an effort to improve intervention strategies. Here, associations 
between TB infection and smoking, indoor air pollution, alcohol use, diabetes, nutrition, 
crowding, migration, aging, and economic trends were projected. Tupasi et al.’s study 
conducted in the Philippines (2016) further supports some of these findings where 
alcohol abuse was a significant limiting factor in MDR-TB treatment adherence. 
However, none of these studies explicitly discuss any such factors in relation to an 
Armenian population living either in the U.S. or in their native country. Findings from 
this study reveal there are some significant differences in knowledge and compliance in 
Armenian versus non-Armenian participants and therefore population-specific education 
and treatment efforts may improve disease outcomes. 
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Limitations of the Study 
One limitation of the study was the population size surveyed for the quantitative 
component. Prior to launching the online survey, an a priori power analysis was 
conducted based on an effect size of 0.363, derived from relevant literature. From this, it 
was estimated that 100 Armenians and 100 non-Armenians be surveyed to achieve 
significant power. After eight months of purposive recruiting, 55 Armenians and 72 non-
Armenians were enrolled and completed the survey. An additional three were eliminated 
for living outside LA County and 14 more were lost to attrition and incomplete surveys, 
most of which were Armenians who failed to respond to any questions relating to TB. 
Challenges with recruiting were likely due to the vastness of LA County and difficulties 
penetrating the Armenian community, despite providing all recruitment and survey 
materials in Armenian. To address this limitation, a post-hoc power analysis using G* 
Power 3 calculator software (version 3.1.4) and logistic regression test (α = 0.05, OR = 
0.347 for “TB route of Transmission” as dependent variable with the weakest significant 
p value, 0.05), was conducted and a satisfactory power analysis > 0.90 was attained.  
Another limitation relates to instrumentation. An original survey and 
questionnaire was generated to ensure cultural sensitivity and relevance to the Armenian 
community. This presents some challenges because, as an original questionnaire, 
assurances regarding its validity and cohesiveness may be lacking. Both were made 
available in English and Armenian, with accuracy of translations for the Armenian 
versions verified by an outside native Armenian speaker. A pilot study of the online 
survey was performed to ensure questionnaire appeal, ease of comprehension, and 
139 
 
 
comfort level within the online environment. The online environment for the quantitative 
survey may limit those who participated as a result of electronic access; however, the 
face-to-face nature of qualitative survey helps overcome this limitation. The online 
environment also allowed for participants to conduct searches to answers prior to 
responding, thereby biasing results; whereas the face-to-face interviews eliminate this 
possibility but instead introduces the possibility of recall bias. This was particularly 
evident with discrepant responses relating to TB transmission, where 63.6% of 
respondents from the online survey believed it was through coughing or sneezing, 
whereas the majority in the qualitative study had no idea.  
Another specific limitation linked to instrumentation is data coding that occurred 
post-data collection and pre-data analysis. Despite conducting pilot testing of the online 
questionnaire prior to conducting the survey and checking the coded responses for errors 
externally in SPSS following data collection, unanticipated problems during analysis 
became evident. This is a consequence of the respondent’s potential to make multiple 
selections or fill in responses for certain TB-specific questions, SQs 22, 34, 35, and 37. 
As can be seen in Tables 9, 10, and 12, these key questions had an abundant number of 
response combinations which complicated and convoluted the analysis. It is likely that 
more factors may have been found to be significant when conducting bivariate and 
multivariate analyses if only single answers were allowed and/or these questions were 
broken up into multiple questions.  
A final limitation of this study effects generalizability or transferability which is 
attributed to ethnography. This study not only focuses on a particular population, 
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Armenians, but is even more selective for those living in LA County. LA County houses 
the second largest population of Armenians in the world, aside from Armenia itself (Hayk 
the Ubiquitous Armenian, 2012), it is therefore believed that the study involved a 
representative pool. However, the social and economic factors impacting the study may 
not be generalizable to Armenians living in other parts of the country or world. This is 
evident when comparing demographic characteristics of the Armenian to the non-
Armenian population surveyed (Table 13, Appendix M). If this study is replicated or 
expanded upon, it is recommended that alterations be made to account for population-
specific attributes, such as culture and demographics. 
Recommendations for Future Research and Practice 
This study fills the gap in understanding TB knowledge and barriers to treatment-
seeking and adherence behaviors in an Armenian population living in LA County. 
Although the data are limited, some significant discoveries were found and may therefore 
be useful for implementing public health strategies specific for an Armenian community. 
From both the quantitative and qualitative component of this study, it is evident that the 
majority of Armenians trust their physician’s ability to effectively diagnose and treat 
tuberculosis. Furthermore, upon diagnosis they would seek treatment immediately and 
adhere to the treatment under a physician’s care. Therefore, it is very important to enroll 
physicians and healthcare workers as stakeholders for information dissemination, 
program planning, evaluation, and execution, particularly those practicing in 
communities heavily populated by Armenians. Within this, the physicians and healthcare 
workers will also stress the important of adherence and work with local spiritual leaders 
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to reinforce this message since Armenians are reportedly spiritual individuals and seek 
spiritual guidance along with physician care. 
While physicians will be an important entity of an Armenian TB-specific public 
health program, information dissemination prior to contraction of the disease is also 
paramount so that disease symptoms can be identified earlier and transmission prevented 
within the community. Data from this study suggests that Armenians have varying 
avenues of knowledge relating to the disease from non-Armenians which can be 
leveraged. Armenians stated that television and family and friends were their main source 
of TB knowledge. Furthermore, the qualitative interviews revealed that the majority of 
Armenians listens to, watches, and reads media that are on Armenian stations and in their 
native language. Therefore, public service announcements should be developed in 
Armenian, utilizing culture-specific elements, and disseminated using the aforementioned 
media avenues detailing disease characteristics, transmission risks, and the benefits of 
treatment adherence. Because Armenians also reportedly gain their knowledge from 
family and friends, the dissemination of information gained from Armenian-specific 
media may begin to snowball as more Armenians become informed and spread the 
information to others. Armenians have tight familial bonds and are eager to help each 
other; therefore the potential to spread the disease through inadequate care or incomplete 
treatment can be leveraged through media, and further enforced through physicians and 
local spiritual leaders. 
While this study provides evidence for Armenian-specific public health efforts, 
further research needs to be conducted in Armenian populations living in LA County, 
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other parts of the United States, and worldwide in order to improve generalizability. Due 
to increased access to the population of interest, studies conducted by medical facilities in 
LA County, more specifically in SPA-2, would further enhance the scope and outreach 
touched upon by this study, and would be beneficial in order to expand the knowledge-
base. The expansion of such studies relating to this topic has potential public health 
implications for TB, as well as other infectious diseases. 
The ability to use data from this study and relate them back to TB case reporting 
and incidence in LA County is a hurdle. Current TB case reporting in California is up to 
date due to extensive reporting mandates. LA County is responsible for 30.5% of the 
reported cases in California with 18% of these cases found in Glendale and surrounding 
cities within SPA-2 (County of Los Angeles Public Health, 2015). The City of Glendale, 
has experienced the largest influx of Armenians nation- and world-wide, making it the 
second largest Armenian community on the planet, behind only Yerevan, Armenia While 
the number of TB cases within SPA-2 has not been classified as Armenian or non-
Armenian, the implication that many of these cases are attributed to Armenians is based 
upon their prevalence in the community and disease incidence in their native country. 
Therefore, in order to get a true assessment of TB cases attributed to Armenians, it is 
recommended that a separate racial category for Armenians be included on medical forms 
in the area as was done for the quantitative survey. This may facilitate improving disease 
outcomes in Armenians by incorporating trends revealed by this study. Support for this is 
demonstrated by a study conducted by Myers et al. (2006) which utilized SEM to explore 
TB transmission in California. Using the U.S. Census data for California, ecological 
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variables such as racial/ethnic distribution, immigration, education level, employment 
status, poverty, and crowding were incorporated and related to new TB cases, using 
pediatric cases as a measurement of transmission. Overall, lower median incomes, 
racial/ethnic minorities, and immigrants were found to have higher rates of pediatric 
tuberculosis. 
Finally, for those conducting additional studies it is recommended that the TB-
specific survey questions be simplified so that the respondents cannot select or write in 
multiple responses. This became a limitation when analyzing the data. As evident in 
Tables 9, 10, and 12, the ability to select multiple responses introduced many 
combinations of possible answers, thereby convoluting results and revealing more factors 
of significance, particularly when conducting bivariate and multivariate analyses.  
Implications 
Literature exploring TB is expansive and covers topics relating to disease 
epidemiology, improved diagnostics, hurdles associated with drug resistance, problems 
associated with adherence, and at-risk populations. The latter is more focused on general 
susceptible populations (e.g., HIV positive, the incarcerated, homeless, immigrants, and 
the poor) with little emphasis on specific cultures where family and traditions may have 
profound influences on TB knowledge and treatment seeking and adherence behaviors. 
Armenians are a susceptible population with strong family influences; however very few 
studies have focused on this group living in their native country or those who have 
immigrated to other countries. Therefore, this research fills the gap in understanding 
treatment-seeking barriers in this susceptible population, with potential public health 
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implications for other diseases in addition to TB. Implications for social change involve 
decreasing TB prevalence in the Armenian population within the United States and 
potentially within native Armenia through more effective disease management, resource 
allocation, and patient care efforts.  
The SEM incorporates key principles from community- and individual-based 
approaches of prevention with an emphasis on the environment. Due to the uniqueness of 
this study, it serves to impact TB disease management in the Armenian community 
primarily at the first two or three levels: individual, interpersonal, and community. It can 
serve as a foundation for future studies to eventually lead to customized social public 
policy to effectively influence change in this at risk population. 
Conclusion 
TB is one of the world’s deadliest, yet curable, diseases, with an estimated 6.0 
million new cases and 9.6 million total individuals who fell sick with the disease in 2014, 
5.4 million of which were men, 3.2 million were women and 1.0 million were children. In 
total, there were 1.5 million TB-associated deaths, ranking alongside HIV as the leading 
cause of death worldwide, primarily afflicting those living in low and middle-income 
countries (WHO, 2015). Armenia, in particular, is adversely affected by TB and 
complications associated with the emergence of MDR-, XDR- and TDR-TB strains. The 
WHO has designated Armenia as one of the 18 high priority countries for TB control 
amongst the WHO’s European Region and the top 27 in MDR-TB burden countries in the 
world (Hayrapetyan, 2012). The Armenian population in LA County, where TB 
incidence is higher than national averages (CDC, 2013; County of Los Angeles Public 
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Health, 2015), is the second largest Armenian community in the world, second only to 
Yerevan (Hayk the Ubiquitous Armenian, 2012). Therefore, implications are that many 
of the TB cases are attributed to Armenians living in the region of California.  
Review of the literature and TB incidence and mortality reports suggests that 
Armenians are a highly susceptible population due to high national incidence of MDR-
TB, inadequate health care, poor disease surveillance, poor disease education, poverty, 
and emigration/immigration (Bakalian, 2011; Hayrapetyan, 2012; Truzyan et al., 2015; 
Vink et al., 2005); however, very few epidemiological or prevention studies have been 
dedicated to this group living either in Armenia or the United States. To the best of my 
knowledge, none of the studies conducted focus on Armenians residing in the United 
States where knowledge regarding access to health care, particularly relative to TB, may 
be lacking. Therefore, this study filled the gap in the literature for this underserved, at-
risk population.  
Using a concurrent mixed-methods study including surveys (quantitative) and in-
depth interviews (qualitative), Armenians and non-Armenians living in LA County were 
interviewed to gain a better understanding regarding TB knowledge and barriers to 
treatment. An understanding of differences in physical, psychosocial, cultural, or 
behavioral factors and beliefs may impact TB knowledge, treatment seeking and 
treatment adherence in Armenians living in LA County from non-Armenian populations, 
potentially influencing public health approaches to effectively treating and decreasing TB 
incidence in this population. For the quantitative component of the study, bivariate chi-
square analysis revealed that factors with the greatest significance and strength relate to 
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how the two populations learned about the disease and how compliant with a doctor’s 
instructions participants would be if diagnosed, resulting in an effect size of 0.434. 
Multivariate multinomial logistic regression analysis revealed predictor factors such as 
classification, the use of home remedies, age, education, and English as the primary 
household language to be significant. 
The qualitative component of the study further corroborated many of the findings 
from the quantitative component where, although the populations were aware that TB 
exists, knowledge relating to TB mode of transmission, global incidence, and treatment 
properties (e.g., duration, effectiveness, and specific types) was generally lacking. One 
major reported difference between populations was that the Armenian population was far 
more eager to help others and urge them to seek treatment upon receiving a positive 
diagnosis, whereas non-Armenians express the lack of willingness to physically assist 
patients. This is also counter to a study conducted by Ige and Lasebikan (2011) in a non-
Armenian population where family members of patients reported increased depression 
and helplessness. In this study, the culturally-based inquiry regarding the presence of 
kapoot ach in their residence revealed all of the Armenian participants had at least one. 
Such a trend may be useful when developing TB awareness and treatment programs for 
this at-risk group. 
This study serves as the first step in understanding perceived barriers to TB 
treatment-seeking and treatment adherence in Armenians living in LA County, with the 
goal of positively impacting TB patient outcomes through improved, population-specific 
public health efforts. Implications for positive social change include evidence to inform 
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more effective disease management, resource allocation, and patient care efforts to help 
decrease TB prevalence in the Armenian population within the United States and 
potentially native Armenia. Regardless of location, this will rely on the involvement of 
Armenian stakeholders including physicians and healthcare workers, spiritual leaders, 
and Armenian media sources to disseminate ethnically-sensitive information within the 
community. 
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Appendix B: Qualitative Interview Guide, Armenian translation 
Հիմնական պատմական տեղեկութիւններ — Հայ Մասնակցողներ 
1. Դուք Հայաստանե՞ն գաղթած էք։ 
 ա. Որք՞ան ժամանակէ կ՝ապրիք Ամէրիկայի Միացեալ Նահանգներ։ 
բ. Ներկայիս ո՞րմէկ քաղաքը կ՝ապրիք։ 
2. Հայերեն գրել ու կարդալ գիտէ՞ք։  Որ՞քան լաւ։ 
3. Ձեր տան մէջ հայերէն կը խօսի՞ք։ 
ա. Որ՞քան հաճախ։  
4. Դուք Հայերեն գրականութիւններ կը կարդա՞ք։ Հայկական հեռուստահաղորդումներ կը 
դիտէ՞ք « օրինակ Հայկական Դելեթայմ» կամ հայկական ռատիոժամ մտիկ կ՝ընէ՞ք։ 
ա. Եթէ այո, որ՞մէկը եւ ո՞րքան յաճախ։ 
5. Դուք կը նախընտր՞էք հովանավորել գործի հաստատութիւններ, կամ բնտրել 
մասնագիտական օգնութիուններ «օրինակ, բժշկական սպասարկութիւններ» մասնաւոր 
հայերու համար? 
6. Կը մասնակցի՞ք համայնքային գործունէութեան կամ կազմակէրպութեան «օրինակ։ 
Հայկական Եկեղէցի, Արարատ Տուն, Մասիս Կիլտ» Որ՞մէկը 
7. Ձեր ընտանիքին մէջ կապույտ աչքեր ունեցող կ՞այ 
Ընդհանուր պատմական հարցարան 
1. Ո՞ր Տարին ծնած ես։ 
2. Ի՞նչ է քու ամուսնական վիճակդ։ 
3. Հաճիս նկարագրէ բնակավայրդ։ 
ա. Անձնակ՞ան Է Թէ վարցու։ 
4. Քա՞նի անձ կը բնակի ձեր տան մէջ 
ա. Հաճիս նկարագր՝է հարաբերութիունը, սեռը, իւրաքանչիւրին տարիքը։ 
5. Ին՞չ են ձեր ամենաբարձր ուսման մակարդակը։ 
6. Ին՞չ գործով կ՝զբաղիք։ 
7. Ին՞չքան է ձեր տարեկան եկամուտը «առանձ տուրքի»։ 
8. Բժշկական ապահովագրութիւն ուն՞իք։ 
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9. Տարին քա՞նի անգամ կ՛այցելէք ձեր տեղական բժիշկին։ 
ա. Դուք կը վստահի՞ք ձեր բժիշկին ։  
10. Եթէ դուք կամ ընտանիքի անդամներէն կամ ընկերներէն մէկը ախտորոշել է ոեւէ     մէկ 
տեսակի հիւանդուդութեան, կը դիմ՞էք հոգեւոր առաջնորդութեան? 
11. Եէթէ հիւանդ զգակ, կը նախնտր՞էք տնային միջոցներ օգտագործել, «օրինակ 
 մերսումներ, խոտաբույսեր, բուսական կամ համեմուած թեյեր» Ո՞րմէկը։ 
ա. Եթէ այո՝, կը նախնտր՞էք տնային բուսական միջոցները փռրձել նախքան բժիշկի 
դիմելը։ 
բ. Եթէ նույնիսկ բժիշկի երթաք կը շարունակէ՞ք տնային միջոցները օգտագործել 
միեւնոյն ժամանակ։ 
Թռքախտի «TB» ճշգրիտ հարցեր 
1. Դուք ծանօ՞թ եք Թոքախտի հիւանդութեան։ 
ա. Եթէ այո, ին՞չ գիտէք թոքախտի մասին, եւ ին՞չ միջոցով կը փոխանձուի։ 
բ. Թոքախտը փոխանձ՞իք է։ Նկարագրէ՝։ 
2. Տեղեկացած է՞ք վերջին լուրերը թոքախտի  վերաբերեալ։ 
ա. Ամէրիկայի միեացեալ նահանգներու մէջ։ 
բ. Տարբեր երկիրներու մէջ։ Ո՞րմէկը։ 
3. Բուժել՞ի է Թոքախտի հիւանդութիւնը։ 
ա. Ին՞չ գիտէք բուժումի մասին։ 
բ. Կը կարծէ՞ք մարդիկ հաւատարմութեամբ կը բուժուին թէ ոչ սպառնալիքով։ 
4. Եթէ Թոքախտի մասին նշուի ձեր ընտանիքէն, ընկերներէն, կամ ալ տեղեկութիւններէն 
մէկուն, ին՞չ կ՛ըլլայ ձեր նախնական արձագանքը եւ զգացմունքները հիւանդութեան 
նկատմամբ։ 
5. Ե՞թէ Թոքախտ էք կամ այդ հիւանդութիւնը ունեցա՛ծ էք անցեալին։ ի՞նչ կ՛զգաք։ 
6. Եթ՞է ոեւէ մէկը ձէր ընտանիքի անդամներէն, ընկերներէն  կամ գործնկերներէն մէկը 
թոխախտ ըլլայ, Ի՞նչ պիտի ըլլայ ձեր զգաձմունքնէրը այդ իրադարձութեան նկատմամբ։ 
7. Ձէր ընտանիքէն ոեւէ մէկը Թոքախտի հիւանթութիուն ուն՞ի։ Եթէ այո, ձեր վերաբէրմունքը 
կը փոխ՞ուի անձին հանդէպ։ 
ա. Նկարագրէ՝ ունեցած սգացումներդ անձին հանդէպ իր ախտաճանաչումէն  ետք։ 
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8. Արդե՞օք տեղեակ էք Լոս Անճելոսի մէջ գտնուող Թոքախտանոցներու եւ կամ բուժող 
ծառայութիուններու մասին։ 
ա. Եթէ ոչ, ուրեմըն եթէ տեղեկութիուններ կարելի ըլլան, «թերեվս հայերենով, միայն 
հայերու համար» կ՚ուզէ՞ք հետազոտել կարդալով հիւանդութեան մասին եւ բաժնեկցիլ 
ուրիշներու հետ ձեր գաղութէն ներս։ 
9. Դուք տեղեակ է՞ք ոեւէ համայնքային աջակցութեան խումբերէն որոնք կ՚զբաղուին 
Թոքախտի հիւանդութեան առնջութեամբ? 
ա. Եթէ այո, նկարագրէ՝։ 
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Appendix C: Quantitative Survey, Armenian translation 
Հիմնական տեղեկութիուններ 
1.  Քա՞նի տարեկան էք։ 
ա. 18-20  բ. 21-30  գ. 31-40  դ. 41-50 
ե. 51-60  զ. 61-70  է. 70 եւ աւելի  
2.  Սեռ 
ա. Իգական  բ. Առական 
3.  Ո՞ր ցեղի կը պատկանիս։ 
ա.  ճերմակ, Ոչ-Սպանախոս կամ Լադին բ ճերմակ, Հայեր 
գ.  ճերմակ, Սպանացի կամ Լադին  դ.Սեւ, Աֆրիկեան Ամերիկացի  
ե. Ասիացի  զ.  Ամերիկացի Հնդիկ/Բնիկ Ալասքացի  
է.    Բնիկ Հավայացի կամ խաղաղ Ովկիանոսցի 
ը.    Երկու կամ աւելի ցեղեր, Հայեր թ. Երկու կամ աւելի ցեղեր, Ոչ-Հայեր 
4.  Ին՞չ էք ծագումով 
ա. Ոչ- Սպանացի, Լադին, կամ Սպանացի ծագումով   
բ. Մեքսիքացի, Մեքսիքացի-Ամերիկացի, չիքանօ գ. Բորդորիքացի   
դ. Գուպացի  
ե. Տարբեր Սպանացի, Լադին, կամ Սպանացի ծագումով օրինակ ( Արժանթինցի, 
Գոլոմպիացի, Տոմինիքացի, Սալվատորցի). 
5. Որ երկիրէն էք ծագումով (լեցուցէք խնդրեմ) ____________________ 
6. Քան՞ի տարի է կ՛ապրիք Ամէրիկայի Միացեալ Նահանքները։ 
ա. 1 տարիէն պակաս  բ. 1-5 տարիներ 
գ. 6-10 տարիներ  դ. 11-20 տարիներ 
ե. 20 եւ աւելի տարիներ  
7. ներկայիս որմէ՞կ քաղաքը կ՛ապրիք։ 
 ա. Կլէնտել  բ. Բասատենա/Հարաւային  Բասատենա 
 գ. Պըրպէնք  դ. Սան Ֆէրնանտօ  ե. Սանդա Մոնիքա/ 
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Արեւմտեան Լոս Անճելոս  զ. Տաունի / Մոնթեպէլլօ / Սաութ կէյդ է. 
Ուրիշ_______ 
8. ին՞չ է ձեր ամուսնական կարգավիճակը։ 
 ա. Միայնակ, չ՛ամուսնացած բ. Ամուսնացած գ. Բաժնուած 
 դ. Այրիացած ե. Զատուած, Մեկուսացած   
9. Ձեզմէ զատ քա՞նի հոգի կ՛ապրի ձեր տան մէջ։ 
 ա. 0  բ. 1  գ. 2-4  
 դ. 5-6  ե. 6 եւ աւելի 
10. Նկարագրէ՛ իրենց հարաբերութիւնները ձեր նկատմամբ։ «ընտրել» 
 ա. Ամուսինը  բ. Երեխաները գ. Եղբայր/Քոյր 
 դ. Տարեց ծնողներ կամ մեծ հայր եւ մեծ մայր ե. Ուրիշ___________ 
11. Ձեր ընտանիքին հիմնական լեզուն Անգլեր՞էն է։ 
 ա. Այո   բ. Ոչ 
12. Ուրիշ լեզուներ կը խօսի՞ք ձեր տան մէջ։ 
 ա. Հայերէն բ. Սպաներէն գ. Ոչ      դ.Ուրիշ _________ 
13. Ին՞չ են ձեր ուսման ամենաբարձր կրթութիունը։ 
 ա. Երկրորդական  բ. Քոլէճ  գ. Բակալաւրի աստիճան 
 դ. Միջին Մասնագիտութիուն / Մասնագիտական կրթութիուն 
14. Ին՞չ գործով կ՛զբաղուիք։ 
 ա. Անգործ  բ. Թոշակառու  գ. Պահող   
 դ. Ուսանող  ե. Մասնագիտական «բժիշկ, իրաւաբան, ուսուցիչ» 
 զ. Բանւոր «հմուտ կամ ոչ հմուտ աշխատող» 
15. Որ՞ն է ձեր ընդհանուր տարեկան եկամուտը։   «նախատուրք» 
 ա. 0-$25,000   բ. $25,000-40,000  
 գ. $40,000-60,000  դ. $60,001-80,000 
 ե. $80,001-100,000  զ. $100,000 եւ աւելի 
16. Բժշկական ապահուագրութիւն ունի՞ք։ 
 ա. Այո   բ. Ոչ 
17. Կը վստահի՞ք ձեր առաջնային խնամքի բժիշկին։ 
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 ա. Այո  բ. Ոչ գ. Գաղաբար չունիմ 
18. Եթէ դուք կամ ձեր ընտանիքի անդամներէն եւ ընկերներէն մէկը հիւանդանա, կը դիմէ՞ք 
հոգեւոր առաջնորդութեան։ 
 ա. Այո   բ. Ոչ 
19. Եթէ հիւանդանաք, կը նախնտր՞էք տնային միջոցներ օգտագործել։ Օրինակ «մրսումներ, 
խոտաբույսեր, բուսական կամ համեմուած թէեէր» 
 ա. Այո   բ. Ոչ 
Թոքախտի (TUBERCULOSIS) ճշգրիտ հարցեր 
1. Լսա՞ծ էք Թոքախտի հիւանդութեան մասին։ 
 ա. Այո   բ. Ոչ 
2. Ին՞չպէս լսած էք Թոքախտի մասին։ «ընտրէ» 
 ա. Հեռոստատեսիլ  բ. Համաձանձ  գ. Օրաթերթ 
 դ. Ընտանիքի անդամներէն կամ բարեկամներէն ե. Ուրիշ_________ 
3. Կը հաւատա՞ք որ Թոքախտը ժամանակակից օրուա առողջապահական խնդիր է Ամէրիկայի 
Միացեալ Նահանքներու մէջ։ 
 ա. Այո   բ. Ոչ 
4. Կը հաւատ՞աք որ Թոքախտը ժամանակակից օրուա առողջապահական խնդիր է 
միջազգայինօրէն։ 
 ա. Այո   բ. Ոչ 
5. Ին՞չպէս Թոքախտի հիւանդութիւնը կը փոխանձուի։ 
 ա. Հազալով  բ. Փռնգտալով  գ. Շոշափելով 
 դ. Սերական կապով ե. Կրդութիուն / ջուր կուլ տալով 
 զ. Անհաւասարակշրութիւն տաքի եւ պաղի  է. Չենք գիտեր 
6. Ի՞նչ են Թոքախտի ընդհանուր ախտանիշը։ 
 ա. հազալը  բ. փռնգտալը  գ. Ախորժակի կորուստ 
 դ Յոգնածութիուն ե. Արիւնահոսութիուն զ. Չենք գիտեր  
7. Դուք գիտ՞էք թէ մատչելի բուժումներ կան Թոքախտի հիւանդութիւնը բուժելու։ 
 ա. Այո   բ. Ոչ 
8. Որ՞քան է բուժման տեւողութիւնը։ 
179 
 
 
 ա. 3 օր   բ. 7 օր   գ. Մէկ ամիս 
 դ. 6 ամիսէն աւելի ե. Չենք գիտեր 
9. Թոքախտի բուժման հարիւր տոկոս արդիւնաւ՞էր է։ 
 ա. Այո   բ. Ոչ   գ. Չենք գիտեր 
10. Թոքախտը բուժել՞ի հիւանդութիւն է։ 
 ա. Այո   բ. Ոչ  գ. Չենք գիտեր 
11. Եթէ Թոքախտի մասին խօսուի ընտանիքիդ կամ ընկերներուդ միչեւ եւ կամ ալ լուրերու 
ընթաձքին, ի՞նչ կ՛ըլլայ ձեր նախնական ցուցմունքները եւ զգացումները։ 
 ա. Վախցած  բ. Տեղեկացած  գ. Անտարբեր 
 դ. Անոգնական  
12.  Դուք կամ ոեւէ մէկը ձեր ընտանիքէն ունեցա՞ծ է Թոքախտի ախտաճանաչում։ 
 ա. Այո   բ. Ոչ 
13. եթէ այո, ին՞չ զգացիք։   «ընտրել» 
 ա. Վախցած  բ. Տեղեկացած  գ. Անտարբեր 
 դ. Անօգնական  ե. Ճնշուած 
14. ին՞չ պատճառներ կրնան գործակից ըլլալ Թոքախտի հիւանդութեան հետ։ «ընտրէ» 
 ա. Աղքատութիւն  բ. Արտաքին ծնունդ   
 գ. Միավ կարգավիճակը  դ. Թմրադեղերի պատ պատմութիւն 
 ե. Ցած հասարակական կարգ զ. Սէռական կողմնորոշում 
 է. Հոգեկան հիւանդութիւն  ը. Կրօնք  թ. Ծխել 
 ժ. Տարածուած հիւանդութիւն  ի. Բուժելի հիւանդութիւն 
 լ. Անհաւասարակշրութիւն տաքի եւ պաղի մ. ազատազրկման 
15. Եթէ ոեւէ մէկը Թոքախտի հիւանդութիւն ունի կը կարծէ՞ք թէ «ընտրէ» 
 ա. Ան հաւանաբար սխալ բան մը ըրած է, օրինակ դեղերու օգտագործում 
 բ. Աստուծոյ կողմէն պատիժ 
 գ. Ան հիւանդութիւնը ունի ցեղային հետին պատճառով 
 դ. Կրնայ ոեւէ մէկուն պատահիլ 
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16.  
 Եթէ դուք Թոքախտի 
հիւանդութիւն ունիք, 
Բ
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  1 2 3 4 5 
 Կը վստահի՞ք ձեր բժիշկին՞      
 Բուժման վերաբերեալ կը 
համապատասխանէք 
բժիշկներուն հրահանքներուն 
     
 Կը նախնտրէ՞ք բուժուիլ 
հիւանդանոցէն դուրս, 
անձնական բուժարաննէրու 
 մէջ. Ընտրել վարի 
ցուցակէն։ 
     
17. Եթէ կը նախնտրէք բուժուիլ անձնական բուժարաններու մէջ, ու՞ր կը դիմէք։  Ընտրել 
ցանկացածը «ընտրէ» 
 ա. քայրոբրէքթըր  բ. Աքուփանքչըր  գ. Հոմոբադիք 
 դ. Բժիշկ/սննդաբան ե. Կրօնական/եկեղեցական առաջնորդ 
 զ. Կենցաղային միջոցներ, օրինակ  «դեղաբոյսեր, թեէր, եիւղեր» 
 զ. Ոչ մէկը 
18. Դուք տե՞ղեակ էք Թոքախտի բուժարաններու եւ մատուցուած ծարայութիւններու մասին Լոս 
Անճելոսի շրջանին մէջ։ 
 ա. Այո   բ. Ոչ 
19. Եթէ ոչ, եւ եթէ տեղեկութիւնները մատչելի են, կը նախնտր՞էք աւելի հետազոտել եւ 
 կարդալ այդ հիւանդութեան մասին եւ տեղեկացնել ուրիշներուն ձեր համայնքէն ներս։  
 ա. Այո   բ. Ոչ 
20. Դուք տե՞ղեակ էք հասարակական աջակցութեան խումբերու մասին որ կը զբաղուի այս 
հիւանդութեամբ ձեր համայնքէն ներս։ 
 ա. Այո   բ.  ոչ  
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Appendix D: Informed Consent Form (Qualitative) 
Informed Consent Form 
Title of Project: Differences in treatment seeking and treatment adherence factors for 
tuberculosis in Armenian versus non-Armenian populations of Los Angeles County 
Name of Researcher: Tanya M Ferguson 
You are invited to take part in a research study regarding tuberculosis knowledge and 
perceptions. The researcher is inviting Armenians and non-Armenians who reside in Los 
Angeles County to be in the study. This form is part of a process called “informed 
consent” to allow you to understand this study before deciding whether to take part. 
This study is being conducted by a researcher named Tanya M. Ferguson, who is a 
doctoral student at Walden University.  
Background Information: 
The purpose of this study is to explore current knowledge and perceptions relating to 
tuberculosis, including the required course of treatment for disease cure. 
Procedures: 
If you agree to be in this study, you will be asked to:  
• Participate in an-depth face-to-face interview, roughly 60 minutes in length. 
Interviews will be recorded for accuracy purposes. 
• Your involvement will only require one interview; however, if there any answers 
that require clarification by the researcher, the researcher reserves the right to 
contact you by phone. 
Here are some sample questions: 
1. Are you familiar with the disease, tuberculosis (TB)? 
a. If yes, please describe what you know about it, including modes of 
transmission. 
2. Is TB infectious to others? Please describe. 
3. Is TB a treatable disease? 
a. What do you know about the treatment? 
b. Are any of these factors a deterrent for seeking or adhering to treatment?  
Which ones? 
4. If TB is mentioned by family, friends, or news reports, what are your initial 
reactions and feelings? 
Voluntary Nature of the Study: 
This study is voluntary. Everyone will respect your decision of whether or not you 
choose to be in the study. No one will treat you differently if you decide not to be in the 
study. If you decide to join the study now, you can still change your mind later. You may 
stop at any time.  
Risks and Benefits of Being in the Study: 
Being in this type of study involves some risk of the minor discomforts that can be 
encountered in daily life, such as stress. Being in this study would not pose risk to your 
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safety or wellbeing. However, if you are dealing any kind of problem regarding this 
research please call the toll free, 24-hour hotline of the Centers for Diseases Control and 
Prevention Lifeline at 1-800-273-TALK (1-800-273-8255); TTY: 1-800-799-4TTY 
(4889) to talk to a trained counselor. 
The goal of this study is learn more knowledge and perceptions relating to tuberculosis 
and tuberculosis treatment in Armenian and non-Armenian populations living in LA 
County. Tuberculosis has great public health implications. A better understanding of key 
factors that may serve as barriers will improve patient management and disease 
outcomes. 
Payment: 
As gratitude for your participation, participants will receive a one-time $10 prepaid gift 
card which will be presented at the termination of the interview. 
Privacy: 
Any information you provide will be kept confidential. The researcher will not use your 
personal information for any purposes outside of this research project. Also, the 
researcher will not include your name or anything else that could identify you in the 
study reports. 
Contacts and Questions: 
You may ask any questions you have now. If you have questions later, you may contact 
the researcher via cell phone at xxx-xxx-xxxx or email to xxxxxxxxxxx. If you want to 
talk privately about your rights as a participant, you can call Dr. Leilani Endicott who is 
the Walden University representative and is available to discuss this with you. Her phone 
number is xxx-xxx-xxxx. Walden University’s approval number for this study is 04-24-
14-0230517 and it expires on 04-2015.  
The researcher will provide you with a copy of this signed consent form to keep as a 
record of your participation in the interview. 
Statement of Consent: 
I have read the above information and I feel I understand the study well enough to make a 
decision about my involvement. By signing below, I understand that I am agreeing to the 
terms described above. 
 
 
  
Printed Name of Participant  
Date of consent  
Participant’s Signature  
Researcher’s Signature  
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Appendix E: Informed Consent Form (Qualitative, Armenian translation) 
Տեղեկացուած համաձայնութեան ձեւ 
Վերնագիր Ծրագրի։ Տարբերութիւնները բուժման նպատակին եւ բուժման պահպանման 
գործոնները Թոքախտի հիւանդութեան ընդեմ ոչ հայ բնակչութեան Լոս Անճելոսի  շրջանին. 
Հետազոտողի Անունը։ Դանիա Մ. Ֆըրկըսըն 
Դուք հրաւիրուած էք մասնակցելու հետազոտական ուսումնասիրութեան վերաբերեալ Թոքախտի 
(tuberculosis) գիտելիքներու եւ պատկերացումներու։ 
Հետազոտ Tanya M. Ferguson կը հրաւիրէ բոլոր հայերը եւ ոչ հայերը որոնք կը բնակին Լոս 
Անճելոս քաղաքի մէջ որպէսզի մասնակցին Թոքախտի ուսումնասիրութեան. Այս ձեւը գործընթացքի 
մէկ մասն է որ կը կ՛ոչուի «Տեղեկացուած Համաձայնութիւն» որ թոյլ կ՛ուտայ հասկնալու այս 
ուսումնասիրութեան  նախքան որոշում առնելը մասնակցելու կամ ոչ։ 
Այս ուսումնասիրութիւնը իրականացուած է հետազոտող Դանիա Մ. Ֆըրկըսընի կողմէն 
Տոքթորական գիտական ուսանող Ուալտըն (Walden) համալսարանի մէջ։ 
Ընդհանուր Տեղեկութիւններ 
Նպատակը այս ուսումնասիրութեան հետազոտել ներկայիս գիտելիքներն ու ընկալումը 
վերաբերուած Թոքախտի հիւանդութեան ինչպէս նաեւ անհրաժեշտութեան պարաքային պէտք եղած 
լուծումը։ 
Ընթացքներ 
Եթէ դուք համաձայն էք մասնակցելու այս ուսումնասիրութեան, ձեզմէ պիտի պահանջուի 
• Մասնակցիլ դէմ առ դէմ հարցազրոյցի 60է վայրկեան տեւողութեամբ։ Հարցազրոյցները 
կ՛արձանագրուի ճշտութեան նպատակով։ 
• Ձեր մասնակցութիւնը կը պահանջէ միայն մէկ անգամ հարցազրուցել բայց եթէ ոեւէ հարցում 
պէտք է որ պարզաբանել, հէտազոտողը իրավունք ունի ձեզ հետ հեռախօսով կապ պահել 
յստակացնելու համար։ 
Այստեղ կը գտնէք նման հարցումներ։ 
1. Դուք ծանօթ է՞ք Թոքախտի հիւանդութեան։ 
 ա. Եթէ այո, հաճիս նկարագրէ՝ ինչ որ գիտես անոր մասին ինչպէս նաեւ եղանակի 
 փոխանձման։ 
184 
 
 
2. Թոքախտը փոխանձ՞իկ հիւանդութիւն է։ Բացատրէ։ 
3. Թոքախտը բուժե՞լի հիւանդութիւն է։ 
 ա. Ի՞նչ գիտէք բուժման մասին։ 
 բ. Ոեւէ մէկը կա՞յ այդ գործոններէն որ սպարնալիքով զսպման կը փնտռէն կամ  
 հաւատարմօրէն բուժման? Որ գործոնները։ 
4. Եթէ Թոքախտի մասին նշուի ձեր ընտանիքէն, ընկերներէն, կամ այլ տեղեկութիւններէն, 
ին՞չ կ՛ըլլայ ձեր նախնական արձագանքը եւ զգացումները։ 
Կամաւոր Բնոյթը Ուսումնասիրութեան 
Այս ուսումնասիրութիւնը կամաւոր է։ Իւրաքանչիւրին անձ պիտի յարգէ ձեր որոշումը, եթէ 
մասնակցիք կամ ոչ, տարբեր վարւելակերպ պիտի չ՛ունենաք, իսկ եթէ որոշէք մասնակցիլ նոյնպէս 
կրնաք միշտ փոխել ձեր միտքը եւ չի շարունակել այս ուսումնասիրութեան։ 
Վտանքները եւ Օգուտները Ուսումնասիրութեան Մասնակցելու 
Այս տեսակի ուսումնասիրութեան մասնակցիլը կը վտանգէ յառաջացնելով մանր 
անհանգստութիւններ առօրեայ կեանքէն ներս. Օրինակ ջղային դրութիւններ բայց չի վտանգեր ձեր 
ապահովութիւնը եւ կամ բարեկեցութիւնը։ 
Այսուամէնայնիւ եթէ ոեւէ մէկ հարց կամ խնդիր ունենաք այս հետազոտութեան առնչութեամբ, կը 
խնդրենք հեռաձայնել 24 ժամ ձրի թիւով հիւանդութիւնները վերահսկողութեան եւ 
կենսապահովման կանխարգիլման կեդրոնը, թիւն է 1-800-273-8255, իսկ լսել անկարողներու 
համար թիւն է 1-800-799-4889։ Միշտ պիտի կրնաք խօսիլ մարզուած խորհրդատուի հետ։ 
Այս ուսումնասիրութեան նպատակն է գտնել եւ սորվիլ աւելի շատ գիտելիգներ եւ 
պատկերացումներ Թոքախտի առնջութեամբ եւ անոր բուժմանը հայերու կամ ոչ հայերու գտնուող 
Լոս Անճելոսի շրջանին մէջ։ 
Թոքախտի հիւանդութիւնը (Tuberculosis) ունի մեծ նշանակութիւն եւ առողջապահական 
հետեւանքներ։ Աւելի լաւ հասկնալու ենք հիմնական գործոննէրուն որոնք կը ծարայէն հիւանդին 
խոչնդոտները բարելաւելով ինչպէս նաեւ կարավարման եւ ելք գտնելու հիւանդութեան։ 
Վճարում 
Որպէս երախտագիտութիւն, մասնակցողները մասնակցելու համար կ՛ստանան մէկ անգամ $10 
Ամէրիկեան տոլար իբրեւ նուէր գարդով որ կը տրուի հարցազրոյցը աւարտելէն ետք։ 
Մենութիւն  / Գաղտնութեան պահպանման 
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Ոեւէ մէկ տեղեկութիւն գաղտնի կը պահուին, հետազոտիչը չ՛օգտագործեր ձեր անձնական 
տեղեկութիւնը նպատակէն դուրս. Նաեւ հետազոտողը չի պարունակեր ձեր անունը կամ 
ինքնութիւնը ուսումնասիրութեան հաղորդումներէն։ 
Կապեր եւ հարցումներ 
Եթէ ոեւէ մէկ հարցում ունիք, կրնաք հիմա հարցնել։ Հետաքային եթէ հարցեր ունենաք, կրնաք 
հետազոտին հասնիլ հեռաձայնելով xxxxxxxxxxxxx կամ գրել հետեւեալ հասցէով 
xxxxxxxxxxxxxxxx եթէ ուզէք անձամբ խօսիլ ձեր մասնակցողական իրաւունքի մասին դուք կրնաք 
հեռաձայնել Dr. Leilan Edincott որ ինք Walden համալսարանի ներկայացուցիչն է, եւ միշտ 
պատրաստ է լսել ձեզ։ Իր հերախօսի թիւն է xxxxxxxxxxxxxxxxxxx։ Walden համալսարանի 
ուսումնասիրութեան հաստատումի թիւն է, 04-24-14-0230517 կ՛աւարտի 04-2015 թուին. 
Հետազոտողը ձեզի պիտի տրամադրէ կրկնօրինակ մը ստորագրուած համաձայնութեան ձեւէն ձեր 
մօտ ունենալու և պահպանելու ձեր հարցազրույցի մասնակցութեան բանաձեւը։ 
Համաձայնութեան Հաշուետուութիւն 
Ես կարդացի վերի գրուած տեղեկութիւնները, գիտակցելով պարունակութեան կրնամ որոշում առնել 
իմ ներգրաւածութեանս մասին. Ստորագրելով ստորեւ, ես կը համաձայնիմ պայմաններուն ինչպէս 
որ նկարագրուած է վերի գրութեան մէջ։ 
Տպագիր։ Անունը Մասնակիցի։ 
Թուականը Համաձայնութեան։ 
Մասնակիցի Ստորագրութիւնը։ 
Հետազոտի Ստորագրութիւնը։ 
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Appendix F: Informed Consent Form (Quantitative) 
Informed Consent Form 
Title of Project: Differences in treatment seeking and treatment adherence factors for 
tuberculosis in Armenian versus non-Armenian populations of Los Angeles County 
Name of Researcher: Tanya M Ferguson 
You are invited to take part in a research study regarding tuberculosis knowledge and 
perceptions. The researcher is inviting Armenians and non-Armenians who reside in Los 
Angeles County to be in the study. This form is part of a process called “informed 
consent” to allow you to understand this study before deciding whether to take part. 
This study is being conducted by a researcher named Tanya M. Ferguson, who is a 
doctoral student at Walden University.  
Background Information: 
The purpose of this study is to explore current knowledge and perceptions relating to 
tuberculosis, including the required course of treatment for disease cure. 
Procedures: 
If you agree to be in this study, you will be asked to:  
• Participate in an online survey, roughly 15 to 20 minutes in length. 
Here are some sample questions: 
1. Have you heard of the disease tuberculosis (TB)? A. yes, b. no  
2. How have you heard about TB: 
a. TV, b. Internet, c. family or friends, d. newspaper/magazine e. other 
3. Do you believe that TB is a modern day health problem in the US? a. yes, b. no 
4. Do you believe that TB is a modern day health problem internationally? a. yes,   
b. no 
5. How is TB transmitted? 
a. Coughing, sneezing, b. touching, c. sexual contact, d. food/water ingestion, e. 
don’t know 
Voluntary Nature of the Study: 
This study is voluntary. Everyone will respect your decision of whether or not you 
choose to be in the study. No one will treat you differently if you decide not to be in the 
study. If you decide to join the study now, you can still change your mind later. You may 
stop at any time.  
Risks and Benefits of Being in the Study: 
Being in this type of study involves some risk of the minor discomforts that can be 
encountered in daily life, such as stress. Being in this study would not pose risk to your 
safety or wellbeing. However, if you are dealing any kind of problem regarding this 
research please call the toll free, 24-hour hotline of the Centers for Diseases Control and 
Prevention Lifeline at 1-800-273-TALK (1-800-273-8255); TTY: 1-800-799-4TTY 
(4889) to talk to a trained counselor. 
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The goal of this study is learn more knowledge and perceptions relating to tuberculosis 
and tuberculosis treatment in Armenian and non-Armenian populations living in LA 
County. Tuberculosis has great public health implications. A better understanding of key 
factors that may serve as barriers will improve patient management and disease 
outcomes. 
Payment: None. 
Privacy: 
Any information you provide will be kept confidential. The researcher will not use your 
personal information for any purposes outside of this research project. Also, the 
researcher will not include your name or anything else that could identify you in the 
study reports. 
Contacts and Questions: 
You may ask any questions you have now. If you have questions later, you may contact 
the researcher via cell phone xxx-xxx-xxxx or email to xxxxxxxxxxxx. If you want to 
talk privately about your rights as a participant, you can call Dr. Leilani Endicott who is 
the Walden University representative and is available to discuss this with you. Her phone 
number is xxx-xxx-xxxx. Walden University’s approval number for this study is 04-24-
14-0230517and it expires on 04-2015. 
Please print or save this consent form as a record of your participation in the survey.  
Statement of Consent: 
I have read the above information and I feel I understand the study well enough to make a 
decision about my involvement. By completing the survey, I understand that I am 
agreeing to the terms described above. 
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Appendix G: Informed Consent Form (Quantitative, Armenian Translation) 
Տեղեկացուած Համաձայնութեան ձեւ 
Վերնագիր Ծրագրի։ Տարբերութիւնները բուժման նպատակինեւ բուժման պահպանման Թոքախտի 
հիւանդութեան հայերու մէջ ընդեմ ոչ հայ բնակչութեան Լոս Անճելոսի շրջանին մէջ։ 
Հետազոտի անունը Tanya M. Ferguson 
Դուք հրաւիրուած էք մասնակցելու Թոքախտի (tuberculosis) հետազոտական 
ուսումնասիրութեան վերաբերեալ գիտելիքներու եւ պատկերացումներու։ Հետազոտողը կը հրաւիրէ 
հայերը որոնք կը բնակին Լոս Անճելոսի շրջանին մէջ որպէսզի մասնակցին ուսումնասիրութեան 
հետազոտութեան։ Այս ձեւը մէկ մասն է գործընթացքի որ կը կ՛ոչուի «Տեղեկացուած 
Համաձայնութիւն» որ թոյլ կ՛ուտայ հասկնալու սոյն ուսումնասիրութիւնը նախքան մասնակիցին 
մասնակցելու որոշում առնելը։ 
Այս ուսումնասիրութիւնը իրականացուած է հետազոտ Դանիա Մ. Ֆըրկըսընի (Tanya M. 
Ferguson) կողմէն Բժշկական Գիտական Ուսանող Walden Համալսարանի մէջ։ 
Ընդհանուր Տեղեկութիւններ 
Նպատակը այս ուսումնասիրութեան հետազոտել ներկայիս գիտելիքներն ու ընկալումը 
վերաբերուած Թոքախտի հիւանդութեան ինչպէս նաեւ անհրաժեշտութեան պարաքային պէտք եղած 
բուժումը։ 
Ընթացքներ 
Եթէ դուք համաձայն էք մասնակցելու այս ուսումնասիրութեան, ձեզմէ պիտի պահանչուի  
• Մասնակցիլ համաձանձի  միջոցով։ Հետազոտութիւնը կը տեւէ մօտաւորապէս 15-20 
վայրկեան։ 
Այստեղ կը գտնէք նման հարցումներ  
1. Դուք ծանօթ է՞ք Թոքախտի հիւանդութեան (TB)։  
 ա. Այո   բ. Ոչ 
2. Ին՞չ ձեւով լսած էք Թոքախտի մասին։ 
 ա. Հեռատեսիլ  բ. Համաձանձ գ. Ընտանիք/բարեկամ 
 դ. Օրաթերթ/ամսաթերթ  ե. Ուրիշ 
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3. Կը հաւատ՞աք թէ Թոքախտը ժամանակակից օրուայ առողջապահական խնդիր է Ամէրիկայի 
Միացեալ Նահանքներու մէջ։ 
 ա. Այո   բ. Ոչ 
4. Կը հաւատա՞ք թէ Թոքախտը (TB) ժամանակակից օրուայ առողջապահական խնդիր է 
միջազքայինօրէն։ 
 ա. Այո   բ. Ոչ 
5. Ին՞չպէս Թոքախտը կը փոխանձուի։ 
 ա. Հազալով/փռնգտալով բ. Շոշաբելով  գ. Սեռական կապով
 դ. Կրթութիւն/ջուր կուլ տալով  ե. Չ՛ենք գիտեր 
Կամաւոր Բնոյթը Ուսումնասիրութեան 
Այս ուսումնասիրութիւնը կամաւոր է, իւրաքանչիւր անձ պարտաւոր է յարգել մասնակիցին 
որոշումը, եթէ անձ մը չի մասնակցի այս ուսումնասիրութեան, տարբեր վարմունք պիտի չունենայ 
չի մասնակցելու համար. Իսկ եթէ որոշէք մասնակցիլ, յետաքային եթէ ձեր միտքը փոխէք, կրնաք 
ձեր աշխատանքին վերջ տալ ոեւէ մէկ ժամանակ։ 
Վտանգները եւ օգուտնեէը ուսումնասիրութեան մասնակցելու 
Այս տեսակի ուսումնասիրութեան մասնակցիլը կը վտանգէ յառաջացնելով մանր 
անհանգստութիւններ առօրեայ կեանքէն ներս. Օրինակ ջղային դրութիւններ բայց չի վտանգեր ձեր 
ապահովութիւնը եւ կամ բարեկեցութիւնը։ 
Այսուամէնայնիւ եթէ ոեւէ մէկ հարց կամ խնդիր ունենաք այս հետազոտութեան առնչութեամբ, կը 
խնդրենք հեռաձայնել 24 ժամ ձրի թիւով հիւանդութիւնները վերահսկողութեան եւ 
կենսապահովման կանխարգիլման կեդրոնը, թիւն է 1-800-273-8255, իսկ լսել անկարողներու 
համար թիւն է 1-800-799-4889։ Միշտ պիտի կրնաք խօսիլ մարզուած խորհրդատուի հետ։ 
Այս ուսումնասիրութեան նպատակն է գտնել եւ սորվիլ աւելի շատ գիտելիգներ եւ 
պատկերացումներ Թոքախտի առնջութեամբ եւ անոր բուժմանը հայերու կամ ոչ հայերու գտնուող 
Լոս Անճելոսի շրջանին մէջ։ 
Թոքախտի հիւանդութիւնը (Tuberculosis) ունի մեծ նշանակութիւն եւ առողջապահական 
հետեւանքներ։ Աւելի լաւ հասկնալու ենք հիմնական գործոննէրուն որոնք կը ծարայէն հիւանդին 
խոչնդոտները բարելաւելով ինչպէս նաեւ կարավարման եւ ելք գտնելու հիւանդութեան։ 
Վճառում։ Անվճառ 
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Մենութիւն/Գաղտնութեան պահպանման։ 
Ոեւէ մէկ տեղեկութիւն գաղտնի կը պահուին, հետազոտիչը չ՛օգտագործեր ձեր անձնական 
տեղեկութիւնը նպատակէն դուրս. Նաեւ հետազոտողը չի պարունակեր ձեր անունը կամ 
ինքնութիւնը ուսումնասիրութեան հաղորդումներէն։ 
Կապեր եւ հարցումներ 
Եթէ ոեւէ մէկ հարցում ունիք, կրնաք հիմա հարցնել ։  Հետաքային եթէ հարցեր ունենաք, կրնաք 
հետազոտին հասնիլ հեռաձայնելով xxx-xxx-xxxx կամ գրել հետեւեալ հասցէով 
xxxxxxxxxxxxxxxxxxxx եթէ ուզէք անձամբ խօսիլ ձեր մասնակցողական իրաւունքի մասին դուք 
կրնաք հեռաձայնել Dr. Leilan Edincott որ ինք Walden համալսարանի ներկայացուցիչն է, եւ 
միշտ պատրաստ է լսել ձեզ։ Իր հերախօսի թիւն է xxx-xxx-xxxx Walden համալսարանի 
ուսումնասիրութեան հաստատումի թիւն է, 04-24-14-0230517 կ՛աւարտի 04-2015 թուին.  
Կը խնդրեմ տպել կամ պահպանել այս համաձայնութեան ձեւը որպէս արձանագրութիւն ձեր 
քննաչափութեան մասնակցութեանը։ 
Համաձայնութեան Հաշուետուութիւն 
Ես կարդացի վերի գրուած տեղեկութիւնները, գիտակցելով պարունակութեան կրնամ որոշում առնել 
իմ ներգրաւածութեանս մասին. Ամբողջացնելով համաձանձային յետազոտութիւնը, կը հասկնամ որ 
ես համաձայն եմ վերի նկարագրուած պայմաններուն։ 
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Appendix H: Recruitment Invitation, Quantitative 
 
Wanted: Volunteers to help investigate differences in tuberculosis knowledge and 
perceptions for Armenians and non-Armenians residing in Los Angeles County 
Who is Eligible? 
• Armenians and non-Armenians residing in Los Angeles County 
• At least 18 years of age 
• Read and write English and/or Armenian fluently (an Armenian version will be 
available online) 
You will be asked to:  
• Provide informed consent 
• To participate in an online multiple-choice survey (approx. 15-20 minutes) 
This study is being conducted by Tanya M. Ferguson, a doctoral student in Public Health 
at Walden University. The title of the project is “Differences in treatment seeking and 
treatment adherence factors for tuberculosis in Armenian versus non-Armenian 
populations of Los Angeles County”. All information provided will remain confidential. 
 
If you have any questions, please contact Tanya M. Ferguson at 
xxxxxxxxxxxxxxxxxx. If you are interested in participating, please go 
to xxxxxxxxxxxx or scan here: 
 
Participants 
needed for online 
research study
TB Study2 
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Appendix I: Recruitment Invitation, Qualitative 
 
Wanted: Volunteers to help investigate differences in tuberculosis knowledge and 
perceptions for Armenians and non-Armenians residing in Los Angeles County 
Who is Eligible? 
• Armenians and non-Armenians residing in Los Angeles County 
• At least 18 years of age 
• Read and write English and/or Armenian fluently (a translator will be available) 
You will be asked to:  
• Sign an informed consent form 
• Participate in a face-to-face interview (approx. 1 hour), with a potential for 
follow-up questioning if necessary* 
*Participants will receive a pre-paid $10.00 cash card as compensation immediately following the 
completion of the study. 
This study is being conducted by Tanya M. Ferguson, a doctoral student in Public Health 
at Walden University. The title of the project is “Differences in treatment seeking and 
treatment adherence factors for tuberculosis in Armenian versus non-Armenian 
populations of Los Angeles County”. All information provided will remain confidential. 
If you have any questions or are interested in participating, please 
contact Tanya M. Ferguson at xxxxxxxxxxxxxxxxxx or scan here: 
 
  
Participants 
needed for 
research study
TB Study1 
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Appendix J: Quantitative Recruitment Invitation, Armenian Translation 
Մասնակիցներ պէտք են  
համաձանձային հետազոտական 
ուսումնասիրութեան համար 
 
Կ՛ուզուին. Կամաւորներ օգնելու հետաքննութեան Թոքախտի (Tuberculosis) առնջութեամբ 
գիտելիքներու եւ պատկերացումներու տարբերութիւնները Լոս Անճելոսի մէջ բնակող հայերու եւ 
Լոս Անճելոսի մէջ չի չբնակող հայերու միջեւ։ 
Ո՞վ Իրավունք ունի։ 
• Հայերը եւ ոչ հայերը որոնք կը բնակին Լոս Անճելոս քաղաքի մէջ 
• Անոնք որոնք առնուազն 18 տարեկան են։ 
• Անգլերէն գրել կարդալ գիտնալ եւ կամ շատ լաւ հայերէն (Հայերէն տարբերակ պիտի գտնէք 
համաձանձի միոցով) 
Պիտի խնդրուի ձեզմէ 
• ներկայացնել տեղեկացուած համաձայնութիւնը 
• Մասնակցիր բազմակի ընտրութիւն հետազոտութեան հարցերուն համաձանձի միոցով (մօտաւորապէս 15 
– 20 վայրկեա տեւողութեամբ)։ 
Այս ուսումնասիրութիւնը իրականացուած ա Դանիա Մ. Ֆըրկըսընի (Tanya M. 
Ferguson)-ի Հանրային Առողջապահութեան Գիտութիւններու Թեկնածու 
Ուսանող Walden համալսարանիմէջ։ Ծրագրի Վերնագիրն է « Տարբերութիւնը 
բուժման նպատակին եւ բուժման հաւատարմութեան Թոքախտի (Tuberculosis) 
հիւանդութեան» Լոս Անճելոսի շրջանի մէջ ապրող  Հայ եւ ոչ Հայ բնակչութեան 
միջէւ։ Տրուած բոլոր տեղեկութիւնները կը մնան գաղտնի 
Եթէ ոեւէ մէկ հարցումներ  ունիք, դիմեցէք Դանիա Ֆըրկըսընի Tanya M. 
Ferguson-ին, համաձանձային հասցենէ xxxxxxxxxxxxxxx Եթէ հետաքրքրուած էք, մասնակցելու համար 
դիմեցեք հետեւեալ հասցէին` 
xxxxxxxxxxxxxxxxxxxx Կամ տուեալներու յաջորդաբար ընթերցումով (or scan). 
Թոքախտի 
Ուսումնասիրութիւն2 
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Appendix K: Qualitative Recruitment Invitation, Armenian Translation 
 Մասնակիցներ պէտք 
են հետազոտական 
ուսումնասիրութեան համար 
Կ՛ուզուին. Կամաւորներ օգնելու հետաքննութեան Թոքախտի (Tuberculosis) առնջութեամբ 
գիտելիքներու եւ պատկերացումներու տարբերութիւնները Լոս Անճելոսի մէջ բնակող հայերու եւ 
Լոս Անճելոսի մէջ չի չբնակող հայերու միջեւ։ 
Ո՞վ Իրավունք ունի։ 
• Հայերը եւ ոչ հայերը որոնք կը բնակին Լոս Անճելոս քաղաքի մէջ 
• Անոնք որոնք առնուազն 18 տարեկան են։ 
• Անգլերէն գրել կարդալ գիտնալ եւ կամ շատ լաւ հայերէն գիտնալ (եթէ պէտք է թարգմանողը միշտ ուժի 
մէջ է)։ 
Պիտի խնդրուի ձեզմէ 
• Ստորագրել տեղեկացուած համաձայնութիեան ձեւը 
• Մասնակցիլ դէմ առ դէմ խորին հարցազրոյցի (մօտաւորապէս 1 ժամ) հետ հնարավորութիւն հետագայի 
հարցաքննութեան եթէ անհրաժեշտ է 
• * Մասնակցողները մասնակցելու համար կ՛ստանան մէկ անգամ $10 Ամէրիկեան տոլար իբրեւ նուէր 
գարդով որպէս երախտագիտութիւն որ կը տրուի հարցազրոյցը աւարտելէն ետք։ 
Այս ուսումնասիրութիւնը իրականացուած ա Դանիա Մ. Ֆըրկըսընի (Tanya M. Ferguson)-ի Հանրային 
Առողջապահութեան Գիտութիւններու Թեկնածու Ուսանող Walden համալսարանիմէջ։ Ծրագրի 
Վերնագիրն է « Տարբերութիւնը բուժման նպատակին եւ բուժման 
հաւատարմութեան Թոքախտի (Tuberculosis) հիւանդութեան» Լոս Անճելոսի 
շրջանի մէջ ապրող  Հայ եւ ոչ Հայ բնակչութեան միջէւ։ 
Եթէ ոեւէ մէկ հարցում ունիք կաք հետաքրքրուած էք մասնակցութեան հարցով, 
դիմեցէք Դանիա Ֆըրկըսընի Tanya M. Ferguson-ին հետեւեալ էլէքդրօնային 
գրութիւնով xxxxxxxxxxxxxxxxxxxxxx (or scan) կամ տուեալներու 
յաջորդաբար ընթերցումը  
Թոքախտի 
Ուսումնասիրութիւն1 
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Appendix L: Quantitative Survey Code Book 
Survey 
Q# 
SPSS Variable 
Name 
Variable Values or Explanation 
1 Consent Consent 1 = Yes 
2 = No 
2 Age Age 1 = 18-20 
2 = 21-30 
3 = 31-40 
4 = 41-50 
5= 51-60 
6 = 61-70 
7 = 71+ 
3 Gender Gender 1 = Male 
2 = Female 
4 Race Race 1= White, Non-Hispanic/Latino; 
Caucasian, Non-Latino 
2 = White, Armenian 
3 = White, Hispanic/Latino; 
Caucasian, Latino 
4 = Black, African American 
5 = Asian 
6 = American Indian/Alaska Native 
7 = Native American/Pacific Islander 
8 = 2 or more races, Armenian 
9 = 2 or more races, non-Armenian 
5 Ethnicity Ethnicity 1= Non-Hispanic, Latino, or Spanish 
Origin 
2=Mexican, Mex American, Chicano 
3= Puerto Rican 
4=Cuban 
5= Other Hispanic, Latino, or Spanish 
Origin (e.g., Argentinian, Columbian, 
Salvadoran, Dominican) 
6 Origin Country of Origin Birth Country (fill-in) 
7 YrsUS Years living in US 1 = < 1 year 
2 = 1 to 5 years 
3 = 6-10 years 
4 = 11-20 years 
5 = > 20 years 
8 CityReside Current city 1=Glendale 
2=Pasadena/South Pasadena 
3=Burbank 
(table continues) 
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4=San Fernando 
5=Santa Monica/West LA 
6=Downey/Montebello/S. Gate 
7=Other (fill in) 
9 MaritalStat Marital Status 1=Single, never married 
2=Married 
3=Divorced 
4=Widowed 
5=Separated 
10 PeopleHH # in Household 1=0 
2=1 
3=2-4 
4=5-6 
5= >6 
11 HHRelation Household 
relationship 
1=Spouse/Partner 
2=Child 
3=Sibling 
4=Elderly parents or grandparents 
5=Other (fill-in) 
12 EnglishHHLang English Primary 
Language 
1=Yes 
2=No 
13 OtherHHLang Other spoken 
language in 
household 
1=Armenian 
2=Spanish 
3=None 
4=Other (fill-in) 
14 Education Education Level 1=High School 
2=Some college 
3=Bachelor’s degree 
4=Graduate/Professional Degree 
15 Occupation Occupation 1=Unemployed 
2=Retired 
3=Homemaker 
4=Student 
5=Professional 
6=Manual Laborer 
16 HHincome Annual Household 
income 
1=$0-$25K 
2=$25001-$40k 
3=$40,001-60k 
4=$60,001-$80k 
5=$80,001-$100k 
6= >$100k 
17 HealthIns Have Health 
insurance 
1=Yes 
2=No 
(table continues) 
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18 PCPTrust Trust Primary Care 
Physician 
1=Yes 
2=No 
3= Don’t have one 
19 SpiritGuid Seek Spiritual 
Guidance 
1=Yes 
2=No 
20 HomeRem Use Home 
Remedies 
1=Yes 
2=No 
21 TBHear Heard of TB 1=Yes 
2=No 
22 TBHearSource Source of TB 
knowledge 
1=TV 
2=Internet 
3=Family/Friends 
4=Newspaper/Magazine 
5=Other (fill-in) 
<More than 1 can be selected> 
23 TBHealthProbUS Modern day health 
problem-US? 
1=Yes 
2=No 
24 TBHealthProbInt Modern day health 
problem-
worldwide? 
1=Yes 
2=No 
25 TBTransmit Mode of 
Transmission 
1=Coughing/Sneezing 
2=Touching 
3=Sexual Contact 
4=Food/Water Ingestion 
5=Smoking 
6=Imbalance of hot/cold 
7=Don’t know 
26 TBSymptom Most common 
symptom 
1=Coughing 
2=Sneezing 
3=Loss of Appetite 
4=Tiredness/fatigue 
5=Bleeding 
6=Do not know 
27 TBtreatavail Aware of available 
treatment 
1=Yes 
2=No 
28 TBtreatlength Treatment length 1=3 days 
2=1 week 
3=1 month 
4=> 6 months 
5=Do not know 
29 TBtreateffective Treatment 100% 
effective 
1=Yes 
2=No 
3= Don’t Know 
(table continues) 
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30 TBcurable Curable disease? 1=Yes 
2=No 
3= Don’t Know 
31 TBreactions Initial 
reactions/feelings 
1=Frightened 
2=Informed 
3=Indifferent 
4=Helplessness 
32 TBDx Tb diagnosis 
person/friend/family 
1=Yes 
2=No 
33 TBDxFeel Feelings regarding 
diagnosis 
1=Frightened 
2=Informed 
3=Indifferent 
4=Helpless 
5=Depressed 
<More than 1 can be selected> 
34 TBAssocFactor Factors associated 
with TB 
1=Poverty 
2=Foreign-Born 
3=HIV status 
4=Drug History 
5=Low Social Class 
6=Sexual Orientation 
7=Mental Illness 
8=Religion 
9=Common Disease 
10=Curable Disease 
11=Smoking 
12=Imbalance of Hot/Cold 
13=Incarceration 
<More than 1 can be selected> 
35 TBcausepercept Perceptions 
regarding TB status 
1=Did something wrong 
2=Punishment by God 
3=Disease due to race 
4=It could happen to anyone 
<More than 1 can be selected> 
36A TBWhatifA 3 scenarios 
(strongly agree-
strongly disagree) 
 
A)Trust Doctor 
1=Strongly agree 
2=Agree 
3=No opinion 
4=Disagree 
5=Strongly Disagree 
36B TBWhatifB 3 scenarios 
(strongly agree-
strongly disagree) 
 
1=Strongly agree 
2=Agree 
3=No opinion 
4=Disagree 
(table continues) 
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B)Compliance 5=Strongly Disagree 
36C TBWhatifC 3 scenarios 
(strongly agree-
strongly disagree) 
C)Seek outside 
treatment 
1=Strongly agree 
2=Agree 
3=No opinion 
4=Disagree 
5=Strongly Disagree 
37 TBalttherapyseek Alternate treatment 
sources 
1=Chiropractor 
2=Acupuncturist 
3=Homeopathic Dr/Nutritionist 
4=Religious / church leader 
5=Massage therapist 
6=Home remedy 
7=I wouldn’t 
<More than 1 can be selected> 
38 TBtreatfacilityLA Aware of TB 
facilities LA county  
1=Yes 
2=No 
39 TBfacilityInform Read about TB if 
info provided? 
1=Yes 
2=No 
40 TBSocsupportgrp Aware of 
community social 
support groups? 
1=Yes 
2=No 
Missing values = 999 
  
200 
 
 
Appendix M: Demographics Comparison for Quantitative Survey 
Table 13 
Descriptive Statistics – Demographic Variables for an Armenian and Non-Armenian 
Population Living in Los Angeles County (n = 127) 
 No. of Individuals 
Armenian (%) 
No. of Individuals 
non-Armenian (%) 
Classification 55 (43.3) 72 (56.7) 
Gender 
Male 
Female 
 
22 (40) 
33 (60) 
 
26 (36.1) 
46 (63.9) 
Age 
18-30 
31-40 
41-50 
>50 
 
17 (30.9) 
22 (40) 
7 (12.7) 
9 (16.4) 
 
15 (20.8) 
27 (37.5) 
21 (29.2) 
9 (12.5) 
Race 
White, Non-Hispanic/Latino 
White, Armenian 
White, Hispanic/Latino 
Black, African American 
Asian 
2 or more, Armenian 
2 or more, non-Armenian 
 
6 (10.9) 
37 (67.3) 
0 
0 
0 
12 (21.8) 
0 
 
49 (68.1) 
0 
10 (13.9) 
1 (1.4) 
8 (11.1) 
0 
4 (5.6) 
Ethnicity 
Non-Hispanic, Latino, or Spanish Origin 
Mexican, Mexican American, Chicano 
Cuban 
Other Hispanic, Latino, or Spanish Origin 
(e.g., Argentinian, Columbian, Salvadoran, 
Dominican) 
 
48 (87.3) 
1 (1.8) 
0 
6 (10.9) 
 
61 (84.7) 
8 (11.1) 
1 (1.4) 
2 (2.8) 
Country of Origin 
Armenia 
Canada 
Egypt 
El Salvador 
European Countries 
Hong Kong 
Iran 
Japan 
Lebanon 
 
4 (7.3) 
0 
1 (1.8) 
0 
0 
0 
3 (5.5) 
0 
9 (16.4) 
 
0 
1 (1.4) 
0 
1 (1.4) 
2 (2.8) 
1 (1.4)  
0 
1 (1.4)  
0 
(table continues) 
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Mexico 
Philippines 
Turkey 
United States 
0 
0 
1 (1.8) 
37 (67.3) 
1 (1.4) 
2 (2.8) 
0 
63 (87.5) 
Years in United States 
≤ 20 years 
> 20 years 
 
11 (20) 
44 (80) 
 
3 (4.2) 
69 (95.8) 
City Residing In (LA County) 
Glendale 
Pasadena/South Pasadena 
Burbank 
San Fernando 
Santa Monica/ West Los Angeles 
Downey / Montebello / South Gate 
Other 
Alhambra 
Altadena 
Azusa 
Canoga Park 
Cerritos 
Claremont 
Glendora 
Hollywood 
La Crescenta 
La Habra 
La Verne 
Long Beach 
Los Angeles 
Monrovia 
North East LA 
Northridge 
Norwalk 
Pomona 
Porter Ranch 
Reseda 
San Dimas 
San Gabriel 
Santa Clarita 
Shadow Hills 
South Bay 
Sun Valley 
Sunland 
Tujunga 
 
6 (10.9) 
16 (29.1) 
2 (3.6) 
2 (3.6) 
3 (5.5) 
2 (3.6) 
24 (43.6) 
0 
1 
0 
1 
0 
0 
0 
0 
1 
1 
0 
0 
0 
0 
0 
4 
1 
1 
3 
1 
0 
0 
1 
1 
1 
1 
1 
2 
 
3 (4.2) 
15 (20.8) 
3 (4.2) 
0 
5 (6.9) 
2 (2.8) 
44 (61.1) 
4 
2 
1 
0 
2 
5 
3 
2 
0 
0 
1 
5 
8 
1 
1 
0 
0 
3 
0 
0 
2 
1 
0 
0 
0 
0 
1 
0 
(table continues) 
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Upland 
Venice 
Winnetka 
0 
1 
1 
1 
0 
0 
Marital Status 
Single, never married 
Married 
Divorced 
Widowed 
Separated 
 
23 (41.8) 
30 (54.5) 
1 (1.8) 
0 
1 (1.8) 
 
30 (41.7) 
37 (51.4) 
3 (4.2) 
1 (1.4) 
1 (1.4) 
Number of People in Household (excluding 
self) 
0 
1 
2-4 
5-6 
>6 
 
 
4 (7.3) 
5 (9.1) 
42 (76.4) 
4 (7.3) 
0 
 
 
11 (15.3) 
20 (27.8) 
39 (54.2) 
1 (1.4) 
1 (1.4) 
Household Relation 
Spouse/ Partner 
Spouse/Partner, Child 
Spouse/Partner, Child, Elderly parent/ 
grandparent 
Spouse/Partner, Child, Other 
Spouse/Partner, Elderly parent/ 
grandparent, other 
Spouse/Partner, other 
Child 
Child, Elderly parent/grandparent 
Sibling 
Sibling, Elderly Parent / grandparent 
Elderly Parent / grandparent 
Other 
Friend 
Housemate / Roommate 
Niece 
Whole family 
 
9 (17.6) 
20 (39.2) 
1 (2) 
 
0 
0 
 
1 (2) 
3 (5.9) 
1 (2) 
1 (2) 
9 (17.7)) 
2 (3.9) 
4 (7.9) 
1 
3 
0 
1 
 
28 (45.9) 
19 (31.1) 
0 
 
1 (1.6) 
2 (3.3) 
 
0 
3 (4.9) 
0 
2 (3.3) 
2 (3.3) 
3 (4.9) 
1 (1.6) 
2 
1 
1 
0 
English Primary Spoken Household 
Language 
Yes 
No 
 
 
35 (63.6) 
20 (36.4) 
 
 
71 (98.6) 
1 (1.4) 
Primary Household Language (non-English) 
Armenian 
Spanish 
None 
 
40 (72.7) 
0 
11 (20) 
 
0 
8 (11.1)  
61 (84.7) 
(table continues) 
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Other 
Arabic 
Armenian, Russian 
German 
Korean 
Mandarin 
Russian, Turkish 
Turkish, Arabic 
4 (7.3) 
1 
1 
0 
0 
0 
1 
1 
3 (4.2) 
0 
0 
1 
1 
1 
0 
0 
Educational Level 
High School 
Some College 
Bachelor’s Degree 
Graduate/Professional Degree 
 
7 (12.7) 
14 (25.5) 
15 (27.3) 
19 (34.5) 
 
0 
12 (16.7) 
31 (43.1) 
29 (40.3) 
Occupation 
Unemployed 
Retired 
Homemaker 
Student 
Professional (e.g., lawyer, doctor, teacher) 
Manual Laborer 
 
2 (3.6) 
2 (3.6) 
6 (10.9) 
12 (21.8) 
30 (54.5) 
3 (5.5) 
 
2 (2.8) 
2 (2.8) 
3 (4.2) 
6 (8.4) 
56 (77.8) 
3 (4.2) 
Annual Household Income 
$0-$40,000 
$40,001-$100,000 
>$100,000 
 
13 (23.6) 
17 (30.9) 
25 (45.5) 
 
8 (11.1) 
25 (34.7) 
39 (54.2) 
Health Insurance 
Yes 
No 
 
51 (92.7) 
4 (7.3) 
 
69 (95.8) 
3 (4.2) 
Trust Primary Care Physician 
Yes 
No 
Don’t have one 
 
45 (81.8) 
1 (1.8) 
9 (16.4) 
 
65 (90.3) 
2 (2.8) 
5 (6.9) 
Seek Spiritual Guidance 
Yes 
No 
 
24 (43.6) 
31 (56.4) 
 
13 (18.1) 
59 (81.9) 
Use Home Remedies (herbs, teas, etc) 
Yes 
No 
 
42 (76.4) 
13 (23.6) 
 
42 (58.3) 
30 (41.7)  
 
